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Abstract 
Breast cancer is a leading cause of cancer related mortality globally, and 
epidemiological studies suggest a link between healthy nutrition and cancer 
prevention. Members of the Brassicaceae family, including watercress, have been 
extensively studied for their anti-cancer and anti-genotoxic potential. Watercress has a 
complex phytonutrient profile characterised by high levels of carotenoids, flavonols 
and glucosinolates Extracts of watercress exhibit strong antioxidant capacity in vitro. 
Watercress and its components have been associated with the inhibition of the three 
stages of carcinogenesis: initiation, proliferation and metastasis in in vitro cancer cell 
models. Phenethyl isothiocyanate (PEITC) is a glucosinolate break-down product and 
watercress is the richest dietary source of it. It has received considerable attention for 
its anti-cancer properties and has been tested in a number of clinical trials.  
In this thesis, the effects of crude watercress extract and PEITC on the 
metabolic and phenotypic responses in breast cancer and healthy breast tissue cell 
lines were examined. Radiotherapy is the most common treatment modality for breast 
cancer patients, it functions by killing cancer cells but it simultaneously damages 
healthy tissues. We set out to examine synergistic responses to irradiation and 
watercress/ or PEITC exposures in breast cancer cells and we further investigated 
whether watercress or PEITC can be protective against radiation induced collateral 
damage.  
Watercress and PEITC effectively modulated important cancer cell metabolic 
pathways associated with anti-cancer endpoints such as cell cycle arrest and DNA 
damage. In this thesis, PEITC has been shown to enhance the sensitivity of cancer cells 
to irradiation making the cancer killing process more effective, whereas watercress can 
protect healthy breast cells from radiation induced damage. These observations 
appear to be mediated by the ability of PEITC and other phytochemicals in watercress 
to interact with the antioxidant glutathione. The results obtained from this work 
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1.1 Molecular basis of cancer 
Cancer is often defined as a disease of uncontrolled and abnormal proliferation of cells 
that leads to tumour formation. It is the result of a multistep process involving genetic 
mutations as well as epigenetic changes progressively driving the transformation of 
healthy cells to malignant derivatives. It has been postulated that cancer cells acquire 
a number of gain of function traits during malignant transformation, indicative of the 
high complexity of this disease (Fig. 1.1). The hallmarks include increased proliferative 
activity, evasion of growth suppressors, induction of angiogenesis, activation of 
invasion and metastasis, resistance to cell death and the enabling of replicative 
immortality [1]. Enabling characteristics, which facilitate tumor progression, involve 
inflammation and genomic instability that expedites the acquisition of the 
aforementioned hallmarks. Advances in the field of cancer research over the past 
decade have led to consideration of the importance of previously understudied cancer 
traits for sustaining tumour cells in vivo. Notably the ability of cancer cells to evade 
challenges from the immune system and to reprogram their metabolism to establish 
as tumours [2]. 
1.2 Breast cancer 
Breast cancer is the most common type of cancer amongst women in the United 
Kingdom (UK), with nearly 53,700 new cases in 2013 and a one in eight estimated 
lifetime risk of diagnosis (Cancer Research UK, 2016). The UK 10 year survival rate is 
increasing and the treatment curative is 78% of all women affected by breast cancer. 
The decline in breast cancer associated mortality is likely due to improved drug 
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treatment despite breast cancer incidence rates increasing in recent years. A national 
screening program means that the majority of the breast cancer cases are now 
diagnosed at an early stage.  
 Genetic predisposition has been identified in individuals with mutations in the 
BRCA1, BRCA2, PTEN and TP53 genes but these mutations account for only a small 
percentage of all breast cancers. This suggests that the majority of cases are caused by 
a complex combination of environmental and inherited factors [3]. 
  
Figure 1.1 The established hallmarks of cancer 




1.2.1 Subtypes of breast cancer 
Breast cancer is a multifaceted disease and is characterised by many subtypes with 
different clinical and molecular features that can have different prognostic attributes 
and therapeutic implications. Breast cancer can be invasive or non-invasive. 
Adenocarcinomas are the most common form of invasive breast cancer and can be 
either ductal or lobular accounting for approximately 85% and 15% of invasive 
adenocarcinomas respectively [4] (Fig. 1.2 depicts the structure of a healthy human 
breast). 
 In addition to invasive breast cancer, non-invasive forms can appear with 
ductal carcinoma in situ  (DCIS) which is the most common type, and lobular 
carcinoma in situ (LCIS). LCIS is rare in comparison to DCIS and is considered as an 










Figure 1.2 Anatomy of the normal human breast 
[By Andrewmeyerson (Own work); adapted to add labels [CC BY-SA 3.0, 
(http://creativecommons.org/licenses/by-sa/3.0)], via Wikimedia Commons Andrewmeyerson]  
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1.2.2 Hormone receptors status and their relevance to treatment 
Hormone receptor status is the major biomarker for breast cancer prognosis and 
response to therapy. Oestrogen receptors (ER) are cellular proteins and are activated 
by the lipophilic steroid, oestrogen. Binding of oestrogen to ER results in a variety of 
signalling cascades involved in DNA synthesis, cell division and the formation of 
proteins including the progesterone receptor (PR). Breast cancer is often characterised 
by higher levels of expression of ER and PR compared to healthy tissue and the 
presence of these receptors (referred to as ER+ or PR+) is generally linked with positive 
prognosis and increased rates of successful endocrine therapy. 
Tamoxifen is the primary drug administered to pre-menopausal women with 
an ER positive status. It is a selective oestrogen receptor modulator that acts by 
binding to ER resulting in conformational changes in the protein and antagonistically 
inhibiting transcription of oestrogen responsive genes, eventually halting cell division 
[6]. For ER+ post-menopausal breast cancer patients, aromatase inhibitors are being 
given as adjuvant therapy for the inhibition of oestrogen synthesis. Aromatase 
catalyses the conversion of androgens to oestrogens; its inactivation thereby reduces 
the mitogenic effects of oestrogens. There are three aromatase inhibitors namely 
anastrozole, exemestane and letrozole that are widely used in the clinical setting [7]. 
 Overexpression of the human epidermal growth factor 2 (HER2) is indicative of 
a more aggressive form of breast cancer with poor prognosis and it is found at 
increased levels in 25-30% of all breast cancer cases [8, 9]. Activation of HER2, and of 
other members of the human epidermal growth factor family (HER), by ligands like 
epidermal growth factor, initiates a signal cascade that alters gene expression 
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affecting biological functions related to proliferation and migration. Trastuzumab 
(Herceptin) is used as a treatment for breast cancer patients overexpressing HER2. It is 
involved in the regulation of proliferation and apoptosis; cancer cells treated with 
Herceptin exhibit G1 cell cycle arrest [10, 11].  
Triple negative cancers do not express ER, PR and do not overexpress HER2. 
These types of cancer are exceptionally aggressive, they do not respond to endocrine 
treatment and are correlated with poor prognosis [12]. Chemotherapy is the chosen 
treatment modality in these cases [13].  
1.2.3 Radiotherapy  
Adjuvant radiotherapy is a crucial element for the treatment of breast cancer. It has 
been used for over 50 years and is undeniably a positive intervention recommended 
to a substantial proportion of patients [14] (the process of radiotherapy is depicted in 
Fig. 1.3). Results from the Early Breast Cancer Trialists’ Collaborative Group (EBCTCG) 
study of 45,000 women with breast cancer in 86 randomised trials, suggest that 
radiotherapy following breast conserving surgery reduced the 5 year recurrence rate 
by 15.7% and the 15 year breast cancer mortality by 4.2% [15].  
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Figure 1.3 Linear accelerator delivering high-energy x-rays to the target cancer site.  
Figure adapted from [16]  
 
The goal of radiotherapy is to damage the DNA and kill cancer cells inducing 
cell death. Charged energy particles and photons can induce direct or indirect 
ionisation of the atoms that make up DNA nucleotides. Indirect ionisation stems from 
the radiolysis of water molecules inside the cell, which then results in the rapid 
formation of reactive free radicals, mainly hydroxyl radicals that can in turn induce 
damage to DNA and cellular compartments (Fig. 1.4). Direct ionisation by charged 
particles usually causes double strand DNA breaks but single strand breaks are also a 
common outcome. Double strand breaks cause substantially more genomic instability 
than single strand breaks and are more likely to result in cell death or poor DNA repair. 
Radiotherapy has the potential to induce a broad range of damage to DNA in addition 
to single and double strand breaks, including base pair alterations, destruction of 
sugars and interstrand crosslinks [17]. Radiation sequelae include activation of signal 
transduction pathways for cell cycle arrest, allowing for DNA repair, or in some 
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instances where the damage is too high, for apoptotic machinery to be employed to 
prevent further DNA replication [18]. The susceptibility of breast cancer cells to 
ionising radiation depends to a great extent on the rate of cell proliferation, the total 
dose of radiation, the fractionation plan and on the capacity of these cells to repair 
DNA damage [19].  
Non-cancerous cells are unavoidably affected in the course of radiotherapy 
treatment however healthy cells are better equipped to scavenge the radiation 
induced damage and may have more efficient DNA repair meachinery [20]. Side 
effects of radiotherapy can be divided into acute and late. Acute side effects include 
mainly skin reactions and are extremely common among patients receiving 
radiotherapy [14]. Late side effects include hyperpigmentation, skin fibrosis and 
potential influence on lung and heart tissues. Cardiac damage has been linked to 
radiotherapy during breast cancer, as have radiation induced sarcomas and lung 
cancers, due to the proximity of these tissues to the breast [15, 21]. Fractionation of 
the total radiation dose is therefore employed allowing the healthy cells to recover 
between treatments. The need for radio-protective agents is of paramount importance 
for oncologists especially in cases of radio-resistant tumours where higher doses of 
radiation have to be administered to the patient.  
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Figure 1.4 Direct and indirect DNA damage induced by ionising radiation and the 
consequences on cellular functions 
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1.3 Cancer cell metabolism 
The metabolic activities of cancer cells are dissimilar to those of normal cells. [2]. 
Cancer cells undergo metabolic reprogramming, acquiring distinct metabolic features 
resulting in enhanced or suppressed activity of conventional metabolic pathways. 
Reprogrammed tumour cell metabolism modifies cellular fitness in such a manner that 
presents a selective advantage during the acquisition of malignant properties 
therefore; deregulated cancer metabolism constitutes one of cancer’s established 
hallmarks 
The metabolic phenotype of cancer cells is shaped by a complex combination 
of intrinsic and extrinsic molecular events involving genetic mutations and 
interactions with the microenvironment. Inherently, proliferating cells have to alter 
their metabolism to meet three basic needs: a) rapid generation of ATP to sustain their 
energy status, b) upregulated biosynthesis of macromolecules for biomass increase c) 
strict maintenance of redox status (Fig.1.5) [22]. To support the essential requirements 
for growth and proliferation, cancer cells rewire the metabolism of all major groups of 
macromolecules: carbohydrates, proteins, lipids, and nucleic acids [23]. 
Growth and survival of cancer cells are processes regulated by oncogenic 
signalling pathways, which are activated by the loss of function of tumour suppressor 
genes like p53 or the activation of oncogenes, like PI3K; this can strongly influence cell 
metabolism. Cell signalling modifications influence metabolism in order to maintain 
function through increases in the rate of cell proliferation. Coupled with the genetic 
alterations that modify cancer cell metabolism, metabolic interactions with the 
microenvironment constitute a major determinant of the metabolic phenotype of 
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cancer cells. Interestingly, a range of genetically stable cell lines (fibroblasts, 
endothelial cells and components of the immune system) alter their metabolic 




Figure 1.5 Causal elements shaping the cancer metabolic phenotype 
Genetic alterations control cancer cell metabolism along with signals from the tumour 
microenvironment. The abnormal metabolic phenotype of cancer cells ultimately satisfies the energy 
requirements of the cells in the form of ATP; it maintains their biosynthetic capacity for cell proliferation 
and ensures maintenance of appropriate redox status.  
 
Cancer cells modify the metabolic configuration of the extracellular milieu as a 
result of their enhanced substrate uptake, catabolism and export of metabolites, 
thereby influencing the phenotype of local normal cells. Reciprocally, the 
microenvironment can induce shifts in the metabolism and signalling cascades in the 
cancer cells per se [25]. The abnormal vasculature of tumours in combination with the 
innately altered cancer cell metabolism generates a spatial and temporal 
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heterogeneity in oxygen concentration, pH, as well as the availability of several 
nutrients like glucose and glutamine, which are all essential requirements for tumour 
progression [22]. Solid tumours need to adapt to these stressful and dynamic 
microenvironment features, developing strategies, which feed into the cancer cells’ 
distorted metabolic phenotype by altering cell signalling, transcriptional regulation 
and redox balance contributing to tumour growth and dissemination [26]. 
1.3.1 Glycolysis 
Cell proliferation is a process during which cells have increased requirements for 
nutrients and it also induces shifts in the manner nutrients are utilised to meet cellular 
needs. Non-proliferating cells in differentiated tissues utilise glucose to generate 
acetyl-CoA in the mitochondrial space, which is oxidised in the tricarboxylic acid (TCA) 
cycle under normoxic conditions. The oxidative reactions of the TCA cycle give rise to 
NAD+/NADH and FAD/FADH2 that then fuel the electron transport chain and ATP is 
produced through oxidative phosphorylation. The net energy yield of oxidative 
phosphorylation is 36 ATP molecules. Under insufficient oxygen conditions, 
differentiated cells undergo anaerobic glycolysis, converting glucose to lactate 
yielding two ATP molecules (Fig. 1.6). 
The carbon economy of tumour cells differs significantly from that of 
differentiated cells. Cancer cells reprogram their biochemical pathways to fulfil their 
needs during cancer progression. Carbon is shuttled to the biosynthesis of 
macromolecules like fatty acids, cholesterol, sugars, nucleotides and non-essential 
amino acids [25]. Cancer cells undergo glycolysis even in the presence of oxygen; a 
 30 
process defined as the Warburg effect and is one of the best-studied metabolic 
characteristics in cancer cells [27]. Under adequate oxygen concentrations, tumour 
cells generate ATP via glycolysis, shifting the primary ATP generation from oxidative 
phosphorylation. The majority of glucose is therefore converted to lactate with only a 
minor percentage (~5%) of pyruvate being metabolised in the TCA cycle [28]. ATP 
generation through glycolysis is a fast process compared to oxidative phosphorylation 
but it is far less efficient in terms of ATP yield. Therefore, cancer cells exhibit 
excessively high rates of glycolysis to cover their bioenergetics, biosynthetic and redox 
needs resulting in the high accumulation of lactate (Fig. 1.6).  
The explanation behind the paradoxical switch of rapidly proliferating cells to 
the less efficient glycolysis is still unclear. It is proposed that because the metabolic 
requirements of cancer cells extend beyond ATP, glycolysis presents a biosynthetic 
advantage for these cells through the branching pathways like pentose phosphate 
pathway and one-carbon metabolism running parallel to glycolysis giving rise to a 
high flux of carbon sources [28] (Fig. 1.7)  
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Figure 1.6 Schematic representation of the oxidative and glycolytic metabolic 
phenotypes of differentiated and proliferative tissues respectively.  
In the presence of oxygen, non-proliferating (differentiated) tissues first metabolize glucose to pyruvate 
via glycolysis and then completely oxidize most of that pyruvate in the mitochondria to CO2 during the 
process of oxidative phosphorylation. Because oxygen is required as the final electron acceptor to 
completely oxidize the glucose, oxygen is essential for this process. When oxygen is limiting, cells can 
redirect the pyruvate generated by glycolysis away from mitochondrial oxidative phosphorylation by 
generating lactate (anaerobic glycolysis). This generation of lactate during anaerobic glycolysis allows 
glycolysis to continue (by cycling NADH back to NAD+), but results in minimal ATP production when 
compared with oxidative phosphorylation. Warburg observed that cancer cells tend to convert most 
glucose to lactate regardless of whether oxygen is present (aerobic glycolysis). This property is shared 
by normal proliferative tissues. Mitochondria remain functional and some oxidative phosphorylation 
continues in both cancer cells and normal proliferating cells. Nevertheless, aerobic glycolysis is less 
efficient than oxidative phosphorylation for generating ATP. In proliferating cells, ~10% of the glucose is 
diverted into biosynthetic pathways upstream of pyruvate production. Figure and legend adapted from 
[28] 
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Figure 1.7 Metabolic pathways active in proliferating cells 
Metabolic pathways active in proliferating cells are directly controlled by signalling pathways involving 
known oncogenes and tumor suppressor genes. This schematic shows our current understanding of 
how glycolysis, oxidative phosphorylation, the pentose phosphate pathway, and glutamine metabolism 
are interconnected in proliferating cells. This metabolic wiring allows for both NADPH production and 
acetyl-CoA flux to the cytosol for lipid synthesis. Key steps in these metabolic pathways can be 
influenced by signalling pathways known to be important for cell proliferation. Activation of growth 
factor receptors leads to both tyrosine kinase signalling and PI3K activation. Via AKT, PI3K activation 
stimulates glucose uptake and flux through the early part of glycolysis. Tyrosine kinase signalling 
negatively regulates flux through the late steps of glycolysis, making glycolytic intermediates available 
for macromolecular synthesis as well as supporting NADPH production. Myc drives glutamine 
metabolism, which also supports NADPH production. LKB1/AMPK signalling and p53 decrease 
metabolic flux through glycolysis in response to cell stress. Decreased glycolytic flux in response to 
LKB/AMPK or p53 may be an adaptive response to shut off proliferative metabolism during periods of 
low energy availability or oxidative stress. Tumor suppressors are shown in red, and oncogenes are in 
green. Key metabolic pathways are labeled in purple with white boxes, and the enzymes controlling 
critical steps in these pathways are shown in blue. Some of these enzymes are candidates as novel 









Tumour cells are highly dependent on glutamine for macromolecular biosynthesis as 
well as robust cell proliferation. Glutamine is intracellularly converted to glutamate by 
the action of glutaminase. Glutamate can then be converted to α-ketoglutarate via 
glutamate dehydrogenase and incorporated into the TCA cycle. Through this process 
of anaplerosis, glutamate can serve as a carbon and nitrogen source for the 
production of nonessential amino acids, purines, pyrimidines, nucleotides and lipids 
[25, 29]. The enzyme glutathione cysteine ligase (GCL) can also convert glutamate 
directly to glutathione which is the most significant antioxidant in cells and has a 
major role in the management of cellular redox status [30].  
1.3.3 Fatty acid synthesis 
Biosynthesis and turnover of fatty acids is often increased in tumour cells to meet the 
anabolic requirements of rapidly proliferating cells. Lipids are shuttled towards the 
formation of cellular membranes and signalling molecules. De novo biochemical 
synthesis of fatty acids requires reducing power coming from NADPH as well as acetyl-
CoA, which is the major lipogenic substrate unit. In the process of fatty acid synthesis 
acetyl-CoA comes from citrate formed in the TCA cycle in the mitochondria and is 
converted to acetyl-CoA by the action of ATP citrate lyase (ACLY). In nutrient-scarce 
circumstances (which is usually the case in vivo), cancer cells have higher rates of 
glycolysis. As such, pyruvate is preferentially converted to lactate rather than being 
oxidised in the TCA cycle to provide citrate for fatty acid synthesis via acetyl-CoA. 
Instead extracellular acetate has been shown to be the source of acetyl-CoA for de 
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novo fatty acid synthesis in a variety of hypoxic brain tumours [31-33]. Acetate can 
hence nourish stressed tumour cells.  
1.3.4 Choline metabolism 
Malignant transformation during carcinogenesis is characterised by active choline 
metabolism as observed by increased levels of choline-containing metabolites as well 
as choline breakdown products like phospholipids [34]. Phospholipids such as 
phosphocholine, phosphatidylcholine, along with phosphatidylethanolamine and 
other neutral lipids are the constituents of the lipid bilayer of cellular membranes and 
have a vital role in the maintenance of membrane integrity. Up-regulated choline 
metabolism is central to sustaining cancer cell proliferation and can also be influenced 
by the tumour microenvironment.  Hypoxic conditions as well as low extracellular pH 
have been found to induce shifts in the concentrations of total choline, 
phosphocholine and glycerophosphocholine [35, 36]. Furthermore, oncogenes, 
cytokines and growth factors can affect choline metabolism [34]. Because choline-
containing metabolites are detectable by non-invasive spectroscopic methods, these 
compounds may form a non-invasive biomarker of cell transformation, the stage of 





1.3.5 ROS and cancer 
Reactive oxygen species (ROS) are a natural by-product of cell metabolism and can 
have pleiotropic effects in all aspects of cell survival. The fate of cells relies heavily on 
the levels at which ROS are present (Fig. 1.8). Low abundance of intracellular ROS 
(yellow area) presents a benefit for cell proliferation and successful progression 
through survival pathways as a result of post-translational modifications [38, 39]. 
Conversely, if the levels of ROS become extremely high (pink area in Fig. 1.8) this 
causes detrimental oxidative stress via macromolecular damage, senescence [40] and 
loss of mitochondrial membrane potential leading to apoptosis [41]; a collection of 
events that can have lethal effects on cells. To counter the outcomes of oxidative 
stress, cancer cells increase their antioxidant content (mainly GSH), limiting the 
accumulation of ROS at excessively high levels preventing irreparable damage [42]. 
Naturally, proliferating cells acquire oncogenic mutations, which favour anomalous 
energy metabolism and protein translation leading to aberrantly increased ROS [43]. 
Through further mutations and adjustments, cancer cells tightly orchestrate the 
cycling of ROS and antioxidant production in a manner that permits cell survival and 
maintenance of ROS at moderate quantities (blue area). This remarkable regulation of 
ROS not only protects cancer cells from catastrophic oxidative damage but also 
ensures that they will benefit from ROS driven mutagenic episodes, which favour 
tumour progression.  
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Figure 1.8 Schematic representation of the influence of ROS levels on cell fate. 
 
1.3.6 Glutathione 
Glutathione (GSH) is a tripeptide made of glutamate, cysteine and glycine. It has a 
critical role in cancer through its role as an intracellular ROS scavenger, controlling the 
intracellular redox state.  Many cultured cancer cell lines demonstrate increased 
intracellular GSH concentrations [44]. GSH scavenging of ROS is mediated by 
glutathione peroxidase. Upon donating its exposed sulfhydryl group, GSH becomes 
reactive and reacts with other glutathione molecules forming glutathione disulphide 
(GSSG), the oxidised form of glutathione. The glutathione pool is maintained mainly in 
a reduced state via the action of glutathione reductase (GR), which has a great affinity 
for GSSG. NADPH is the source of reducing equivalents for GSH regeneration from its 
oxidised equivalent and this reaction is catalysed by GR (Fig. 1.9). NADPH is formed 




Figure 1.9 Glutathione ‘recycling’ between its reduced and oxidised state 
1.3.7  Metabolic biomarkers of breast cancer 
Breast cancer tissue metabolomic analyses using primarily HR-MAS NMR have revealed 
important metabolic features of the disease that correlate with in vivo observations. 
The potential biomarkers unveiled thus far appear to be robust, with particular interest 
in the changes in choline metabolism during cancer. The list of potential biomarkers 
from cancer tissue biopsies also includes glycine as a choline breakdown product, 
lactate as a marker of glycolytic metabolism, taurine and several lipids [45-47]. The 
metabolic alterations during breast cancer are highly multifaceted and are interrelated 
with genetics and receptor status. 
Urine and blood are the most commonly used biofluids for diagnostic purposes. 
Review of the available literature revealed potential metabolic signatures in breast 
cancer, however no definitive consensus on potential biomarkers. Possible metabolic 
biomarkers from blood include histidine, proline, phenylalanine, glutamate, 3-
hydroxybutyrate, lactate and lipids [48-50]. Studies examining potential breast cancer 
biomarkers in urine are very limited for conclusive results. 
Studies exploring potential breast cancer biomarkers in breast tissue, serum and 
urine in the last 25 years have been recently reviewed by Gunther UL, 2015 [37] 
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1.4 Watercress  
Watercress (Nasturtium officinale) belongs to the family of Brassicaceae together with 
broccoli, cabbage, mustard and Brussels sprouts. It is a perennial herb, grown in 
aquatic or semi-aquatic conditions originating in Europe but also cultivated in Asia 
and the Americas. Watercress has been known since the first century AD mainly for its 
medicinal purposes besides being consumed as a raw salad crop [51]. While still being 
eaten as a raw vegetable in salads, watercress is becoming increasingly popular in 
cooked foods. The rising interest in healthy diets and the shift towards natural foods in 
the last decade has put watercress under the ‘microscope’ of the nutritional science 
community as well as the health-conscious public. Watercress is a known rich source 
of phytochemicals such as glucosinolates, carotenoids, flavonols, vitamins and 
minerals and recent studies have provided evidence for potential chemopreventive 
properties of watercress [52, 53]  
1.4.1 Phytochemical components of watercress 
1.4.1.1 Glucosinolates  
Glucosinolates are plant secondary metabolites, found predominantly in cruciferous 
vegetables of the Brassicaceae family. They are nitrogen and sulfur-containing 
glycosides - β-thioglycoside, Ν-hydroxysulfates - along with a variable amino acid 
derived R-group. Glucosinolate metabolism is driven by the action of a β-
thioglycosidase enzyme, myrosinase, in glucosinolate containing plants. This enzyme 
is located in a different cellular compartment of the plant to the glucosinolates [54] 
Glucosinolates are stable compounds that exist in the cytoplasm of the plant cell. 
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However, when the plant tissue is damaged such as upon cooking, cutting, 
mastication or digestion, an enzyme-substrate interaction occurs resulting in the 
hydrolysis of the glucosinolates and the formation of a range of bioactive products 
including isothiocyanates, thiocyanates and nitriles (Fig. 1.10) [54]. Table 1.1 
summarises the glucosinolates commonly found in watercress along with their 
respective isothiocyanates. 
The chemical structure and proportion of these breakdown products are 
dependent upon the hydrolysis conditions like temperature and pH, as well as the R-
group nature of the glucosinolate. In humans the conversion of glucosinolates to their 
hydrolysis products can also be driven by the gut microbiota, which possess a low-
level myrosinase activity [55]. The distinctive bitter and pungent taste and aroma of 
cruciferous vegetables is attributed mainly to isothiocyanates generated from 
glucosinolates and it is suggested that this is adapted as a defense mechanism by the 
plants, making them unattractive to predators [56]  
 
Figure 1.10 Glucosinolate hydrolysis via myrosinase reaction  
Figure adapted from [56]  
 
 Table 1.1 Glucosinolate and isoothiocyanate content of watercress. Reported values were obtained from Gill et al.  [57] represent 
mean ± SD from 8 replicates and Rose et al. [58] mean ± SE from 12 replicates. 
   
GLUCOSINOLATE  ISOTHIOCYANATE  








17.98 ± 4.31[57], 
23.7 ± 0.64 [58] 
6-Methylsulfinylhexyl-GLS Glucohesperin 6-Methylsulfinylhexyl-ICT 0.2 ± 0.00[58] 
7-Methylsulfinylheptyl-GLS Glucoibarin 7-Methylsulfinylheptyl-ICT 1.07 ± 0.03 
[57],  
3.9 ± 0.09 [58] 
8-Methylsulfinyloctyl-GLS Glucohirsutin 8-Methylsulfinyloctyl-ICT 0.68 ± 0.15
[57], 
2.1 ± 0.05[58]  
7-Methylthioheptyl-GLS - 7-Methylthioheptyl-ICT 1.8 ± 0.14[58] 
8-Methylthiooctyl-GLS - 8-Methylthiooctyl-ICT 0.8 ± 0.06[58] 
4-Methoxy-3-indolylmethyl-GLS 4-Methoxyglucobrassin 4-Methoxy-3indolylmethyl-ICT 0.79 ± 0.05[57] 
3-Indolylmethyl-GLS Glucobrassicin Indole-3-carbinol* 0.43 ± 0.26[57] 
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1.4.1.2 Isothiocyanates 
Watercress is the source of a number of glucosinolates, which can be further 
hydrolysed to their respective isothiocyanates. Phenethyl isothiocyanate (PEITC) is the 
most abundant isothiocyanate derived from watercress and watercress is the richest 
dietary source of this compound. This isothiocyanate is the result of the myrosinase 
enzymatic conversion of gluconasturtiin. Other naturally occurring isothiocyanates 
include sulforaphane prevalent in broccoli and allyl-isothiocyanate that occurs in 
mustard (Fig. 1.11). 
 
Figure 1.11 Chemical structures of common ITCs 
 
Isothiocyanates are electrophilic compounds with the general chemical 
formula R-N=C=S. Their biological properties are underlined by their highly 
electrophilic central carbon unit [59]. As a result, isothiocyanates can rapidly conjugate 
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with thiol groups like cysteine and lysine via thiocarbamoylation (Fig. 1.12). For this 
reaction the thiol group is converted to a thiolate ion, allowing for the nucleophilic 
attack on the carbon atom. This will break one of the N=C double bonds so that 
nitrogen can attract a hydrogen giving a thiol-isothiocyanate conjugate [60].  
 
Figure 1.12 PEITC thiocarbamoylation reaction 
 
The most abundant intracellular thiol is GSH that also acts as the major 
antioxidant therefore ITCs strongly interact with GSH. ITCs including PEITC passively 
diffuse across the plasma membrane and enter the intracellular space where they bind 
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to glutathione forming an ITC-GSH conjugate, which is then exported outside the cell 
through efflux pumps. Extracellularly, the exported conjugate dissociates releasing a 
free ITC and a GSH molecule. ITCs can then re-enter the cell and conjugate to more 
thiol containing peptides (Fig. 1.13). This process eventually depletes the cell of its 
glutathione content, and results in the accumulation of ITCs intracellularly [61]. 
Glutathione depletion can result in excessively high ROS concentrations that can lead 
to substantial cell damage.  
Figure 1.13 Intracellular accumulation of ITCs 
Isothiocyanates diffuse across the plasma membranes (1) and once located in the intracellular 
space they bind to thiol groups in glutathione (GSH), upon the action of glutathione-S-
transferase (GST) (2). The glutathione-isothiocyanate conjugate is then exported from the cells 
via efflux pumps (3). The conjugate is hydrolysed extracellularly (4) giving rise to a free 
isothiocyanate, which can then re-enter the cell. This cycle results in a rapid accumulation of 
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isothiocyanates and the concurrent depletion of intracellular glutathione, allowing 
isothiocyanates to bind via thiol groups to other proteins (5) via thiocarbamoylation. Figure 
adapted from [61].  
 
1.4.1.2.1 Metabolism of isothiocyanates 
PEITC, and all isothiocyanates, passively diffuse across the plasma membrane into the 
cell where it reversibly conjugates with glutathione forming a glutathione 
dithiocarbamate (Fig. 1.14). The PEITC-GSH conjugate can be expelled from the cells 
by transporters, like multidrug resistance protein 1 (MRP1), and enter the mercapturic 
acid pathway for further metabolism. Extracellularly, the PEITC conjugate undergoes a 
series of enzymatic modifications forming PEITC-cysteine-glycine via the action of γ-
glutamyltransferase (γGTP), followed by cleavage of the glycine residue by 
cycteinglycinase (CG) giving PEITC-cysteine conjugate. This conjugate is then 
transported to the liver where it gets acetylated by Ν-acetyltransferases to mercapturic 
acid namely PEITC-N-acetylcysteine conjugate (PEITC-NAC). Upon acetylation, the 
conjugate is transported to the kidneys and eliminated via urine excretion [62].  
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Figure 1.14 Schematic representation of the mercapturic acid pathway for the 
metabolism of PEITC.  
Following ingestion of watercress gluconasturtiin is hydrolysed to PEITC by the action of 
myrosinase. After diffusion into the cells [1] PEITC conjugates with glutathione via GST action 
forming a glutathione dithiocarbamate conjugate [2]. The PEITC-GSH conjugate can be 
expelled from the cells by MRP1 [3] and enter the mercapturic acid for further metabolism. 
PEITC-GSH conjugate undergoes a series of enzymatic modifications [4-5] resulting in the 
formation of a PEITC-cysteine conjugate, which is transported [6] and metabolised in the liver 
and converted to mercapturic acid [7] (PEITC-NAC conjugate). The PEITC-NAC conjugate goes 
to the kidneys and is excreted in urine. Urinary ITC-NACs serve as a marker of ITCs 
bioavailability. 
Figure adapted from [63] and [62]. 
 
Isothiocyanates are detectable in the urine in their NAC conjugate form and 
recovery of these molecules in urine is therefore commonly used to study the 
bioavailability of isothiocyanates. A study observed that the isothiocyanate-NAC 
conjugates are biologically active and their properties are similar to that of the parent 
compounds, possibly prolonging the effects of isothiocyanates at the systemic level 
[64]. A study examined the urinary excretion of PEITC-NAC following consumption of 
30 g of watercress containing 21.6 mg of gluconasturtiin (equivalent to 7.6 mg of 
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PEITC), of which 30-67% was recovered as PEITC-NAC in urine [65]. The concentration 
of PEITC-NAC in the urine peaked between 2-4 hours and was not present in the urine 
by 24 hours, indicating rapid metabolic clearance of PEITC.  
It is important to highlight the role of GST in isothiocyanate metabolism and 
effective chemoprevention by isothiocyanates overall. Some epidemiological data 
suggest that the anticancer properties of isothiocyanates are greater in individuals 
bearing GSTM1 or GTT1 null-null genotypes compared to those with a positive GSTM1 
or GTT1 genotype due to the impaired metabolism of isothiocyanates in these 
individuals [66]. However some studies noted a greater risk reduction in individuals 
with the most active or expressed genotypes [67, 68]. Loss of GST enzymatic activity 
would result in a limited conjugation of isothiocyanates to glutathione and 
subsequent elimination from the cells, extending their presence in the system possibly 
enhancing their protective effects in vivo. Some evidence supports this hypothesis 
[69], however in a study where volunteers consumed 200 ml of watercress juice no 
effect of GSTT1 or GSTM1 status was observed on isothiocyanate conjugates excretion 
[70].  
1.4.1.3 Watercress polyphenols 
Flavonoids are a diverse group of polyphenolic compounds, ubiquitously found in the 
plant kingdom mainly as glycosides. Watercress contains molecules from the flavone 
and flavonol subgroups (Table 2) as well as other phenolics, hydroxycinnamic acid 
derivatives, in high concentrations [52]. Flavonoids have received intense interest due 
to their potential favourable effects on human health. They can act as direct 
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antioxidants in vitro [71, 72] and indirectly through the stimulation of detoxification 
enzymes like the cytochrome P450. Flavonoids also inhibit tumor proliferation and 
induce apoptosis [73]. Collectively, these actions may be associated with a decreased 
risk of cancer, cardiovascular disease and chronic inflammation [74] 
 
Table 1.2 Flavonoid content of watercress. Data obtained from the USDA Nutrient 
Data Laboratory [75]. Data represent mean ± SE of nutrient values reported in different 
studies.  
Flavonoids mg/100g FW 
Flavones  
Apigenin 0.0 ± 0.00 
Luteolin 0.0 ± 0.01 
Flavonols  
Kaempferol 23.0 ± 3.66 
Myricetin 0.2 ± 0.05 
Quercetin 30.0 ± 6.74 
 
1.4.1.4  Carotenoids  
Carotenoids are isoprenoid, lipid-soluble pigments found in the chloroplasts of 
photosynthetic organisms. This class of phytochemicals can be divided into two main 
groups: the oxygenated xanthophylls like lutein and zeaxanthin, and the carotenes 
that are un-oxygenated like α-carotene and β-carotene. Numerous health benefits are 
attributed to dietary carotenoids, including antioxidant and anti-carcinogenic 
activities [76]. Watercress is an exceptional source of carotenoids with concentrations 
ranging from 2.5 to 5.9 mg β-carotene/100g fresh weight (FW) and 5.77 to 10.71 mg 
lutein/100 g FW [75, 77]. Gill et al. [57] have shown that adults who consumed 85 g of 
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raw watercress for eight weeks had significantly higher concentrations of lutein and β-
carotene in their plasma. This is likely related to the concurrent reduction in markers of 
DNA damage in their lymphocytes. This may be attributed to the antioxidant effect of 
carotenoids in combination with other health promoting compounds in watercress. 
1.5 Anti-cancer potential of PEITC 
1.5.1 Chemopreventive agent 
Phase I (Cytochrome P450 (CYP)) drug metabolising enzymes (DMEs) activate dietary 
pro-carcinogens through oxidation, reduction or hydrolysis creating electrophilic 
intermediates which may form adducts in DNA [78]. 
PEITC has been shown to have a dual effect on the expression and activity of DMEs. In 
primary hepatocytes PEITC induced up-regulation of the expression of CYP1A1 and 
CYP1A2, both of which are carcinogen-activating enzymes [79]. However, in 
baculovirus-infected insect cells carrying human CYP isoforms, PEITC was found to 
completely inhibit a range of CYPs including CYP1A2 [80]. Further studies support the 
notion that PEITC can be a potent inhibitor of phase I CYPs including CYP2E1, CYP3A4 
and CYP2A3 [81-83]. 
Data from human and rodent studies provide evidence for the inhibition of 
carcinogen-induced carcinogenesis by PEITC. In a recent phase II clinical trial 
conducted by Yuan et al. [84] eighty-two smokers, smoking only deuterated NNK 
cigarettes for the duration of the study, were randomly assigned to a placebo and a 
PEITC receiving group. The metabolic activation of NNK, a nicotine-derived potent 
lung carcinogen, was significantly reduced by PEITC treatment as measured by the 
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urinary excretion of NNK metabolites. It is worth noting that the effect was stronger in 
subjects with the null genotype of both the GSTM1 and the GSTT1 polymorphisms, as 
well as in women. Similar results were obtained from earlier rodent studies where NNK 
treated animals receiving a diet rich in PEITC developed significantly fewer lung 
tumours than those without the PEITC intervention [85]. Further to this, pre-treatment 
of mice with PEITC for a week followed by NNK administration, resulted in increased 
urinary excretion of NNK derivatives in comparison to the non-PEITC treated animals 
and correlated with a reduced tumour burden [86]. The chemopreventive effects of 
PEITC are therefore suggested to be a result of its potential to modulate the activity of 
phase I and phase II DMEs. 
Phase II enzymes constitute a protective mechanism of the cells through their 
role as detoxifying agents of reactive phase I metabolites. They conjugate compounds 
with large polar molecules like glutathione, glucuronide or sulfate limiting the 
biotransformation of damaging carcinogens and facilitating their elimination through 
the urine or bile [87]. Isothiocyanates including PEITC can induce the expression of 
phase II DMEs with known chemopreventive properties such as glutathione S-
transferase (GST), NAD(P)H:quinone oxoreductase 1 (NQO1) and UDP-
glucuronosyltransferase (UGT) [88].  
A number of studies have demonstrated the potential of PEITC to induce the 
activity of phase II enzymes. PEITC treatment significantly increased the induction of 
GST isoenzymes in a murine liver [89] and along similar lines hepatic activity of GST 
was stimulated by PEITC administration in rats but with no effect in the lungs or 
kidneys [90]. Treatment of human liver biopsies with increasing concentrations of 
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PEITC showed a varied response in the induction of phase II enzymes characterised by 
inter-individual and inter-enzyme variation [91].  
1.5.2 Cell proliferation 
Cancer cells are characterised by up-regulated pro-proliferative signals in order to 
generate new cells, expand in size and establish as tumours. Activation of the Ras 
family of proteins is vital to sustain proliferation and PEITC has been shown to inhibit 
several components of the Ras family including the Akt (protein kinase B). Akt has a 
central role in apoptosis and cell proliferation and it is overactive in many types of 
cancers. PEITC has been shown to inhibit its activity in a number of models including 
breast cancer [92-95]. It has been suggested that this is mediated through inhibition of 
the epidermal growth factor receptor (EGFR) and of HER2; both of which are 
significant regulators of Akt [93, 96, 97].  
1.5.3 Cell cycle arrest 
Cell cycle progression involves a series of processes, which direct dividing and 
proliferating cells through the G, S, G2 and M phases. It is mediated by the activation 
of cyclin dependent kinases (Cdk) and their associated cyclins and PEITC can modulate 
cell cycle and inhibit proliferation of cancer cells by targeting this complex [98].  
PEITC has been shown to induce cell cycle arrest at the G1/S phase, the growth 
and proliferation phase. The G1 checkpoint is the point of assessment of adequate 
nutrients and growth factors and detection of DNA damage levels. If a cell carries 
substantial amount of damaged DNA this signals the delay or arrest of the cell cycle in 
G1 repressing the transition to the subsequent phases. In the case of cancer, the cell 
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cycle process is deregulated resulting in different growth characteristics in these cells, 
and ultimately uncontrolled cell proliferation.  
In HT-29 colon cancer cells, PEITC induced G1 cell cycle arrest by down-
regulating cyclin A, D and E [99]. PEITC has also been shown to inhibit the growth of 
oral squamous carcinoma HSC-3 cells through G1/S cell cycle arrest mediated by 
reductions in the levels of Cdk2, Cdk6 and their associated cyclins with concomitant 
increases in the expression of protein levels of cyclin-dependent kinase inhibitors p15, 
p53, p27 and p21 [100]. Arrest in the S phase of the cell cycle has also been observed, 
upon PEITC treatment in sarcoma cells and this observation was associated with a 
reduction in protein levels of cyclin A, the S phase cyclin regulator [101]. PEITC-
induced cell cycle arrest in the G2/M phase is related to the down-regulation of Cdk1, 
cyclin B1 and the cell division cycle 25C (Cdc5C) [102, 103]. Cdk1 forms complexes with 
cyclin B. Subsequently; Cdc25C targets this complex for dephosphorylation of Cdk1 
promoting its activation, which is necessary for transition into mitosis (M phase). Cell 
cycle arrest by PEITC is the result of a decrease of the levels of Cdk1 or cyclin B or by 
inhibition of Cdk1 phosphorylation [102].  
1.5.4 Tumour Metastasis 
Healthy cells, once they have specialised and differentiated do not migrate to other 
tissues and remain in the organ or tissues they have specialised for. In cancer, cells 
reverse from their differentiated state and behave like pluripotent cells, invading 
blood circulation and metastasise to secondary organs from their original primary 
location, resulting in extensive spread of cancer. Cancer invasion and metastasis is 
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associated with a much poorer prognosis and increased mortality. Development of 
anti-invasive and anti-metastatic therapies is therefore an important target of cancer 
research. A number of studies have shown that PEITC can significantly suppress 
invasion and negatively influence metastasis. This activity was related to the 
attenuation of the protein and mRNA expression of matrix metalloproteinases that are 
known to promote cell migration, invasion and proliferation [103-105]. Interestingly, 
Gupta et al. [96] have demonstrated the anti-metastatic potential of PEITC in vivo in a 
breast cancer metastasis mouse model. In this model, MDA-MB-231 brain seeking 
breast cancer cells were injected into the left ventricle of the heart of female mice and 
a part of these cells migrated to the brain through blood circulation and established as 
metastatic tumours [96]. Oral administration of the mice with 10 μΜ of PEITC 
significantly prevented the migration of the breast cancer cells to the brain of these 
animals. Additionally, in a secondary experiment PEITC administration following 
tumour cell implantation, limited the growth of the metastasized tumours in the brain 
area and also prolonged the survival of the mice with cancer [96].  
1.5.5 Angiogenesis 
A recognised mechanism by which PEITC inhibits growth and survival of established 
cancer cells is through the inhibition of angiogenesis. This is a hallmark in the process 
of tumour progression during which new blood vessels are formed from existing 
vasculature to meet the increasing demands of cancer cells for nutrients and oxygen 
[61]. A study explored the impact of PEITC on a specific pathway central to 
angiogenesis by exposing human MCF-7 breast cancer cells to PEITC and measuring 
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hypoxia-inducible factor 1α (HIF-1α) signalling activity [106]. HIF-1α stimulates the 
expression of the vascular endothelial growth factor (VEGF), a master regulator of 
angiogenesis. PEITC was shown to be an effective inhibitor of HIF-1α protein 
expression, which is stably expressed in hypoxic conditions, contributing to the anti-
angiogenic properties of ITCs. To further substantiate the data obtained from this 
study Alwi et al.  [107] demonstrated that, similar to PEITC, crude watercress extracts 
inhibited cancer cell growth and HIF activity in vitro. Furthermore, 6 to 8 hours after 
dietary intake of 80 g watercress by four healthy human volunteers, peripheral blood 
cells exhibited significantly attenuated HIF signalling activity, suggesting that dietary 
intake of watercress may be sufficient to modulate potential anti-cancer pathways 
[107]  
1.5.6 Apoptosis 
Apoptosis is a critical process to ensure clearance of non-functional, damaged or aged 
cells. Cells undergo apoptosis when proliferation can no longer be controlled by the 
cell cycle checkpoints. Defects in the apoptotic pathway can lead to cancer formation, 
and pro-apoptotic therapies present attractive targets in cancer research.  
 PEITC induces apoptosis in several cancer cell lines via the intrinsic and 
extrinsic pathways [108-112]. Mitochondria are the central organelle mediating signal 
transduction apoptotic pathways and have a major role in the intrinsic apoptosis 
pathway [113, 114]. PEITC is a potent intracellular ROS generator inducing oxidative 
mitochondrial damage [115-117]. These observations are likely to be a result of the 
continuous intracellular conjugation of PEITC with glutathione and subsequent export 
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outside the cell, diminishing the cell of its antioxidant potential leading to increased 
ROS and oxidative damage [118]. Additionally, ROS accumulation as a result of PEITC 
treatment can result in lipid peroxidation of the mitochondrial membrane 
accompanied by loss of the mitochondrial integrity, which triggers the release of 
apoptosis inducing factor (AIF) and of cytochrome c [116]. This leads to caspase 
cleavage and activation that eventually elicits apoptotic events. PEITC treatment 
reduces the levels of the anti-apoptotic proteins Bcl-2 and Bcl-xL, which are 
overexpressed in cancer and can inhibit the activation of the pro-apoptotic Bax 
protein and the release of cytochrome c with an immediate effect on the caspase 
cascade and activation of the apoptosis pathway [100, 112, 119].  
PEITC-mediated apoptosis can also ensue via the extrinsic pathway through its 
interaction with the tumour necrosis factor related apoptosis-inducing ligand (TRAIL) 
and the elevated expression of death receptors, which bind to TRAIL and lead to 
apoptosis exclusively in cancer cells [120, 121]. The predominant apoptosis pathway 
induced by PEITC can vary between different cell types [98].  
1.6 Health implications of watercress consumption 
Research has highlighted a promising chemopreventive role of watercress and its 
components. Boyd et al.  [53] showed inhibition of three stages of carcinogenesis: 
initiation, proliferation and metastasis in HT29 colon cancer cells after incubation with 
watercress extract. In the same study, watercress extract appeared to be protective 
against oxidative DNA damage induced by genotoxic compounds like 4-hydroxy 
nonenal (4-HNE), faecal water and hydrogen peroxide (H2O2). Inhibition of cell cycle 
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progression at the S phase of these cells was also observed as well as suppressed 
invasion of HT115 cells (a highly invasive colon cancer cell line) through matrigel. 
Along similar lines, Kassie et al.  [122] showed that pretreatment of hepatoma Hep G2 
cells with watercress extract, reduced the genotoxic effects of benzo(a)pyrene (B(a)P) 
in DNA damage measurements. In the same study, treatment of the cells with the 
watercress extract significantly increased the activity of drug metabolising enzymes 
GST and CYP1A1. However this effect cannot solely be attributed to the reduction of 
DNA damage, since garden cress in the same study setting also protected against 
B(a)P but had no observable effect of the activity of GST or CYP1A1 [122]. These results 
cannot be attributed to PEITC since it was not detected in the watercress extract by 
LC-MS. Kassie et al. did detect PEITC using gas chromatography, but when it was 
added to Hep 2G cells in similar concentrations as those present in the extract, it was 
not protective against B(a)P induced genotoxicity. It can therefore be suggested that 
phytochemicals present in watercress, other than PEITC, can have chemopreventive 
effects and that this impact is not restricted to modifications to drug metabolizing 
enzymes.  
Evidence was also provided that isothiocyanates other than PEITC possess anti-
genotoxic and anti-carcinogenic properties [58]. The compounds 7-methylthioheptyl-
ICT and 8-methylthiooctyl-ICT were found to be present in watercress at 
concentrations three times lower than PEITC. These components were shown to have 
a much stronger potency for inducing quinone reductase activity in murine hepatoma 
Hepa 1c1c7 cells compared to PEITC, providing further evidence for the ability of 
watercress to induce phase II enzymes. 
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Additional information derived from a study conducted by Gill et al.  [57] during 
which 60 volunteers consumed 85 g of raw watercress for eight weeks; showed a  
decrease in markers of DNA damage in lymphocytes with concomitant increases in 
circulating β-carotene and lutein. Reduced DNA damage was much greater in 
smokers, suggesting that increased smoking-derived ROS led to lower antioxidant 
status and they therefore benefited more from watercress-derived antioxidants than 
non-smoking individuals. The activity of two detoxifying enzymes namely, superoxide 
dismutase (SOD) and glutathione peroxidase (GPX) were analysed in this study, with 
insignificant differences between the control and intervention phase of the study 
providing further evidence that cruciferous vegetables may not exert their 
chemopreventive effects via modulation of SOD and GPX [123]. A minor but significant 
increase was observed in GPX and SOD only in individuals with the GSTM1 null 
phenotype [124]. 
A study by Hecht et al. [125] provides further evidence to support the 
chemopreventative effects of watercress. In this work the consumption of 56.8 g of 
watercress for three days was found to inhibit the metabolic activation of a tobacco-
specific lung carcinogen NNK in a group of smokers. This anti-carcinogenic 
observation was attributed to PEITC activity, due to notable shifts in the urinary 
excretion of PEITC-NAC, which correlated with elevated urinary detoxification 
metabolites that are used as biomarkers of NNK oxidative metabolism.  
On the basis of the evidence currently available, it seems fair to suggest that 
watercress supplementation may further prove useful in the modulation of cancer 
progression and disease recurrence. The metabolic and molecular mechanism behind 
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its potential mechanism of action are not yet fully understood.  
1.7 Epidemiological data for the chemopreventive impact of cruciferous 
vegetables consumption 
Population studies from different geographical locations provide contradicting 
evidence for the inverse relationship between the risk of developing cancer and 
increased dietary intake of cruciferous vegetables. Despite the fact that these studies 
do not provide direct correlation between cancer occurrence and specific ITCs, a 
number of them suggest a correlation between total ITCs intake from dietary sources 
and reduced risk of certain types of cancer. Total ITCs are however an arguable 
measurement as there are numerous variables biasing their calculation such as variety 
of cultivar, growth period, climate and harvest method [63]. Further to this, different 
cooking regimes can have a crucial impact on the ITC content of cruciferous 
vegetables. 
Epidemiological studies in the Netherlands [126], United States [127] and 
across Europe [128] analysed the daily consumption of cruciferous vegetables and 
found insignificant or modest associations with prostate cancer risk. Cohort studies in 
the United States and the Netherlands found no evidence for inverse correlation 
between colorectal cancer and cruciferous vegetable dietary intake [129-131]. In 
contrast, the Netherlands Cohort Study on Diet and Cancer concluded that individuals 
with high intake of cruciferous vegetables (more than 3 servings per day) had a 
reduced risk of colon cancer compared to those with a lower intake [132].  
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 Varying results from epidemiological studies also arise in the case of lung 
cancer [133-135]. The majority of these studies report little or no association between 
lung cancer risk and cruciferous vegetables but one study based on the Nurses’ Health 
Study and the Health Professionals’ Follow up Study suggested that women 
consuming over four portions of cruciferous vegetables weekly had a lower risk of 
developing lung cancer (relative risk = 0.74, 95% CI = 0.68-1.20) [136].  
Regarding breast cancer, a meta-analysis carried out from 17 studies (14 case-
control and 3 cohort studies) evaluating breast cancer risk in association with 
vegetables intake, suggested that consumption can reduce 25% of the breast cancer 
risk (relative risk = 0.75, 95% CI = 0.66-0.85) [137]. However, a meta-analysis of seven 
large prospective studies performed in the United States, Canada, Sweden and the 
Netherlands did not show any association [138]. Total intake of cruciferous vegetables 
was not significantly associated with reduced risk of breast cancer in pre or post 
menopausal women irrespective of a monthly serving exceeding 1000 g with odds 
ratios of 0.7 (95% CI = 0.5-1.2) and 0.8 (95% CI = 0.6-1.2) respectively [139]. 
Interestingly, examination of a cohort of breast cancer survivors showed reduced 
cancer recurrence correlating with dietary cruciferous vegetables intake [140]. 
This heterogeneous body of evidence can be a result of a number of 
confounding factors in the studies like the differences in the subject population, 
duration of cruciferous vegetables dietary intake, age of the subjects as well as 
differences in the isothiocyanate content of the reported vegetables. It is also 
important to note that people’s food and lifestyle habits have significanltly changed 
over the past decade a factor which can have a major effect on the outcomes of 
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studies with wider durations. Epidemiological studies can also be confounded by the 
participants’ reporting bias.  
Consequently, based on the current epidemiological data and the lack of long term 
chronic human clinical trials in the literature, no definitive conclusions can be drawn 
about the effective protection of cruciferous vegetables and cancer risk  
  
 1.8 Thesis framework  
On the basis of the reviewed literature herein it is apparent that watercress and PEITC 
potentially modulate a range of factors implicated in cancer onset and progression and are 
influential in the efficacy of cancer treatment. Characterising the biochemical effects of 
watercress components and PEITC on cellular energetics is key to understanding the 
mechanisms through which they exert their beneficial effects. As such, a central aim of this 
thesis is to define the metabolic impact of watercress and PEITC exposures on breast cancer 
and healthy cells lines. 
Further we aim is to assess the potential of watercress and PEITC to act as 
radiosensitising or radioprotective agents in breast tumour or normal cells respectively. The 
relevance of the obtained data will be evaluated in a human clinical trial involving breast 
cancer patients consuming watercress during radiotherapy.  
1.8.1 Aims 
1. Investigate the impact of watercress and PEITC on the metabolome of breast cancer 
and healthy breast cells 
2. Evaluate the interactions between watercress or PEITC with ionising radiation on 
markers of cellular function and metabolism of breast cancer and healthy breast cells 
3. Examine the effects of domestic cooking methods on the phytochemical profile of 
watercress and formulate recommendations for optimal preparation to maximise 
nutrient ingestion  
4. Assess the metabonomic impact of watercress consumption during radiotherapy 








2 Metabonomics and Chemometrics  
 Metabonomics 2.1
Metabonomics is a term first coined in 1999 and is defined as ‘the quantitative measurement 
of the dynamic multiparametric metabolic response of living systems to pathophysiological 
stimuli or genetic modification’ [141]. Metabolic profiling is facilitated by analytical platforms 
like NMR spectroscopy and mass spectrometry (MS) and aims at the coverage of the complete 
spectrum of metabolites, the metabolome, in a given biological sample. This collection of 
metabolites serves as a direct snapshot of the biochemical activity in a system [142] and 
provides information on physiological status and perturbations arising from exogenous 
stimuli like diet and the gut microbiome [143]. Metabolic profiling approaches are versatile in 
that they can be applied in several biological matrices such as urine, plasma, homogenised or 
intact tissues and cells [144, 145]. Metabonomics is a top-down ‘systems level’, dynamic 
approach and it is being used as an increasingly popular tool in the fields of medicine for 
diagnostic [146] and prognostic [147] purposes as well as in nutritional sciences [148] and 
toxicology [149].  
Metabonomic data are interpreted and latent information is extracted using 
multivariate statistical analysis. Statistical interpretation is naturally followed by biological 
interpretation, which often generates new hypotheses for exploration.  A metabolic change 
can be probed by further experiments to assess its validity as a functional biomarker.  
Validation of biomarkers with diagnostic value is of paramount importance, and it is often 
performed in an independent cohort of experimental samples to establish the biological basis 
of a molecule that serves as a potential biomarker. 
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Integration of metabonomic data with ‘omic’ data derived from other platforms or data from 
large-scale consortia projects, can provide a richer and more comprehensive understanding 
of complex diseases by exploring the interactions between genetic, metabolic and other 
physiological shifts in a system.  
 1H Nuclear magnetic resonance (NMR) spectroscopy  2.2
1H NMR spectroscopy is an analytical method facilitating the profiling of a vast array of low 
molecular weight compounds (<1000 Daltons), in bio-fluids, tissues and cells [145]. This 
technique benefits from high reproducibility and simple sample preparation as well as short 
experiment times. NMR-based metabolic profiling is an invaluable tool in the field of 
metabonomics capturing and delivering highly informative snapshots regarding the 
metabolic state of the sample under study.  
2.2.1 The NMR Spectrometer 
An NMR spectrometer is comprised of a superconducting magnet, made of coils of 
superconducting wire, which is cooled using liquid helium to temperatures very close to 
absolute zero, to enable a strong magnetic field. A central component of the NMR 
instrumentation is the probe, which accommodates the NMR sample tube and facilitates the 
generation and transmittance of the radiofrequency pulse to the sample. The signal from the 
excited nuclei is detected by the probe and through the receiver coil surrounding the sample. 
Figure 2.1 depicts the components of an NMR superconducting magnet. 
 64 
 
Figure 2.1 Internal configuration of an NMR spectrometer.  
Inside the magnet a liquid nitrogen tank is located, whose main function is to insulate the 
inner liquid helium tank. At the centre of the electromagnet there is the bore, a long tube 
from the top of which the sample is inserted and sits in the probe.  
 
2.2.2 Principles of 1H NMR spectroscopy 
The principle of NMR spectroscopy is based in the physical properties of the atomic nuclei 
that are composed of protons and neutrons. The nuclear property of interest in NMR 
experiments is the nuclear angular momentum spin quantum number (I), commonly referred 
to as nuclear spin. This number depends on the number of protons (atomic number) and the 
number of neutrons (atomic mass) [150]. If the number of neutrons and protons are both 
even, then the nucleus has I=0 (e.g. 12C, 16O, 32S). In cases where the number of neutrons and 
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the number of protons is odd, then the nucleus has I=1/2  (e.g. 1H, 13C, 31P). When the number 
of neutrons and the number of protons are both odd then the nucleus has I=1.  
Any nucleus with a spin quantum number (I) different from zero can be analysed using 
NMR spectroscopy. Proportional to the nuclear spin is the magnetic moment (μ), which is the 
vector of the positive charge of the nucleus as a result of nuclear spinning and of the angular 
momentum through the gyromagnetic ratio (γ). The gyromagnetic ratio is a fundamental 
constant, unique to each nucleus. It can therefore be deduced that if a nucleus, with I =0 will 
not have a magnetic moment and will not be detected by NMR. Some of the isotopes used in 
NMR spectroscopy in biological applications are those with I =1/2 such as 1H, 13C, 15N, 31P. 
Hydrogen (1H) is the most commonly used atom in metabolic profiling, since it is the most 
abundant element in biological molecules. The natural abundance of 1H is 99.98%, 
substantially higher than that of 13C, which is 1.1%.  
When a magnetic field is applied to nuclei with a spin quantum I>0, the nuclear 
moments of spins will orient themselves and the number of possible energy levels can be 
calculated by the equation: 2I+1. The magnetic quantum number mI designates these energy 
levels of nuclei. The spin quantum number (I) of 1H is equal to 1/2 and will therefore have two 
possible orientations (energy states) in the presence of a magnetic field (Fig. 2.2). Upon 
transition from a random to an oriented state, the nuclei spin around the axis of the applied 
magnetic field in a motion known as the Larmor precession with a frequency ν and an angular 
speed ωο [150]. 
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Figure 2.2 Energy levels of a nucleus with a spin quantum number 1/2 
Schematic representation of the energy level of a nucleus with I =1/2 and transition upon 
application of an external magnetic field B0. The nucleus aligns with or against the applied 
magnetic field in a low (α, mI=+1/2) or high (β, mI=-1/2) energy state respectively. The 
difference between the two energy states is described as ΔΕ.  
 
The population of the protons between the two energy states is given by the Boltzmann 
distribution: 𝑁!𝑁! =  𝑒!!"/!" 
 
Nα and Nβ represent the number of nuclei that occupy the lower and upper energy 
state respectively; K is the Boltzmann constant and T the absolute temperature in degrees 
Kelvin. ΔΕ is the energy difference between the two energy states α and β and the energy 
required for the transition (flipping) of the nuclear spins.  
It is important to note that there will be a slight excess of nuclei in the lower energy 
state at thermal equilibrium. The net absorption of energy by the nuclei that change spin 
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states will in turn give an NMR signal. The energy needed for the flipping between the two 
orientations is provided by electromagnetic radiation and can be calculated using the 
following equation: 𝛥𝛦 = 𝜈ℎ = 𝛾ℎ𝛣!/2𝜋 
 
Where 𝜈 is the Larmor frequency; h is the Planck’s constant; γ corresponds to the 
gyromagnetic ratio (unique for each nucleus and defines the direction of the spin) and B0 is 
the strength of the external magnetic field.  
ΔΕ is equal to νh meaning that electromagnetic radiation is proportional to the 
resonance frequency. This means that an exact frequency should be applied for the nuclei to 
resonate (flip) between the energy levels, and allow for an NMR signal to be detected. In 
addition, considering that ΔΕ is directly related to the applied magnetic field (B0 ) the Larmor 
frequency (resonance) will also be proportional to B0. 
Energy for the excitation of nuclei is provided in the form of radiofrequency (RF) pulses 
during an NMR experiment. The RF pulses used interact with all the nuclei of an isotope in a 
sample. The fact that there are differences in the population distribution of nuclei in the two 
energy levels, and therefore different Larmor frequencies, creates a net magnetisation vector 
M0 in the same direction as B0 (z-axis) (Fig. 2.3a). Application of a short 90° RF pulse rotates the 
magnetisation vector away from the z-axis to the x-y plane (Fig. 2.3b). When the pulse stops, 
the nuclei will relax and return to equilibrium (Fig. 2.3c). During the precession movement 
back to z-axis, the magnetisation vector will release an oscillating voltage, detected by the 
receiver coil and amplified by the receiver. This detectable NMR signal is know as free 
induction decay (FID) and it represents the sum of these oscilations. The speed of relaxation 
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and the RF pulse determines the differences between molecules. The FID recorded in a time 
domain is converted into the frequency domain and into an NMR spectrum by Fourier 
transformation (Fig. 2.3d).  
 
Figure 2.3 The NMR signal acquisition process 
a) Precession of the magnetisation vector around the z-axis b) application of a 90° RF pulse 
causes a transition of the vector along the x-y plane c) release of RF pulse and free induction 
decay to return back to equilibrium d) signal acquisition and Fourier transformation. 
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Relaxation describes the process during which excited nuclei release their previously 
absorbed energy and return to equilibrium. The relaxation of the nuclear spin magnetisation 
is not an intrinsic characteristic of excited nuclei but is facilitated by two processes: the spin-
lattice (longitudinal) relaxation time (T1) and the spin-spin (transverse) relaxation time (T2). 
During spin lattice relaxation, nuclei in a higher energy state release energy to the lattice (the 
sample in which the nuclei are held) and lose energy returning to the lower state. This process 
happens exponentially with time and it is essentially the time constant for a nucleus to return 
to its equilibrium state (z axis).  
For spin-spin relaxation to occur, inter-nuclei interactions take place during which 
there is an exchange of energy between nuclear spins in the higher and lower energy state. T2 
is therefore defined as the time constant for the nuclear spins to lose energy in the XY plane 
[150]. 
2.2.2.1 Chemical shift 
A property of NMR spectroscopy that can provide further structural and conformational 
details about a molecule, is that each nucleus experiences the applied magnetic field (B0) 
differently resulting in distinct resonance frequencies. The electron cloud surrounding the 
interrogated nucleus influences this effect, in that the external applied magnetic field (B0) will 
generate a local magnetic field in the electron cloud, which will be smaller, and in the 
opposite direction of B0. This phenomenon is known as nuclear shielding and essentially 
reduces the magnetic field experienced by the nucleus. The extent to which each nucleus will 
be shielded depends on the electronegativity of the atoms in the molecule. For instance, if a 
proton nucleus is bound to a highly electronegative atom like oxygen, it will have a lower 
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electron density because the oxygen nucleus will attract more electrons. This will decrease 
the shielding of the proton nucleus against B0 and result in the protons experiencing a higher 
overall magnetic field and resonating at higher frequencies. On the contrary, proton nuclei of 
a methyl group will have a greater electron density leading to a higher degree of shielding, a 
weaker experienced magnetic field and therefore a lower resonance frequency.  
Nuclear shielding essentially corresponds to the difference between the applied and 
the experienced magnetic field by the nucleus. The chemical shift (δ) can be defined by the 
following formula: 
δ(ppm) = [(!observed - υreference) (Hz)] ! !"!!"#$%&'(#%#& !"#$%#&'( (!") 
Where υobserved is the resonance frequency of the samples proton nucleus, and υreference is the 
resonance frequency of a reference nucleus. In the NMR experiments described in this thesis 
the reference compound used is 3-(trimethylsilyl)-[2,2,3,3,-2H4]-propionic acid (TSP). TSP is a 
highly shielded compound, meaning that it absorbs energy at low frequency therefore its 
resonance does not overlap with the resonances of other metabolites in the sample of 
interest. Molecules are characterised by their chemical shift relative to the reference 
compound in an experiment rather than the frequency of the line due to the fact that 
different applied magnetic fields can cause the observed peaks to appear at slightly different 
frequencies, but the position in relation to the reference compound peak is always constant 
when expressed as the chemical shift (ppm).  
2.2.2.2 The spin-spin coupling 
The spin-spin coupling (or J coupling) phenomenon occurs extensively when two nuclei are 
in close proximity, and serve as minor independent magnetic fields. Adjacent nuclei in the 
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same molecule interact with each other, as well as with the external applied magnetic field, 
resulting in the splitting of the NMR signal and subsequent spectral peak multiplicity. NMR 
spectra are characterised by the presence of not only singlet peaks, but also doublets, triplets 
and multiplets. Spin-spin coupling occurs when adjacent protons affect the NMR signal as 
such, that splitting of the resonance peak occurs into further components. The peak pattern 
of shape and intensity is in accordance with Pascal’s triangle (Fig. 2.4). If all couplings to a 
particular proton are the same there will be 2nI+1 peaks, where I is the spin quantum number 
and n is the number of adjacent nuclei (n + 1 for 1H I = 1/2).  
In 1H NMR spectroscopy, spin-spin coupling is observed in protons that are up to three 
bonds apart, but any unsaturated bonds can influence the distance up to which the electron 
exchange occurs [150]. J coupling interactions are not affected by the applied magnetic field 
in a given sample, meaning that the observed peak patterns are constant regardless of the 
external magnetic field strength [151]. This feature of NMR spectroscopy is of great 
importance for molecular structure characterisation since it depends on chemical bonds, 






Figure 2.4 Example of J coupling in the generation of different peak shapes and intensities 
following the Pascal’s triangle (n; number of adjacent nuclei) [152] 
 
2.2.3 Pulse sequences 
A single pulse sequence employed in 1D NMR experiments can be broken down into several 
sections. The preparation time, also known as the relaxation delay (s), the pulse width (μs) and 
lastly the acquisition time. During the relaxation delay (RD) the spin system is prepared for the 
spins to reach equilibrium. This is an important step to ensure maximum signal to noise ratio. 
Insufficient relaxation of the spin system will result in poor quality peaks. For a complete spin 
system relaxation, RD lasts about four to five times the T1 relaxation time. Following RD is the 
pulse width during which the radiofrequency generator is rapidly turned on and then off (5-
15 μs) and this results in the perturbation of the spin system. Subsequently, the signal from 
the excited spins relaxing back to their original state (FID) is recorded during the acquisition 
period. The pulse sequence is repeated multiple times during an experiment to compensate 
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for the rather low sensitivity of the NMR compared to other spectroscopy based methods. 
Increasing the number of acquired scans increases the signal to noise ratio. 
Pulse sequences in NMR experiments can be modified accordingly, to facilitate the metabolic 
profile acquisition from different samples. The following two sections describe the pulse 
sequences used in this thesis.  
2.2.3.1 Standard one-dimensional solvent suppression pulse sequence  
One-dimensional experiments with water pre-saturation allow for the acquisition of the 
resonance of all 1H-containing molecules in a given sample including signals from small 
molecules as well as broad signals from larger molecules. This type of pulse sequence is used 
for the acquisition of spectra from urine samples, aqueous tissue extracts as well as cell 
extracts, which are characterised by a poor macromolecular content. The water resonance is 
irradiated during this sequence with a low power continuous wave for pre-saturation and 
attenuation of the resonance before acquisition [153]. Figure 2.5 shows a representative 1H 
NMR spectrum obtained from the hydrophilic fraction of cell extracts using a standard one-
dimensional pulse sequence.  
2.2.3.2 The Carr-Purcell-Meiboom-Gill (CPMG) pulse sequence  
This experiment is particularly relevant for samples with substantial macromolecular content 
such as tissue extracts and plasma samples. The CPMG spin-echo pulse sequence attenuates 
the signals of macromolecules like proteins and lipids, allowing for a better signal acquisition 
from small molecules (carbohydrates, amino acids, nucleic acids). The pulse sequence is as 
follows: RD - 90° - (t -180° – t)n – 90° -acquire; where t is the spin- echo delay, n represents the 
number of loop and 180° is the 180° radiofrequency pulse [145]. During the CPMG pulse 
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sequence the amplitude of the received signal decays over time as a result of the T2 
relaxation. Naturally, larger molecules have faster T2 relaxation therefore their signal decays 
first and their resonance weakens.  
 
Figure 2.5 Representative 1H NMR spectrum of the hydrophilic metabolites extracted from 




Metabonomic analytical platforms generate thousands of signals from metabolic 
fingerprinting. Multivariate data analysis is the ideal tool to be used in instances where the 
number of variables obtained substantially exceeds the number of samples, which is a typical 
case in metabonomics. Univariate statistical analyses lack the ability to account for 
multicolinearities, where highly correlated variables can mutually define and predict a class, 
rendering the analysis less robust than multivariate statistical analyses. 
The purpose of multivariate statistics undertaken for large datasets is to summarise 
and visualise the main sources of variation in the data and facilitate the extraction of useful 
information from such complex datasets, usually in the form of plots and model summary 
statistics. Unsupervised and supervised modelling methods are used in metabonomics to 
facilitate biological interpretation and biomarker discovery. 
2.3.1 Unsupervised methods – Principal components analysis 
Principal component analysis (PCA) is an unsupervised method of multivariate data analysis 
meaning that no existing hypothesis of the dataset is needed for model generation. It is a 
data projection-based method facilitating the representation of a multivariate dataset matrix 
(X) consisted of n rows (samples) and k columns (variables) by reducing the large 
dimensionality of the dataset while maintaining important information for data 
interpretation. In PCA, each observation is represented by one point in as many dimensions as 
there are variables, and placed on the plane according to the variables values. 
PCA calculates the line of least squares, which passes through the origin. The first 
fitted line is called the first principal component (PC1) in the multidimensional space, and this 
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will be in the direction that explains the greatest degree of variation in the dataset. A single 
principal component cannot adequately explain the variation in a model of biological data. 
Therefore, subsequent principal components are implemented to further explain the 
variation and are calculated orthogonally to the previous principal component. Figure 2.6 
shows how PC1 and PC2 form a model plane in the multivariate space, on which every 
observation is projected.  
  PCA is interpreted by the scores and loadings plots. From each principal component, 
the respective scores and loadings can be produced. Scores represent the projections of the 
observations on the corresponding principal component. Scores plots (graphical 
representation of the projection-score value (t)) reveal any existing similarity or difference 
among the samples in the new reduced dimensional space as a function of the variance 
explained by each of the principal components calculated. PCA constitutes a useful tool for 
the detection of outliers in the dataset matrix. Loadings (P) are the cosine angle of a variable 
from a specific principal component. It calculated to examine the degree of contribution of 
each variable (for NMR spectral data each variable corresponds to a signal and therefore a 
metabolite) to the model for each of the principal component, and allows for the 
identification of the metabolites driving any specific patterns observed in the scores plot. The 
matrix is therefore modelled by the equation: 
 𝑋 =  𝑇𝑃’+ 𝐸 
 
X represents the metabolite data; T is the scores; P transposed represents the loadings and E 
is the residuals. The residuals represent the deviation between the true position of a data-
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point and the position projected on the model plane, and constitute the part of the dataset 
matrix that cannot be explained by the model. 
 
 
Figure 2.6 Geometric representation of the PCA process [154] 
Variables in the X matrix (X1, X2, X3) that contains 12 samples are placed in a lower dimension plane. 
Each dimension represents one variable. The scores and loadings plots are provided from the model 
plane. Scores plots provide information on any existing groupings, trends or outliers in the dataset 
and the loadings plots explains the contribution of each of the variables (X1, X2, X3) in the model.  
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2.3.2 Centring & Scaling 
In metabonomic datasets variables can have considerably different ranges and this can 
modify the quality and the quantity of information obtained by a statistical model.  PCA, like 
all projection-based methods, is sensitive to scaling of the variables, meaning that the 
variables with highest value range will substantially influence and dominate the model [154]. 
In order to adjust for this, two data modification methods are employed prior to model 
construction; mean centring and scaling (Fig. 2.7). 
Mean centring is a data pre-processing method, which, as the name suggests, ensures 
that the mean of each variable is centred on the origin of the axes. This is achieved by 
calculating the mean of each of the variables and subtracting it from the value of each 
variable, thus removing the mean trajectory from the dataset [154, 155]. The interpretation of 
the obtained result will be relative to the spread around the mean and all of the variables will 
have the same reference point. The first principal component will therefore represent the 
covariance in the dataset and will not be dominated by the mean of each variable. 
Scaling of data adjusts the weight of each variable on each axis, and prevents the 
skewed interpretation of the results as a consequence of differences in the range of values for 
each of the variables. In unit variance scaling the value of each variable is divided by its 
standard deviation, hence variables have equal variances and no variable can dominate over 
any other.  
Pareto scaling is a scaling method used in metabonomic data analysis, and is 
calculated by dividing each variable by the square root of its standard deviation [154]. It 
minimises the differences in the range of the variables values, while maintaining the order of 
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the starting variance of each variable. Pareto scaling up-weights medium features without 
inflating baseline noise, which is the case in unit variance scaling [156].  
 




2.3.3 Supervised methods – Projections to latent structures and Orthogonal 
projections to latent structures 
While PCA is an unsupervised method of data modelling, projections to latent structures (PLS) 
method and its iterations are supervised methods, meaning that a priori knowledge is 
required for model construction. In these methods a response variable (Y) is implemented 
corresponding to continuous or discrete variables such as age, gender or treatment group. 
When the Y matrix contains discrete data, discriminant analysis is performed (PLS-DA).  
PLS method relates matrices X (predictor, metabolite data) and Y (response variable to 
be predicted) aiming to explain the maximum covariance between the two and allow for any 
true metabolic variation related to a response variable to be shown (Fig. 2.8). This method is 
particularly useful in metabonomic studies where the number of variables surpasses the 
number of observations. Similarly to PCA, the first PLS component calculated in the X and Y 
multivariate space must describe the maximum variation within the matrices and therefore 
maximise the covariance of the scores t1 and u1 (Fig. 2.8). Further components are calculated 
perpendicular to the previous one. The new PLS model can be expressed by the following 
equations: 𝑋 = 𝑇𝑃! + 𝐸 𝑌 = 𝑈𝐶! + 𝐹 
 
Where T and U correspond to the matrix of scores that summarise the X and Y variables 
respectively. P’ and C’ represent the loadings for the correlation between X and Y and the 
score vectors U and T respectively.  E and F are the residual matrices.  
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Figure 2.8 Schematic representation of the principle of PLS model 
 
Orthogonal projections to latent structures (OPLS) and orthogonal projections to latent 
structures – discriminant analysis (OPLS-DA) are variants of the PLS models facilitating the 
filtering of extraneous variation irrelevant to the biological class. Variable (X) matrices 
obtained from NMR metabolic profiling often contain variation that is uncorrelated to the Y 
matrix that can introduce noise in the PLS/ PLS-DA model and compromise its interpretability 
(e.g. instrumental issues, sampling problems and uncontrolled sources of biological 
variation). In OPLS and OPLS-DA models an integrated Orthogonal Signal Correlation (OSC) 
filter is implemented during model construction. This added orthogonal component divides 
the X matrix variation into a predictive component (variation correlating between X and Y) 
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and an orthogonal component that accounts for the variance that is uncorrelated to Y [154]. It 
therefore describes the unwanted systematic variation unrelated to the biological variation 
(Y). This partitioning of the X matrix variation positively impacts model interpretation by 
separating between-class and within-class variation, something that cannot be facilitated by 
PLS models [154, 157]. 
Similarly to PCA, loadings in OPLS-DA are displayed in the form of a pseudo-NMR 
spectrum, plotting the covariance between the metabolites and the Y matrix (classes). OPLS-
DA covariance plots are obtained by back-scaling the unit-variance scaled model (multiplying 
the model coefficients by the standard deviation of the corresponding variable) to a 
correlation matrix [157, 158]. The pseudo-spectrum is coloured with scale; the colour of each 
resonance on the plot is the square of the correlation of each metabolite with the class 
relationship (R2: the proportion of the X matrix predictable by Y).  
2.3.3.1 Model diagnostics and validation 
PLS and its derivative models are prone to over-fitting. This phenomenon occurs when a 
model despite its apparent ability for fitting training data, it has a poor predictive ability for 
future observations and therefore predicts noise or random error. R2Y represents the 
proportion of X needed to describe Y, and this value is known as the ‘goodness of fit’ [159]. It 
signifies the ability of the model to fully characterise the dataset, therefore a high R2Y value 
suggests a low residual value. In order to overcome the problem of over-fitting, a cross 
validation step is implemented in the data analysis to assess the true predictive ability of a 
model. Cross validation is performed by removing 1/7th of the X matrix, and using the 
remaining data to predict the missing values back into the model. If the interrogated model is 
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valid it will accurately predict the missing data. This procedure is repeated until every 
observation has been back-predicted once. Cross validation facilitates the determination of 
the Q2Y value, which represents the predictive power of the model i.e. how well X predicts Y 
in the model.  
In most cases, R2 value is expected to be higher than Q2 as the model complexity 
increases but the difference should not be more than 0.2-0.3. R2 will continue to increase with 
complexity due to greater variation explained by the model. On the contrary, Q2 value will 
reach a peak when the model is saturated, in terms of the number of fitted components, and 
will then start to decline. This is a result of the fact that when additional variation is added to 
the model, the more noise is added too leading to a reduction in the predictive ability of the 
model.  
2.3.3.2 Permutation testing  
A permutation test is used to calculate the significance of the estimated predictive power Q2Y 
of the model, to validate the model. Here, data are shuffled (permutated) resulting in the 
random assignment of observations in correct or incorrect classes. Virtual OPLS-DA models 
are then constructed based on the newly generated dataset, and the R2Y and Q2Y values are 
obtained. The Y matrix is normally permutated 1000 times and the R2Y and Q2Y values are 
ranked. The rank of the Q2Y from the real model against the virtual random models provides a 
significance value. The real model is considered significant if its Q2Y value ranks within the top 
5% of the Q2Y values obtained from the virtual models (p <0.05). Hence a genuine association 




3 Characterising the metabolic perturbations induced by watercress and 
phenethyl isothiocyanate exposure in MCF-7 and MCF-10A cells 
 
Hypothesis 
It is hypothesised that phenethyl isothiocyanate (PEITC) and the watercress extract will induce 
significant metabolic modifications with anti-carcinogenic potential in breast cancer cells and 
that these effects will be different from those in healthy breast cells.  
Aims 
• Characterise the basal metabolic profiles of MCF-7 and MCF-10A cells. 
• Investigate the metabolic response of MCF-7 and MCF-10A cells in response to crude 
watercress extract and PEITC. 
• Study how crude watercress extract and PEITC influence markers of cellular 
genotoxicity.  
Objectives 
• 1H NMR metabonomics and multivariate statistics will be used to characterise the 
metabolic profiles of the two cell lines following exposure to different doses of the 
watercress extract and PEITC. 
• Treatment genotoxicity will be evaluated by measuring DNA damage using the Comet 
assay, assessing cell cycle stages using flow cytometry and measuring mitochondrial 





Watercress (Nasturtium officinale) belongs to the family of Brassicaceae together with broccoli, 
Brussel sprouts and kale. Epidemiological studies suggest a link between the consumption of 
Brassica vegetables and a reduced risk for many types of cancers [160] including breast cancer 
[161, 162]. Watercress has a complex phytochemical profile characterised by high levels of 
carotenoids, flavonols and glucosinolates [163] and extracts of watercress exhibit strong 
antioxidant capacity in vitro [52, 57]. Watercress and its components have been associated 
with the inhibition of the three stages of carcinogenesis: initiation, proliferation and 
metastasis in in vitro cancer cell models [53, 58, 164]. 
Plant tissue damage such as cutting or chewing, induces the release of the plant 
enzyme myrosinase (β-thioglucoside glycohydrolase; EC 3.2.3.1), which hydrolyses 
glucosinolates present in the tissue, forming reactive isothiocyanates [63]. It is this group of 
bioactive compounds that have received considerable attention for their potential anti-
cancer properties. Watercress is particularly rich in gluconasturtiin, which is the glucosinolate 
precursor to phenethyl isothiocyanate (PEITC). Research has highlighted promising 
chemopreventive and chemotherapeutic activities of PEITC. Due to its highly electrophilic 
nature PEITC reacts with cellular thiols via thiocarbamoylation and after its cellular uptake it 
reacts with glutathione (GSH), which is the major intracellular antioxidant [60, 108, 165] 
depleting cells of their GSH content. GSH has a vital role in the maintenance of cellular redox 
status [30] and tight regulation of intracellular reactive oxygen species (ROS) through the 
induction of antioxidant mechanisms is central to cancer cell survival. Low levels of ROS can 
have a proliferative advantage for cancer cells [166]. Excessively high levels of ROS though, 
will result in disruptions in redox balance can lead to mitochondrial damage underpinned by 
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oxidative stress, and ultimately cancer cell death [22]. To manage this, cancer cells use 
antioxidants such as GSH, to prevent ROS from accumulating at detrimentally high levels. 
Malignant cells are commonly characterised by elevated ROS levels compared to non-
cancerous cells [166] PEITC treatment has therefore a selective detrimental effect on cancer 
cells since they rely on their antioxidant mechanisms for survival and PEITC depletes the 
cellular levels of their main antioxidant, GSH.  
At the cellular level PEITC has been extensively shown to have direct anti-cancer 
effects in in vitro cancer models.  It causes cell cycle arrest in a wide variety of cell lines and it is 
a potent inducer of apoptosis [99, 102, 108]. PEITC increases the activity of Nrf2, a key 
transcription factor relevant to the activation of oxidant/electrophile response genes 
mediating chemopreventive functions [167]. PEITC also inactivates the nuclear factor kappa B 
(NF-kB) pathway affecting important steps in carcinogenesis including, inflammation, cancer 
cell survival, differentiation and proliferation [168-170]. Inflammation is a central process in 
cancer development and PEITC has been shown to decrease the expression of inducible nitric 
oxide synthase (iNOS) and cyclooxygenase-2 (COX-2) resulting in an attenuated secretion of 
pro-inflammatory mediators [171]. Other targets of PEITC include the hypoxia inducible factor 
(HIF) [106] negatively regulating angiogenesis as well as inhibiting mTOR, which plays a key 
anabolic role in translation and functions as a vital metabolic integration point joining 
nutrient availability with growth signals [22, 95]  
 
Metabolic regulation is a determining element of the cell growth machinery and 
cancer cells have adapted to several oncogenic signals to modify their metabolic phenotype 
as such, to support their needs for growth, survival and malignant transformation. Core 
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cancer cell metabolism serves the three basic needs of proliferating cells: i) rapid ATP 
generation to sustain energy status, ii) increased need for the biosynthesis of 
macromolecules, proteins, lipids and nucleotides, iii) maintenance of appropriate cellular 
redox status.  
To our knowledge, limited work has been done on the effects of PEITC and of crude 
watercress extract on cancer cell energetics and metabolism. PEITC impacts a great range of 
oncogenes and tumour suppressor genes, which can all cause shifts in intracellular signalling 
pathways involved in cancer cell metabolism. It is therefore central to get an insight into the 
effect of such a bioactive compound on the global metabolic profile of cancer cells. This 
chapter will investigate the biochemical response of MCF-7 breast cancer cells to increasing 
doses of watercress extract and to PEITC using 1H NMR metabonomics. This will then be 
compared to the metabolic response of immortalised but non-tumorigenic MCF-10A cells to 
the same treatments. Biochemical observations will be related to inducible cancer related 
phenotypic changes in cell behaviour.  
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3.2 Materials and methods 
5.1.1 Cell Culture 
The MCF-7 human breast adenocarcinoma cell line was purchased from the American Type 
Culture Collection (ATCC) (LGC standards, Middlesex, UK). Cells were cultured in Dulbecco’s 
Modified Eagle’s Medium (DMEM; Lonza Group Ltd, Basel, Switzerland) supplemented with 
10% (v/v) foetal bovine serum (FBS; Lonza Group Ltd), 2 mM glutamine (Thermo Fisher 
Scientific, Loughborough, UK), 50 U/ml penicillin and 50 U/ml streptomycin (Thermo Fisher 
Scientific, Loughborough, UK) and 1% non-essential amino acids (Sigma-Aldrich, Dorset, UK).  
The MCF-10A, non-tumorigenic breast epithelial cell line was kindly provided from 
Prof. Graham Packham (University of Southampton, Southampton, UK). Cells were maintained 
in Ham’s F12:DMEM (1:1) (Lonza Group Ltd), 20 ng/ml epidermal growth factor (EGF) 
(PeproTech, London, UK), 0.1 μg/ml cholera toxin (Sigma-Adrich), 10 μg/ml insulin 
(Invitrogen), 500 ng/ml hydrocortisone (Sigma-Aldrich), 5% horse serum (Invitrogen) and 50 
U/ml penicillin and 50 U/ml streptomycin (Thermo Fisher Scientific, Loughborough, UK). 
 Cells were grown in an incubator at 37 ºC with 5% CO2 and 95% humidity in 75 cm2 
culture flasks and were routinely passaged at approximately 70% confluency. The medium 
was changed every 2-3 days. For passaging, cells were washed with phosphate buffer saline 
(PBS; Lonza Group Ltd) before detaching with 5ml of Trypsin-Versene® (EDTA) mixture (Lonza 
Group Ltd) for 3-5 mins for MCF-7 cells and 18-20 mins for MCF-10A cells. Media (5 ml) was 
then added to the cells to inactivate the trypsin and the cell suspensions were centrifuged at 
300 g for 3 mins. Cell pellets were resuspended in complete media in the flask and incubated.  
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5.1.2 Compounds and Extracts 
3.2.1.1 Analytical grade compounds 
Phenethyl isothiocyanate (PEITC) was purchased from Sigma (Dorset, UK). PEITC stock 
solution (30 mM) was made up in DMSO fresh on the day of use. 
3.2.1.2 Watercress extracts 
Fresh watercress samples were obtained directly from Vitacress Salads Ltd. (Andover, UK). 
Samples were snap frozen in liquid nitrogen and stored at -80 ºC. 2 g of leaf and 2 g of stem 
were weighed and placed in a 20 ml syringe (BD Biosciences, Oxford, UK) that had had the 
plunger removed and a circular 25 mm glass microfiber filter (Whatman, Dassel, Germany) 
placed at the bottom. The syringe was then placed inside a 50 ml centrifuge tube without the 
lid and centrifuged at 1500 g for 30 mins to collect the extract. This crude watercress extract 
was then filtered through a 0.22 μm filter and used in the cultures. 
5.1.3 Cell proliferation 
For the determination of cell proliferation MCF-7 and MCF-10A cells were seeded in 96-well 
microplates at 5x103 cells per well and incubated at 37 ºC with 5% CO2 and 95% humidity for 
24 hours. Cells were exposed to the watercress extract at 6.25, 12.5, 25 and 50 μl/ml and PEITC 
at 5, 10, 20, 30 μM for 24 hours. The treatments were then removed by aspiration. Cells were 
permeabilised with 100 μl of ice-cold methanol for 5 mins at room temperature. Methanol 
was removed and the plates were allowed to air dry for 15 mins in a hood, followed by 
addition of 100 μl of DAPI in PBS (70 μl of 30mM DAPI stock solution in 10.43 ml of PBS). Cells 
were incubated in the dark for 30 mins at 37 ºC and absoprtion was measured using GENios 
microplate reader (TECAN Group Ltd., Mannedorf, Switzerland) with absorbance at 340 nm 
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and emission at 465 nm. The experiment was performed in triplicate with three technical 
replicates per experiment.  
5.1.4 NMR Metabonomics 
The metabolic profiles of MCF-7 and MCF-10A cells were analysed using 1H NMR 
spectroscopy. Cells were seeded at 1x105 cells per well into six well plates and treated at 80% 
confluency. Cells were exposed to the watercress extract at 6.25, 12.5, 25 and 50 μl/ml and 
PEITC at 5, 10, 20, 30 μM for 24 hours. Media was transferred into eppendorf tubes and cells 
on the surface of the plate were washed twice using 1 ml cold (4ºC) PBS and were quenched 
using 1 ml of ice-cold methanol (maintained on dry ice). Cells were allowed to lyse for 2 mins 
and were detached from the plate using a cell scraper and transferred into an Eppendorf 
tube. Methanol quenching was repeated to maximise metabolite recovery. A vacuum 
concentrator (SpeedVac) was used to dry down the cell suspensions before reconstitution in 
80 μl of phosphate buffer (pH 7.4) in 100% deuterium oxide containing 1 mM of the internal 
standard, 3-(trimethylsilyl)-[2,2,3,3,-2H4]-propionic acid (TSP).  
For every sample, a standard one-dimensional NMR spectrum was acquired using a 
600 MHz Bruker NMR spectrometer, with water peak suppression using a standard pulse 
sequence (recycle delay (RD)-90°-t1–90°-tm-90°-acquire free induction decay (FID) RD= 4s, 
t1=8.62 μs, tm= 100 ms). For each spectrum 256 scans and 8 dummy scans were obtained, 
collected in 64K data points with a spectral width of 12.001 ppm. 1H NMR spectra were 
manually corrected for phase and baseline distortions and referenced to the TSP singlet at δ 
0.0. Spectra were digitized using an in-house MatLab (version R2012a, The Mathworks, Inc.; 
Natwick, MA) script. Metabolites were identified using an in-house database of standards and 
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Chenomx NMR suite (version 7.7, Chenomx Inc). Multivariate modelling, including principal 
component analysis (PCA) and orthogonal projections to latent structures discriminant 
analysis (OPLS-DA), was performed on the samples using in house scripts  
5.1.5 Cell Cycle  
MCF-7 and MCF-10A cells were seeded at a 1x105 cells per well in six well plates and incubated 
as required. The cells were then exposed to the watercress extract and PEITC at 6.25, 12.5, 25, 
50 μl/ml and 5, 10, 20, 30 μM, respectively for 24 hours. Following treatment removal, the cells 
were washed with cold PBS (4°C) and harvested by trypsinisation. Cells were pelleted by 
centrifugation at 300 g for 3 mins and the supernatant was discarded. The cell tissue was then 
resuspended in 200 μl of cold PBS and fixed with drop-wise addition of 70% (v/v) fresh ice-
cold methanol. The samples were then stored at -20 °C until analysis.  
On the day of the analysis, samples were centrifuged at 300 g for 3 mins and the 
supernatants were discarded. The cell pellets were then resuspended in 200 μl of PBS and 25 
μl of 1 mg/ml RNAse was added to the suspensions. The samples were incubated at 37°C for 
30 mins and 2.5 μl of 400 μg/ml of PI dye were added to the cells which were then incubated 
for a further 30 mins at room temperature under dark conditions. The final volume of the cell 
suspensions was adjusted to 600 μl with PBS. Cellular DNA content of 15,000 cells was 
quantified via flow cytometry. The flow cytometry analysis was performed using the FL2 
channel on a BD AccuriTM C6 flow cytometer (Germany). Data analysis was facilitated using the 
Flow Jo software (version 7.6, Tree star Inc, Oregon, USA). Cell cycle progression was 
evaluated accounting for the percentage of cells in each of the phases Gap0/1 (G0/1), 
Synthesis (S), Gap2/mitosis (G2/M) and apoptotic cells (sub G0/1). The principle of the cell 
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cycle analysis is based on the fluorescence intensity of the PI nuclear dye that is proportional 
to the DNA concentration of the cell. 
5.1.6 Comet Assay 
The Comet assay is used for the measurement of DNA strand breaks in single cells. MCF-7 and 
MCF-10A cells were seeded in T25 cells culture flasks at a concentration of 1x106 and 
maintained at 37 °C with 5% CO2 and 95% humidity. The cells were then exposed to the 
watercress extract and PEITC at 6.25, 12.5, 25, 50 μl/ml and 5, 10, 20, 30 μM, respectively for 24 
hours. The treatment solutions were then removed via aspiration followed by washing with 
PBS and detaching from the cell culture flask with trypsin. Cell suspensions were adjusted to a 
concentration of 1x106 cells/ml.  
Following the treatments, 20 μl of the cell suspensions were resuspended in 200 μl of 
warm low melting point agarose (LMA) (0.85% w/v) and applied 75 μl of this was dispensed 
on Comet Slides (Trevigen). The LMA was allowed to solidify at 4°C for 15 mins. The slides 
were then transferred into a staining jar, lysis buffer (2.5M NaCl, 0.1M EDTA, 0.01M Tris and 1% 
(v/v) Triton X – added just prior to use – pH 10) was added and the cells were allowed to lyse 
for 1 hour at 4°C). 
Following lysis of the cells, the slides were placed in a horizontal electrophoresis tank 
and incubated for 20 mins in alkaline buffer (0.3M NaOH, 1mM EDTA – pH 13) at 4°C in dark 
conditions. Electrophoresis was carried out at 26 V, 300 mA for 30 mins at 4°C. Immediately 
after electrophoresis the slides were washed in neutralising buffer (0.4M Tris – pH 7.5) three 
times for 5 mins.  
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The slides were then stained with 10 μl of ethidium bromide (20 μl/ml) and DNA 
migration from the nucleus was visualized with a fluorescence microscope (Olympus BX51). 
The computer-based image analysis software, Komet 4.0 (Andor Technology, South Windsor, 
CT) was used to calculate the proportion of DNA that had migrated from the head to the tail 
of the comet (% tail DNA). The mean value from 100 randomly scored cells was taken as an 
index of damage for each replicate well.  
5.1.7 Mitochondrial membrane potential assay 
Mitochondrial membrane potential was assessed using the JC-10 mitochondrial membrane 
potential kit according to the manufacturer’s instructions (Sigma, Dorset, UK). Briefly, 1x104 
MCF-7 and MCF-10A cells were seeded in a 96 well plate and allowed to attach overnight. The 
cells were then exposed to the watercress extract at 6.25, 12.5, 25 and 50 μl/ml and PEITC at 5, 
10, 20, 30 μM for 24 hours. JC-10 dye-loading solution  (50 μl) was added to each well and 
incubated for 60 mins before measuring fluorescent intensities (Ex/Em= 485/520 nm and 
Ex/Em=544/590 nm). The shifts of mitochondrial membrane potential were measured as the 
ratio between aggregate (Em =520 nm) and monomeric forms (Em =590 nm) of the JC-10 dye 
using FLUOstar Omega (Isogen Life Science, De Meer, the Netherlands). Increasing ratio 




5.1.8 Cell Proliferation 
Cytotoxicity of increasing doses of the crude watercress extract and PEITC was assessed in 
MCF-7 and MCF-10A cells. The dose response curves for cytotoxicity as assessed by DAPI 
staining are presented in Fig. 3.1 (A-D). Treatment with the watercress extract did not impact 
MCF-10A proliferation but caused a 20% and 25% decrease in proliferation in MCF-7 cells 
treated with 25 and 50 μl/ml of the extract, respectively. PEITC caused a significant decrease 
in cell proliferation in MCF-7 cells reaching up to 46% in the highest PEITC dose (30 μM). 
Treatment of the MCF-10A cells with 30 μM of PEITC showed evidence of cytotoxicity 
compared to the untreated cells.  
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Figure 3.1 Cytotoxicity of the crude watercress extract and PEITC in MCF-7 (A&B) and MCF-
10A (C&D) cells. 
Data presented as mean ± SEM percentage cell survival. Statistically significant differences 
between control and treated cells are indicated *p<0.05, **p<0.01, ***p<0.001 after one-way 
ANOVA followed by Dunnett’s multiple comparison test. Data shown represent the average of 







5.1.9 Comparative metabonomic profiling of MCF-7 and MCF-10A cells 
Metabolic profiles were acquired from the hydrophilic methanol extracts of MCF-7 and MCF-
10A cells using 1H NMR spectroscopy. Principal components analysis (PCA) was applied to the 
baseline metabolic profiles of MCF7 and MCF-10A cells to observe the main drivers of 
variation within the metabolic data. From the scores plot obtained from this PCA model 
(Figure 3.2A) clear separation was observed between the two cell lines in the first principal 
component (PC1). This indicates that the tumorigenic difference of the cell lines is the main 
source of variation accounting for 22% of the total variation within the data (metabolites). The 
loadings plot for PC1 from this model (Fig. 3.2B) indicates that this variation was explained by 
an increased amount of lactate, phosphocholine and glycine in the MCF-7 cells compared to 
the MCF-10A.  
An orthogonal projection to latent structures discriminant analysis (OPLS-DA) model 
was built to make a pair-wise comparison between the two cell lines. An OPLS-DA model with 
strong predictive ability (Q2 Ŷ = 0.56, R2Ŷ = 0.98) was obtained and validated by permutation 
testing (1000 permutations; p = 0.001). The correlation coefficients plot from this model is 
presented in Fig. 3.3. MCF-7 cells contained greater amounts of lactate, the amino acids 
alanine, glutamine, glutamate, methionine serine and glycine. MCF-10A cells contained 
higher amounts glucose, myo-inositol, choline and creatine phosphate compared to the MCF-
7, threonine, as well as phosphocholine.  
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A B 
Figure 3.2 Comparison of the metabolic profile obtained from the two cell lines. (A) PCA 
scores plot (PC1 vs PC2). (B) PCA loadings plot of PC1. 
Figure 3.3 OPLS-DA model identifying metabolic associations with cell type. GPC, 
glycerophosphocholine.  
(Q2 Ŷ = 0.56, R2Ŷ = 0.98, p = 0.001) 
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5.1.10 Metabolic profiling with increasing doses of crude watercress extract 
5.1.11 MCF-7 
PCA was performed on untreated samples and samples treated with increasing doses of the 
watercress extract. A clear clustering was observed between the low and the high treatment 
doses on the first principal component representing 17% of the variation (Fig. 3.4A).  No 
observable separation was observed between the untreated samples and those treated with 
the two lower doses (6.25 and 12.5 μl/ml) of the watercress extract. This metabolic transition 
from low to high doses was explained by increases in the intracellular lactate content of the 
cells (Fig. 3.4B). Valid OPLS-DA models with good predictive ability (Q2Ŷ) were returned for 
all the pair-wise comparisons of control MCF-7 cells and cells treated with the different 
watercress extract doses (Table 3.1). 
Watercress treatment of the MCF-7 cells caused a number of metabolic perturbations 
including an increase in lactate production at the highest dose (50 μl/ml), elevated amino acid 
abundance (valine, leucine, isoleucine, alanine, asparagine) and also an increase in the 
glutathione content of these cells. Significant increases of NAD+ were also observed 
accompanied by increased AXP (indistinguishable spectral differences between AMP and 



























Figure 3.4 (A) PCA scores plot of the MCF-7 cells treated with increasing concentrations of 
the watercress extract for 24 hours. (B) PCA loadings plot of PC1 
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Table 3.1 Summary of the OPLS-DA models returned for the comparisons between untreated 
control cells against cells treated with the watercress extract (6.25 -50 μl/ml) and PEITC (5-
30μΜ) for 24 hours from both MCF-7 and MCF-10A cells. 
Treatment R2Ŷ Q2Ŷ P-value 
MCF-7 
Control vs WX 6.25 0.9579 0.4645 0.006 
Control vs WX 12.5 0.9871 0.4948 0.002 
Control vs WX 25 0.9666 0.7333 0.001 
Control vs WX 50 0.9716 0.7525 0.001 
Control vs PEITC 5 0.9809 0.4917 0.002 
Control vs PEITC 10 0.9884 0.9056 0.002 
Control vs PEITC 20 0.9709 0.9317 0.001 
Control vs PEITC 30 0.9978 0.9041 0.001 
MCF-10A 
Control vs WX 6.25 0.9250 0.4678 0.018 
Control vs WX 12.5 0.9344 0.5708 0.004 
Control vs WX 25 0.9639 0.7038 0.001 
Control vs WX 50 0.9782 0.8248 0.001 
Control vs PEITC 5 0.9774 0.0520 0.590 
Control vs PEITC 10 0.8776 0.2292 0.250 
Control vs PEITC 20 0.9079 0.6422 0.001 
Control vs PEITC 30 0.9538 0.8483 0.001 
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Figure 3.5 OPLS-DA coefficients plot comparing the metabolic profiles of untreated control 
MCF-7 cells and the highest dose of WX (50 μl/ml) treated cells. (AXP: indistinguishable 




Treatment of MCF-10A cells with the watercress extract caused a metabolic transition from 
the low to high doses as observed in the PCA scores plot with the different groups separating 
along PC1 (Fig. 3.6A). Similarly to the MCF-7 cells, increased lactate explained the variation 
across the treatment groups (Fig. 3.6B). An OPLS-DA model was constructed to probe for 
discriminating features between control and watercress treated cell samples (50 μl/ml). As 
expected, the model was dominated by elevated lactate in the watercress treated cells with 
concomitant increases in acetate, succinate and 4-aminobuturate (4-AB) as well as choline 
and glycerophosphocholine. The metabolic profile of the untreated MCF-10A cells contained 
higher phosphocholine, the amino acids valine, leucine, isoleucine, glutamate, glutamine, 
methionine and glutathione compared to the watercress treated samples (Fig. 3.7).  
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Figure 3.6 (A) PCA scores plot of the MCF-10A cells treated with increasing concentrations of 





Figure 3.7 OPLS-DA coefficients plot comparing the metabolic profiles of untreated control 




5.1.13 Metabolic profiling with increasing doses of PEITC 
5.1.14 MCF-7 
PCA of untreated and increasing PEITC dose data from MCF-7 cells revealed separation in the 
first principal component based on the PEITC dose representing 42% of the variance in the 
dataset (Fig. 3.8A). PCA demonstrated a metabolic trajectory between low and high doses of 
PEITC driven by lower phosphocholine in the high dose samples compared to the control and 
low dose samples (Fig. 3.8B). 
OPLS-DA models were constructed for a pair-wise evaluation of the effect of the 
four PEITC dose treatments compared to control treatment in the MCF-7 cells. Valid models 
with good predictive ability (Q2Ŷ) were returned for the comparisons between control and 
treated MCF-7 cells (Table 3.1). PEITC treatment induced a strong perturbation in the 
biochemical signature of these cells in a dose dependent manner. Following the high dose 
exposure to PEITC lactate, valine, leucine, isoleucine, methionine and threonine, glutamate 
and glutamine were increased compared to the control treatment and low dose samples. 
PEITC significantly decreased the amount of choline-related metabolites, phosphocholine 
and glycerophosphocholine and glycine. MCF-7 cells treated with a high PEITC dose 
exhibited a characteristic depletion in their glutathione content and taurine to a lesser 
extent (Fig. 3.9). Interestingly, PEITC appears to have a biphasic effect on glutathione, which 




Figure 3.8 (A) PCA scores plot of the MCF-7 cells treated with increasing concentrations of 






Figure 3.9 OPLS-DA coefficients plot comparing the metabolic profiles of untreated control 
MCF-7 cells and PEITC (30 μM) treated cells. 
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5.1.15 MCF-10A  
The metabolic response of MCF-10A cells to PEITC was found to differ compared to that of 
MCF-7 cells. A dose dependent effect was observed with no discernible differences between 
control samples and those treated with the 5 or 10 μM of PEITC. Clustering of the cells treated 
with 30 μM of PEITC was observed on the first principal component (Fig. 3.10A) and was 
driven by decreased levels of alanine and phosphocholine in these samples (Fig. 3.10B).  
Pairwise OPLS-DA models were constructed comparing the effect of the four PEITC 
dose treatments with the control treatment in the MCF-10A cells. The low doses of PEITC (5 
and 10 μM) did not have a significant impact on the metabolic profile of the MCF-10A cells. 
On the contrary, the models built for the pair-wise evaluation of the effects of the two 
highest PEITC dose treatments were of strong predictive ability (PEITC 20μΜ, Q2Y = 0.64, 
PEITC 30μΜ, Q2Y = 0.85) and valid upon permutation testing (PEITC 20μΜ, p = 0.001, PEITC 
30μΜ, p = 0.001). MCF-10A cell respond to PEITC treatment with reductions in their amino 
acid pool (valine, leucine, isoleucine, threonine, alanine, glutamate, glutamine, 
methionine) and phosphocholine and glycine abundance (Fig. 3.11). Strikingly, the higher 
doses of PEITC did not cause depletion in the levels of glutathione or taurine as it was the case 
in the MCF-7 cells but rather increased their levels.   
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Figure 3.10 A) PCA scores plot of the MCF-10A cells treated with increasing concentrations of 






Figure 3.11 OPLS-DA coefficients plot comparing the metabolic profiles of untreated control 




5.1.16 In vitro effects of watercress and PEITC in MCF-7 and MCF-10A cells 
The metabolic alterations observed from the OPLS-DA models were used to perform 
unsupervised hierarchical clustering of the metabolites by integrating the corresponding 
peaks. The results are summarised in Fig 3.12A and Fig 3.12B. A clear metabolic separation of 
all treatments and doses was observed in the MCF-7 cells but the response of the MCF-10A 
cells to the different treatments was varied and characterised by some overlap. No observable 
effects of the low PEITC doses were noted in the MCF-10A cells. MCF-7 cells respond to 
watercress and PEITC treatments by shifting their metabolic phenotype in an anti-parallel 
manner. Metabolites like glutathione, aspartate, glycine, phosphocholine and alanine are 
significantly lower in the MCF-7 cells treated with the higher doses of PEITC but are found in 
higher levels in the watercress treated cells. In addition, amino acids (threonine, glutamine, 
methionine, tyrosine, phenylalanine, leucine, isoleucine, valine and histidine) are 
characteristically elevated in the PEITC treated MCF-7 cells whereas their levels are lower in 
the watercress treated groups.  Comparing the metabolic profiles of the two treated cell lines 
reveals significant differences in the response of cancer and non-transformed cells upon 




Figure 3.12 Unsupervised hierarchical clustering heat-map of metabolites from MCF-7 (A) 
and MCF-10A (B) cells treated with watercress extract or PEITC at increasing concentrations. 




(scaled expression value) of each metabolite is plotted in red-blue colour. The red colour 
indicates metabolites that are high in abundance and blue indicates metabolites low in 
abundance 
 
5.1.17 Cell cycle analysis 
Propidium iodide staining was used to assess the impact of watercress extract and PEITC on 
the cell cycle distribution of MCF-7 and MCF-10A cells.  
At the basal level, untreated MCF-7 cells had 10% greater cell distribution in the S 
phase and 8% in the G2 phase as compared to untreated MCF-10A cells. In MCF-7 cells (Fig. 
3.13) watercress (50 μl/ml) caused a significant 11% reduction in the G1 phase and a parallel 
increase in the proportion of the cells in the S phase. PEITC induced a cell cycle arrest at the 
G1 phase only at the highest doses (20 and 30 μΜ) with concomitant decrease in the 
proportion of cells in the S phase. 
A similar effect of the watercress extract was observed with the MCF-10A cells with an 
8% reduction of cells in the G1 phase and a 4% increase of cells in the S phase (50 μl/ml). In 
contrast, PEITC did not induce a cell cycle arrest at the G1 stage as observed in the MCF-7 
cells. PEITC caused a significant increase in the percentage of cells in the S and G2 phase and a 
concomitant decrease of the cells in the G1 phase only at the two highest doses.  
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Figure 3.13 Cell cycle analysis of MCF-7 (A&B) and MCF-10A (C&D) exposed to a range of 
crude watercress extracts (0-50 μl/ml) and PEITC (0-30μΜ) for 24 hours.  
Data presented as mean ± SEM percentage cell survival. Statistically significant differences 
between control and treated cells are indicated *p<0.05, **p<0.01, ***p<0.001 after one-way 
ANOVA followed by Dunnett’s multiple comparison test. Data shown represent the average of 
three independent experiments with three replicates per sample. WX, watercress. 
5.1.18 DNA oxidative damage 
MCF-10A cells possessed slightly lower basal DNA damage (8.8 ± 1.4%) compared to MCF-7 
cells (13.6 ± 1.6%) (Fig.3.14). Crude watercress extract did not induce any significant 
genotoxic effects in either cell line at any of the concentrations tested. PEITC on the other 
hand was genotoxic in both cell lines at 20 and 30 μM with significantly increased % tail DNA. 
In MCF-7 cells PEITC 20 μM and 30 μM caused 14.1% and 19.2% additional damage 
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respectively. In MCF-10A cells the same treatments induced a further 4.7% and 8.2% damage 
respectively.  
 
Figure 3.14 Genotoxic effects of the crude watercress extract and PEITC on MCF-7 (A&B) and 
MCF-10A (C&D) cells after a 24-hour incubation.  
Data presented as mean ± SEM percentage cell survival. Statistically significant differences 
between control and treated cells are indicated *p<0.05, **p<0.01, ***p<0.001 after one-way 
ANOVA followed by Dunnett’s multiple comparison test. Data shown represent the average of 




5.1.19 Mitochondrial membrane potential 
The impact of increasing doses of the crude watercress extract and PEITC on the 
mitochondrial membrane potential was assessed by fluorescent JC-10. Crude watercress 
extract did not affect the membrane potential of MCF-10A cells but induced significant 
increase in the polarisation of the mitochondrial membrane of MCF-7 cells (Fig.3.15). A 
remarkable loss of mitochondrial membrane potential was observed in the PEITC treated 
groups with the polarisation increasing by 148% in the highest PEITC dose in MCF-7 cells. 
MCF-10A cells were more resistant to the lower doses of PEITC but showed 65% and 115% 
increase in polarisation in the two high PEITC doses respectively. 
 
 
Figure 3.15 Impact of PEITC and the crude watercress extract on the mitochondrial 
membrane potential of MCF-7 and MCF-10A cells as evaluated by increased JC-10 
monomer/aggregate ratio (520/590 nm).  
Data presented as mean ± SEM percentage cell survival. Statistically significant differences 
between control and treated cells are indicated *p<0.05, **p<0.01, ***p<0.001 after one-way 
ANOVA followed by Dunnett’s multiple comparison test. Data shown represent the average of 




Crude watercress extract and PEITC induced a range of phenotypic changes in cell behaviour 
both in MCF-7 and MCF-10A cells. PEITC G1 cell cycle arrest in MCF-7 cells was accompanied 
by significant decreases in cell proliferation as well as elevated DNA damage in this cell line. 
DNA damage can lead to the activation of the tumour suppressor p53, which can then induce 
the expression of p21 that then binds to G1/S cyclin-dependent kinases (Cdk) inhibiting their 
activity and arresting the cells in the G1 phase [100]. PEITC was also shown to cause loss of the 
mitochondrial membrane potential in agreement with other studies [111, 117], which is 
considered the trigger for further downstream events in the apoptotic cascade. Crude 
watercress extract caused an accumulation of cells in the S phase of the cell cycle in MCF-7 
cells. Our results are corroborated by those of Boyd et al. [53] who also observed cell cycle 
delay in the S phase of HT-29 cells treated with a watercress extract. Watercress is known to 
inhibit Cdk gene expression preventing the cells from progressing through the cell cycle. The 
watercress extract also caused minor decreases in cell proliferation and mitochondrial 
potential without however having a genotoxic effect in either cell line. MCF-10A cells were 
highly resistant to any watercress driven phenotypic changes in cell progression and also less 
sensitive to the genotoxic PEITC effects. It should be noted though that the high dose of 
PEITC is cytotoxic to MCF-10A cells, suggesting a hormetic role for this ICT.  
1H-NMR spectroscopy based metabonomics was successfully applied to tumorigenic 
MCF-7 and non-tumorigenic MCF-10A breast cells to examine the fundamental differences in 
their metabolic phenotype. The biochemical impact of crude watercress extract and PEITC 
was then examined on these two cell lines. To our knowledge this is the first study looking at 
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the comparative metabolic responses of these cell lines to bioactive compounds of nutritional 
importance. 
Metabolic phenotype of MCF7 and MCF-10A 
Through basal metabolic profiling it was possible to differentiate between the cancerous 
MCF-7 cell line and the non-transformed MCF-10A cell line. As expected the cancerous MCF-7 
cell line appeared to be more reliant on glycolysis for energy generation as indicated by the 
higher content of lactate. Similarly, greater amounts of phosphocholine were measured in the 
MCF-7 cells, relative to the non-transformed cells. This may be an adaptation to the higher cell 
proliferation rate and the demand for the synthesis of new cellular membranes, and it may be 
coupled to sparing of fatty acids in a glycolytic cellular environment.  
MCF-7 cells also contained higher levels of glutamine. Glutamine is interchangeable 
with glutamate and alpha glutarate in the TCA cycle, which may be redundant in these cells, it 
also acts as a precursor in the biosynthesis of nucleotides and as an amino acid for protein 
synthesis. Higher amounts of the antioxidants glutathione and taurine were also observed in 
the MCF-7 cells. These compounds serve as antioxidants and their increased abundance 
facilitates the maintenance of appropriate cellular redox status by keeping the amount of ROS 
at a level that enables cell proliferation and survival. 
Glutathione 
The MCF-7 breast cancer cells exhibited non-linear but dose-dependent changes in 
glutathione concentrations in response to watercress and PEITC treatments. PEITC appears to 
induce a biphasic response in the glutathione abundance of MCF-7 cells, with increased 
concentrations at low doses and depletion at the two higher doses. The ability of 
isothiocyanates to act as both pro-oxidants and indirect antioxidants may explain the dose-
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dependent fluctuations in cellular glutathione content. Prolonged exposure to low 
isothiocyanate concentrations can induce phase II enzymes, which regulate antioxidant gene 
expression [56] potentially explaining the increase in glutathione observed in the MCF-7 cells 
treated with the lower doses of PEITC. PEITC effectively depletes cells of glutathione by 
continued intracellular conjugation and efflux hence disabling the glutathione antioxidant 
system [60, 165]. Glutathione depletion accompanied by compromised mitochondrial 
function ultimately results in excessive oxidative stress, as demonstrated by the increased 
levels of DNA damage with higher PEITC exposure and this may help explain the observed 
cell cycle arrest and cell cytotoxicity in the PEITC treated MCF-7 cells. Interestingly, PEITC did 
not deplete MCF-10A cells of glutathione and these cells were also less sensitive to PEITC 
induced DNA damage.  PEITC has previously been shown to selectively kill cancer cells with 
lower antioxidant status over non-tumorigenic cell lines [116, 172, 173]  
Glutathione increased in MCF-7 cells with increasing concentrations of the watercress 
extract. This is likely to be a result of the complex mixture of compounds in the watercress 
extract such as phenolics and flavonoids with proven antioxidant properties. Flavonoids 
increase the expression of γ-glutamylcysteine synthetase, which is directly proportional to 
elevated glutathione levels [174]. Watercress is also a rich source of folate [75] which can be 
used in one-carbon metabolism pathway, adding to the cellular glutathione pool. 
Energy status, glycolysis and mitochondrial function 
The ‘’Warburg effect’’ is a well established metabolic phenotype observed in cancer cells. It 
postulates that tumour cells generate ATP through enhanced glycolysis rather than oxidative 
phosphorylation, characterised by higher lactate as seen here in MCF-7 cells, even when 
oxygen is not a limiting factor and although they possess the functional properties to 
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maintain oxidative phosphorylation. As a result the majority of the glucose is converted to 
lactate via glycolysis, providing a rapid source of ATP. However, this is a far less efficient 
process in terms of ATP molecules produced per mol of glucose input.  
Results from the mitochondrial membrane potential assay indicate that the watercress 
extract and PEITC significantly compromise mitochondrial function. Oxidative 
phosphorylation can therefore no longer occur in the mitochondria resulting in cellular 
energy depletion. Up-regulated glycolysis, evidenced by increased lactate levels, is an 
essential adaptation to cope with the limited capacity for ATP generation through oxidative 
phosphorylation. Pyruvate dehydrogenase (PDH) kinase is inhibited by increasing 
concentrations of ROS, which may increase as a result of the observed glutathione depletion 
[175]. PDH kinase catalyses the conversion of pyruvate to acetyl-coA dictating the rate at 
which the TCA cycle occurs and its inhibition may therefore favour lactate production [175].  
One-carbon metabolism 
Significant decreases in glycine were observed in MCF-7 cells treated with the higher 
concentrations of both the PEITC and the watercress extract. Rapidly dividing cells rely heavily 
on the maintenance of their biosynthetic potential as well as redox status for survival. 
Continuous shuttling of carbon molecules in the one-carbon metabolism pathway, which has 
a central role in cell proliferation and cancer progression, ensures the availability of the 
building blocks necessary for the construction of new cellular components. This also sustains 
the formation of reducing power compounds for redox balance. Upon conversion from 
serine, glycine enters the glycine cleavage system and fuels the folate cycle of the one-carbon 
metabolic network. Following a series of reduction and methylation reactions, the folate cycle 
is coupled to the methionine cycle. The two interconnected cycles constitute one-carbon 
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metabolism, the product of which is a multitude of compounds for synthesis of 
macromolecules like proteins, lipids and nucleotides necessary for cell growth [176].  
Glycine has a multifaceted role in cancer cell proliferation and survival. It is involved in 
purine and nucleotide biosynthesis, which forms the basis of DNA synthesis and repair that is 
a central metabolic feature of cell proliferation. Data from a mathematical modelling study in 
60 cell lines (NCI60 panel) suggest that glycine metabolism is positively correlated with 
increased proliferation rates and provides further evidence on its role in purine, ATP and 
NADPH synthesis [177]. Consequently, reductions in glycine content with PEITC treatment is 
consistent with impaired cell survival observed in our results.  
Cellular redox balance is also regulated by glycine/one-carbon metabolism via 
glutathione synthesis and maintenance of NADP+/NADPH ratio. Therefore, glutathione 
depletion by PEITC can be a combined result of both conjugation followed by extracellular 
transport of glutathione as well as a consequence of reduced synthesis of this antioxidant due 
to lack of glycine uptake and conversion.  
Antagonising glycine uptake and its mitochondrial biosynthesis in HeLa cells and in a 
range of other cells resulted in compromised proliferation by prolongation of the G1 phase of 
the cell cycle without any observed effect on protein synthesis, consistent with a defect in 
nucleotide synthesis through one carbon metabolism [178]. Consistently, in our study, PEITC 
caused a significant cell cycle prolongation in the G1 phase of the MCF-7 cells suggesting that 
glycine reductions are likely to be contributing to this effect. 
Threonine and methionine also have an important role in one-carbon metabolism. 
Interestingly the higher doses of PEITC increase the abundance of these amino acids in MCF-7 
cells but not in the MCF10A cells. Threonine, apart from serine, acts as a glycine precursor and 
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is introduced into the one-carbon metabolism pathway via the glycine cleavage system [179]. 
Methionine per se is necessary for protein synthesis, but adenylation of methionine gives rise 
to S-adenosylmethionine (SAM), which in turn acts as a methyl donor in a number of 
metabolic pathways as well as reactions that produce phospholipid head groups for new cell 
membrane composition [176]. SAM is also involved in glutathione synthesis through 
transsulfuration reactions.  
Accumulation of these amino acids in the PEITC treated MCF-7 cells is suggestive of a 
blockage in one-carbon metabolism pathway resulting in the inability of these cells to 
maintain their needs in macromolecules necessary for proliferation.  
Collectively, these observations provide novel evidence for the impact of PEITC and 
watercress in negatively regulating one-carbon metabolism, further substantiating their role 
as anti-cancer agents.   
Lipid metabolism and inflammation 
A prominent target of the crude watercress extract and of PEITC is lipid and phospholipid 
metabolism. Major shifts were observed in both cell lines upon treatments involving choline, 
phosphocholine and glycerophosphocholine. Phosphocholine is a major constituent of cell 
membranes therefore reduced levels of phosphocholine are directly related to loss of cell 
membrane homeostasis and compromised cell proliferation and viability. Elevated 
phosphocholine levels are positively correlated with the expression of COX-2 enzyme, which 
is a pro-inflammatory marker [180]. PEITC has been shown to down regulate the expression 
and activity of COX-2 [171], which is associated with the inactivation of NF-κB. It is plausible 
that reduced phosphocholine observed here reflects COX-2 inhibition as part of an anti-
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inflammatory phenotype in cancer cells. The role of choline metabolism in cancer is highly 
complex and merits further investigation both in in vitro and in vivo models. 
Amino acid metabolism 
PEITC and watercress strongly interact with the metabolism of amino acids in both cell lines. 
PEITC at the higher doses, but not watercress, induced a strikingly selective increase in the 
pool of amino acids in MCF-7 cells, but not in the MCF-10A cells, including branched chain 
amino acids (valine, leucine, isoleucine) and glutamine.  
Glutamine and protein translation 
Glutamine together with glucose represents the two molecules that appear to be the most 
important for cellular metabolic needs. Catabolism of glutamine supplies the cells with 
carbon, nitrogen, energy molecules and reducing equivalents to sustain cancer cell growth 
and proliferation. In the process of glutaminolysis, glutamine is converted to glutamate by 
the action of glutaminase enzymes. Glutamate can then be directly converted to glutathione 
by the enzyme glutathione cysteine ligase (GCL), which in turn regulates the cellular redox 
status. Glutaminolysis can also yield substrates to refuel the TCA cycle. These anaplerotic 
reactions maintain the carbon levels needed for the TCA cycle to preserve its function as a 
biosynthetic ‘hub’ [22].  Increases in the amino acid levels of the cells treated with watercress 
and PEITC suggest that they are not being used for maintaining TCA function which 
ultimately results in energy depletion and cease in proliferation.  
Glutamine is an essential amino acid for biosynthesis establishes and is a key 
component for the protein translational requirements of cancer cells. mTORC1 is master 
regulator of translation, which is inhibited by PEITC [95, 181] but is positively regulated by the 
abundance of glutamine. It is therefore unlikely that PEITC exhibits its inhibitory effects on 
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mTORC1 via glutamine. PEITC causes mitochondrial damage that essentially increases the 
AMP/ATP ratio due to energy depletion, which in turn activates AMPK. AMPK acts upstream of 
mTORC1, ultimately inactivating it and suppressing translation. MCF-10A cells have a lower 
basal mTORC1 activity as compared to the MCF-7 cells [182] suggesting that PEITC has a 
stronger affinity for cells with increased rates of translation.  
3.5 Conclusions 
1H-NMR metabonomics has been successfully applied in profiling and distinguishing between 
tumorigenic and non-transformed cells as well as mapping the responses of MCF-7 and MCF-
10A breast cells to PEITC and crude watercress extract. Our results suggest that the most 
prominent metabolic targets of the two treatments include glutathione metabolism, energy 
metabolism as well as phospholipid and amino acid metabolism. Metabolic biomarkers 
identified in this study provide further evidence on the biphasic impact that PEITC has on the 
oxidative status on breast cancer cells and that the observed effects are distinct between 
malignant and normal cells. Watercress and PEITC can induce significant changes in the 
cancer cell metabonome accompanied by genotoxic effects such as cell cycle arrest, 
mitochondrial damage and oxidative stress. Collectively, these can potentially result in 
increased sensitivity to radiation and DNA damaging chemotherapeutic drugs.  
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4 Sensitisation of human breast cell lines to ionising radiation by 
phenethyl isothiocyanate and watercress extract 
 
Hypothesis 
It is hypothesised that phenethyl isothiocyanate (PEITC) sensitises cancer (MCF-7) cells, but 
not healthy (MCF-10A) cells, to ionising radiation (IR) and that watercress extract protects 
healthy cells from IR induced collateral damage while enhancing the deleterious effects of IR 
in cancer cells.  
 
Aims 
• Examine the combined effect of PEITC or watercress pre-treatment with IR on 
physiological parameters of cell function and genotoxicity 
• Characterise the metabolic response of MCF-7 and MCF-10A cell lines to IR. 
• Investigate how the metabolic profile of the MCF-7 and MCF-10A cells mediated by IR 
exposure following pre-treatment with PEITC or with watercress 
 
Objectives 
• MCF-7 and MCF-10A cells will be exposed to X-ray IR and DNA damage levels will be 
measured using the Comet assay, and cell cycle progression will be assessed using 
flow cytometry.  
• 1H NMR metabonomics and multivariate statistics will be used to define the metabolic 




Breast cancer represents a leading cause of cancer related mortalities globally. Nearly 250,000 
new breast cancer cases are projected to occur solely in the United States in 2016 accounting 
for over 40,000 deaths [183]. In the United Kingdom (UK), breast cancer is the most common 
type of cancer in women, with nearly 53,700 new cases in 2013 and a one in eight estimated 
lifetime risk of diagnosis (Cancer Research UK, 2016). Radiotherapy is a primary treatment 
modality for many breast cancer patients and it aims to damage cellular DNA. Fractionated 
delivery of high-energy X-ray beams generates within the targeted tissue highly reactive free 
radicals, which cause DNA damage via lipid peroxidation or oxidative cellular respiration. 
Radiation-induced damage activates several signal transduction pathways whose primary 
role is to detect genomic injury leading to cell cycle arrest, where DNA is repaired or, in 
occasions of substantial damage, endogenous apoptotic machinery of cells is triggered to 
inhibit further replication of the damaged DNA [184]. Radiotherapy is indisputably a positive 
intervention [14] however as its primary mode of action is the killing of cancer cells to prevent 
replication, other non-cancerous cells can be affected as well. Therapeutic selectivity is 
therefore a vital issue in cancer therapy, and essentially an ideal anticancer agent should be 
toxic to cancerous cells but exert minimum toxicity in healthy cells.  
 Dietary isothiocyanates have been widely studied for their anti-cancer role as well as 
their ability to act as radiosensitisers and radioprotective agents. Benzyl isothiocyanate 
sensitises human pancreatic cancer cells to X-ray irradiation by inducing apoptosis [185] and 
allyl isothiocyanate exerts synergistic effects with IR against lung cancer cells [186]. 
Sulforaphane, a broccoli derived isothiocyanate, has been shown to mitigate genotoxicity 
induced by γ-radiation in human lymphocytes in vitro [187].  
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PEITC has been extensively shown to have direct anti-cancer effects in in vitro cancer models.  
It possesses genotoxic properties causing cell cycle arrest and mitochondrial damage in a 
wide variety of cell lines and it is a potent inducer of apoptosis [99, 102, 108, 188]. Combined 
treatment of cancer cells with PEITC along with established chemotherapeutic agents such as 
cisplatin and doxorubicin potentiates their cancer-killing properties [189, 190] providing 
preliminary evidence for the use of PEITC as an adjuvant treatment during radiotherapy in 
breast cancer patients. PEITC, due to its highly electrophilic nature reacts with cellular thiols 
via thiocarbamoylation. After its cellular uptake it also reacts with glutathione (GSH), the 
major intracellular antioxidant, depleting cells of their GSH content and impacting cell 
survival [60, 108, 165]. As radiotherapy works primarily by inducing DNA damage through the 
formation of free radicals, the ability of PEITC to deplete the radical scavenger GSH is likely to 
contribute to its radiosensitising properties. 
 Epidemiological studies suggest a link between the consumption of Brassica 
vegetables, which are the main dietary source of isothiocyanates, and a reduced risk for many 
types of cancers [160] including breast cancer [161, 162]. Watercress is the main dietary 
source of PEITC as well as a rich source of other phytochemicals such as carotenoids and 
flavonols, and it has been shown to have anti-cancer properties by inhibiting initiation, 
proliferation and metastasis in vitro [53, 58, 164].  
 We previously showed that PEITC and watercress are potent modulators of the cellular 
metabolic landscape and can affect cellular physiology (Chapter 3).  In this study we 
examined the DNA damage response, cell cycle arrest and the metabolic impact of PEITC or 
watercress extract combined with X-ray irradiation exposure on cancerous and non-
transformed breast cells.   
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4.2 Materials and methods 
4.2.1 Cell Culture 
The MCF-7 human breast adenocarcinoma cell line was used as a breast cancer model. The 
cells were purchased from the American Type Culture Collection (ATCC) (LGC standards, 
Middlesex, UK). Cells were cultured in Dulbecco’s Modified Eagle’s Medium (DMEM; Lonza 
Group Ltd, Basel, Switzerland) supplemented with 10% (v/v) foetal bovine serum (FBS; Lonza 
Group Ltd), 2mM glutamine (Thermo Fisher Scientific, Loughborough, UK), 50 U/ml penicillin 
and 50 U/ml streptomycin (Thermo Fisher Scientific, Loughborough, UK) and 1% non-
essential amino acids (Sigma-Aldrich, Dorset, UK).  
The MCF-10A is a non-tumorigenic breast epithelial cell line used as a model of typical 
breast function. The cells were kindly donated by Prof. Graham Packham (University of 
Southampton, Southampton, UK). Cells were maintained in Ham’s F12:DMEM (1:1) (Lonza 
Group Ltd), 20 ng/ml epidermal growth factor (EGF) (PeproTech, London, UK), 0.1 μg/ml 
cholera toxin (Sigma-Aldrich), 10 μg/ml insulin (Invitrogen), 500 ng/ml hydrocortisone 
(Sigma-Aldrich), 5% horse serum (Invitrogen) and 50 U/ml penicillin and 50 U/ml 
streptomycin (Thermo Fisher Scientific, Loughborough, UK). 
Cells were grown in an incubator at 37ºC with 5% CO2 and 95% humidity in 75 cm2 
culture flasks and were routinely passaged at approximately 70% confluency. The medium 
was changed every 2-3 days. For passage, cells were washed with phosphate buffer saline 
(PBS; Lonza Group Ltd) before adding 5ml of Trypsin-Versene® (EDTA) mixture (Lonza Group 
Ltd) and allowing the cells to detach for 3-5 mins for MCF-7 cells and 18-20 mins for MCF-10A 
cells. 5 ml of medium was then added to the cells to inactivate the trypsin and the cell 
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suspensions were centrifuged at 300g for 3 mins. Cell pellets were then resuspended in 
complete media in the flask and incubated.  
4.2.2 Compounds and Extracts 
4.2.2.1 Analytical grade compounds 
Phenethyl isothiocyanate (PEITC) was purchased from Sigma-Aldrich (Dorset, UK). 20 mM 
PEITC stock solution was made up in DMSO fresh on the day of use. 
4.2.2.2 Watercress extracts 
Fresh watercress samples were obtained directly from Vitacress Salads Ltd. (Andover, UK). 
Samples were snap frozen in liquid nitrogen and stored at -80 ºC. Leaves (2 g) and stems (2 g) 
were weighed and placed in a 20 ml syringe (BD Biosciences, Oxford, UK) that had had the 
plunger removed and a circular 25 mm glass microfiber filter (Whatman, Dassel, Germany) 
placed at the bottom. The syringe was then placed inside a 50 ml centrifuge tube without the 
lid and centrifuged at 2600 rpm for 30 mins at 4 ºC to collect the extract. This crude 
watercress extract was then filtered through a 0.22 μm filter (Whatman) and used in the 
cultures. 
4.2.3 Irradiation 
MCF-7 and MCF-10A cells were plated in the respective culture plates for each experiment 
and next day were treated with the crude watercress or PEITC for 24 hours. At the end of the 
treatment period the cells were exposed to 5 Gy X-ray radiation using an orthovoltage X-ray 
unit (Gulmay Medical D3225, Xstrahl, UK). The irradiator was at a stable distance from the cell 
culture plates and the irradiator field was approximately 20 x 20 cm. The cell culture plates 
were placed in the centre of the irradiation field.  
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Following radiation treatment cells were returned in the incubator and were allowed to rest 
for 1 hour. The cells were then collected and used in the experiments.  
4.2.4 Cell viability 
Cell viability was assessed using the MTT (3-[4,5- dimethylthiazol-2-yl]-2,5-diphenyl 
tetrazolium bromide) based in vitro toxicology assay kit (Sigma-Aldrich, Dorset, UK) according 
to the manufacturers instructions. Briefly, 5x103 MCF-7 or MCF-10A cells were seeded in 96 
well plates. Cells were allowed to attach overnight and were then treated with PEITC (10, 20 
μΜ) or the watercress extract  (12.5, 50 μl/ml) for 24 hours. Three hours before the end of the 
treatment duration cell were irradiated and allowed to rest as described above. Two hours 
before the end of duration of the treatment MTT solution was added to each well equal to 
10% of the culture medium volume and the cells were incubated for the remaining 2 hours. 
Following MTT incubation, the formazan crystals formed were dissolved in MTT solubilisation 
solution equal to the original culture medium volume. Plates were shaken to enhance 
dissolution and absorbance was measured at 570 nm and 690 nm (background absorbance)  
4.2.5 Cell Cycle  
Cell cycle progression was evaluated accounting for the percentage of cells in each of the 
phases Gap0/1 (G0/1), Synthesis (S), Gap2/mitosis (G2/M) and apoptotic cells (sub G0/1). The 
principle of the cell cycle analysis is based on the fluorescence intensity of the PI nuclear dye 
that is proportional to the DNA concentration of the cell. MCF-7 and MCF-10A cells were 
seeded at a 1x105 cells per well in 6 well plates and incubated as required. The cells were then 
exposed to the watercress extract and PEITC at 12.5, 50 μl/ml and 10, 20, respectively for 24 
hours and then irradiated with 5 Gy IR and allowed to rest for 1 hour. Following treatment 
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removal, the cells were washed with cold PBS (4°C) and harvested by trypsinisation. Cells were 
pelleted by centrifugation (brand) at 300g for 3 mins and the supernatant was discarded. Cells 
were resuspended in 200 μl of cold PBS and fixed with drop-wise addition of 70% (v/v) fresh 
ice-cold methanol (1 ml). The samples were then stored at -20°C until analysis.  
On the day of the analysis, the samples were centrifuged at 300g for 3 mins and the 
supernatants were discarded. Cell pellets were then resuspended in 200 μl of PBS and 25 μl of 
1 mg/ml RNAse was added to the suspensions. The samples were incubated at 37°C for 30 
mins and then 2.5 μl of 400 μg/ml of PI dye was added to the cells and samples were 
incubated for a further 30 mins at room temperature under dark conditions. The final volume 
of the cell suspensions was adjusted to 600 μl with PBS. Cellular DNA content of 15,000 cells 
was quantified via flow cytometry. The flow cytometry analysis was performed using the FL2 
channel on a BD AccuriTM C6 flow cytometer (Germany). Data analysis was facilitated using the 
Flow Jo software (version 7.6, Tree star Inc, Oregon, USA).  
4.2.6 Comet Assay 
The Comet assay is a semi-quantitative measure of DNA strand breaks in single cells. MCF-7 
and MCF-10A cells were seeded in T25 cells culture flasks at a concentration of 1x106 and 
maintained at 37°C with 5% CO2 and 95% humidity. The cells were then exposed to the 
watercress extract and PEITC at 12.5, 50 μl/ml and 10, 20μM, respectively for 24 hours. Cells 
were then irradiated as explained above. The treatment solutions were then removed via 
aspiration followed by washing with PBS and detaching from the cell culture flask with 
trypsin. Cell suspensions were adjusted to a concentration of 1x106 cells/ml. 
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Following the treatments, 20 μl of the cell suspensions were resuspended in 200 μl of 
warm low melting point agarose (LMA) (0.85% w/v) and applied 75 μl of this was dispensed 
on Comet Slides (Trevigen). The LMA was allowed to solidify at 4°C for 15 mins. The slides 
were then transferred into a staining jar, lysis buffer (2.5M NaCl, 0.1M EDTA, 0.01M Tris and 1% 
(v/v) Triton X – added just prior to use – pH 10) was added and the cells were allowed to lyse 
for 1 hour at 4°C). 
Following lysis of the cells, the slides were placed in a horizontal electrophoresis tank 
and incubated for 20 mins in alkaline buffer (0.3M NaOH, 1mM EDTA – pH 13) at 4°C in dark 
conditions. Electrophoresis was carried out at 26 V, 300 mA for 30 mins at 4°C. Immediately 
after electrophoresis the slides were washed in neutralising buffer (0.4M Tris – pH 7.5) three 
times for 5 mins.  
The slides were then stained with 10 μl of ethidium bromide (20 μl/ml) and DNA 
migration from the nucleus was visualized with a fluorescence microscope (Olympus BX51). 
The computer-based image analysis software, Komet 4.0 (Andor Technology, South Windsor, 
CT) was used to calculate the proportion of DNA that had migrated from the head to the tail 
of the comet (% tail DNA). The mean value from 100 randomly scored cells was taken as an 
index of damage for each replicate well.  
4.2.7 1H NMR spectroscopy-based metabonomics 
The metabolic profiles of MCF-7 and MCF-10A cells were analysed using 1H NMR 
spectroscopy. Cells were seeded at 1x105 cells per well into 6 well plates and treated at 80% 
confluency. The cells were then exposed to the watercress extract at 12.5 or 50 μl/ml of 
extract and PEITC at 10 or 20 μM for 24 hours and treated with IR following the method 
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described above. Media was transferred into eppendorf tubes and cells on the surface of the 
plate were washed twice using 1 ml cold (4ºC) PBS and were then quenched using 1 ml of ice-
cold methanol (maintained on dry ice). The cells were allowed to lyse for 2 minutes and were 
detached from the plate using a Starstedt cell scraper and transferred into an eppendorf tube. 
Methanol quenching was repeated to maximise metabolite recovery. A vacuum concentrator 
(SpeedVac) was used to dry down the cell suspensions before reconstitution in 80 μl of 
phosphate buffer (pH 7.4) in 100% deuterium oxide containing 1 mM of the internal standard, 
3-(trimethylsilyl)-[2,2,3,3,-2H4]-propionic acid (TSP).  
For every sample, a standard one-dimensional NMR spectrum was acquired using a 600 
MHz Bruker NMR spectrometer, with water peak suppression using a standard pulse 
sequence (recycle delay (RD)-90°-t1–90°-tm-90°-acquire free induction decay (FID), RD= 4s, 
t1=28.96 μs, tm= 100 ms). For each spectrum 256 scans and 8 dummy scans were obtained, 
collected in 64K data points with a spectral width of 12.001 ppm. 1H NMR spectra were 
manually corrected for phase and baseline distortions and referenced to the TSP singlet at δ 
0.0. Spectra were digitized using an in-house MatLab (version R2012a, The Mathworks, Inc.; 
Natwick, MA) script. Metabolites were using an in-house database of standards and Chenomx 
NMR suite (version 7.7, Chenomx Inc). Multivariate modelling, including principal component 
analysis (PCA) and orthogonal projections to latent structures discriminant analysis (OPLS-




4.3.1 Cell viability 
The impact of combined IR and PEITC or watercress treatment on cell survival was assessed 
using the MTT assay. At the dose applied IR decreased mean cell survival in both cell lines, 
although this was not statistically significant (p>0.05). Significant decreases in the survival of 
both cell lines were observed with PEITC pre-treatment prior to IR (Fig. 4.1). At 20μM of PETIC 
cell viability was decreased by 86 % in MCF-7 (p<0.01) and 66 % in MCF-10A (p<0.05) relative 
to IR alone. 10 μM of PEITC did not affect MCF-10A cell viability. Exposure to the watercress 
prior to IR did not have an impact on cell viability in MFC-10A cells compared to irradiated 
cells. Combined exposure to both doses of watercress and IR resulted in significant decrease 
in cell viability of MCF-7 cells when compared to the non-irradiated controls (p<0.01). 
 
Figure 4.1 Effect of PEITC and watercress extract (WX) pretreatment (24 hours) combined 
with 5 Gy of IR on MCF-7 (A) and MCF-10A (B) cell viability.  
Statistically significant differences between groups are indicated as follows: ##p<0.01, 
###p<0.01 for comparisons to ‘Control – IR’ *p<0.05, **p<0.01 for comparisons to ‘Control+IR’ 
after one-way ANOVA followed by Dunnett’s multiple comparison test. Data shown represent 
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the average of three independent experiments with three replicates per sample. WX, 
watercress. 
4.3.2 Cell cycle analysis 
Cell cycle kinetics were assessed using propidium iodide staining; the MCF-7 cultures had a 
much higher number of cells in S-phase than was observed with the MCF-10A cells, this is 
consistent with a higher proliferative capacity for the cancer cell line. The response to a 5 Gy 
IR dose also differed; in the MCF-7 cells there was an accumulation of cells in G2 arrest 
coupled to a decrease in the number of cells in S phase. In contrast the MCF-10A cells 
responded to IR by increasing the proportion of cells in the G1 phase of the cell cycle (~6%) 
(Fig. 4.2B) coupled to an 11% reduction in the percentage of cells in G2.  
Pre-treatment of MCF-7 and MCF-10A cells with the watercress extract or with PEITC 
differentially sensitised cells to a subsequent dose of 5 Gy IR, (Fig. 4.2A and 4.2B). In the MCF-7 
cells pre-treatment with PEITC (20 μM) led to a further reduction in the number of irradiated 
cells in S-phase, and an accumulation of irradiated cells in G1 cell cycle arrest with a reduction 
in the proportion of cells in G2 relative to non-pretreated irradiated controls. The same dose 
of PEITC alone caused a 7.6% increase in the proportion of the cells in G1 phase but when 
combined with IR the proportion increased to 18.4% (Fig. 4.2C). In the MCF-10A cells, PEITC 
caused a minor decrease in the proportion of the cells on the G2 phase coupled to an increase 
in the percentage of the cells in the S phase.  
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 In contrast to PEITC, watercress increased the percentage of IR cells in S phase in both 
cell lines. In the MCF-7 cells this was coupled to a decrease in the proportion of cells in G2, 
whereas in the MCF-10A cells the proportion of cells in G1. These observations were not 
observed in non-irradiated watercress treated cells.  
Figure 4.2 Cell cycle analysis of MCF-7 (A) and MCF-10A (B) cells exposed to 5 Gy of IR 
following a 24 hour pre-treatment with PEITC or crude watercress extract. Statistically 
significant differences between irradiated control and treated cells are indicated *p<0.05, 
**p<0.01, ***p<0.001 and significant differences between non-irradiated and irradiated 
cells are indicated ##p<0.01, ### p<0.001 after one-way ANOVA followed by Dunnett’s 
multiple comparison test. (C) % Distribution of MCF-7 cells in G1 upon treatment with 
PEITC or IR. Different letters suggest statistical significance (p<0.05).  
Data shown represent the average of three independent experiments + SEM with two 
replicates per sample. WX, watercress. 
 137 
4.3.3 DNA oxidative damage 
To further assess if the observed cell cycle arrest was a response to DNA damage, MCF-7 and 
MCF-10A cells were treated with PEITC and the crude watercress extract for 24 hours followed 
by exposure to 5 Gy of IR and DNA lesions were quantified using the Comet assay. IR induced 
a 39 % increase in tail DNA in MCF-7 cells and pre-treatment with 20 μM of PEITC significantly 
increased the damage by a further 15 % resulting in a final 66% tail DNA content (Fig. 4.3). 
Exposure of the MCF-7 cells to 50 μl/ml of the watercress extract also increased DNA damage 
levels by 7% compared to the irradiated but non-treated control cells.  
MCF-10A cells exhibited sensitivity to IR but to a lesser extent than the cancerous cells. 
IR induced an 11% increase in tail DNA in these cells. Following a 24 hour pretreatment with 
10 μM of PEITC and 50 μl/ml of watercress extract reduced the comet tail from 19.37% in the 
irradiated cells to 13.88% and 10.5% respectively. The highest dose of PEITC combined with 5 
Gy of IR was genotoxic to the non-tumorigenic cells resulting in a final 44 % tail DNA.  
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Figure 4.3 DNA damage levels in MCF-7 and MCF-10A cells exposed to 5 Gy of IR following 24 
hour pre-treatment with PEITC or crude watercress extract. Statistically significant differences 
between groups are indicated as follows *p<0.05, **p<0.01, ***p<0.001 after one-way ANOVA 
followed by Dunnett’s multiple comparison test.. Data shown represent the average of three 




4.3.4 Metabonomic profiling of MCF-7 and MCF-10A cells in response to IR exposure 
MCF-7 
Metabolic profiles were obtained from the cell extracts of MCF-7 cells exposed to 5 Gy IR and 
of untreated control cells. Principal component analysis (PCA) was applied to these profiles to 
reveal the main source of variation within the metabolic data. The scores plot obtained from 
the PCA model (Fig. 4.4A) showed a separation between the two groups along the first 
principal component, indicating that IR exposure is responsible for the largest amount of 
variance in the data. The loadings plot for PC1 from this model (Fig.4.4B) shows that 
phosphocholine and glycine explained the variation in the model being present in lower 
amounts in the irradiated MCF-7 cells.  
An orthogonal projections to latent structures discriminant analysis (OPLS-DA) model 
was constructed to perform a pair-wise comparison between the untreated and irradiated 
cells. A valid OPLS-DA model with good predictive ability (Q2Ŷ=0.462) was obtained and 
validated by permutation testing (1000 permutations; p=0.005). The metabolites associated 
with IR in MCF-7 cells are shown in the coefficients plot extracted from the OPLS-DA model 
(Fig. 4.5). Irradiated MCF-7 cells contained lower amounts of glutathione and phosphocholine 
as well as glutamine and glutamate, but had higher amounts of lactate, taurine and glucose 
compared to the non irradiated cells.  
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Figure 4.4 (A) PCA scores plot of MCF-7 untreated cells and cells exposed to 5 Gy IR. (B) PCA 
loadings plot for PC1. 
 
Figure 4.5 Correlation coefficients plot obtained from the OPLS-DA model identifying 
metabolic changes in the MCF-7 cells induced by 5 Gy of IR exposure. GPC, 





Exposure of MCF-10 A cells to IR caused a uniform metabolic response in these cells, indicated 
by the tight clustering in the PCA scores plot (Fig. 4.6A). Clear separation can be seen in the 
first principal component, which explains 47% of the total variation within the data. In 
contrast to the MCF-7 cells, irradiated MCF-10A cells had higher amounts of phosphocholine 
(Fig. 4.6B).  
An OPLS-DA model with strong predictive ability (Q2Ŷ=0.87) and valid upon 
permutation testing (p=0.001) was constructed to probe for the discriminating features 
between non-irradiated and irradiated MCF-10A cells (Fig. 4.7). The non-tumorigenic cells 
response to irradiation exposure is characterised by an increase in glutathione, this is in stark 
contrast to the irradiated cancer cells. Irradiation treatment also causes increases in the 
lactate, phosphocholine and amino acid (valine, isoleucine, leucine, alanine, threonine) 
content of these cells.   
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Figure 4.6 (A) PCA scores plot of MCF-10A untreated cells and cells exposed to 5 Gy IR. (B) 
PCA loadings plot for PC1.  
 
Figure 4.7 OPLS-DA model constructed on the metabolic profiles of cell extracts obtained 






4.3.5 Comparative metabolic impact of IR in MCF-7 and MCF-10A cells 
Comparing the metabolic profiles of irradiated MCF-7 and MCF-10A cells returned a 
significant OPLS-DA model (Q2Ŷ=0.895, p= 0.001) (Fig. S1-appendix). Following irradiation the 
metabolic differences between the cell types were consistent with the differences observed 
pre-treatment with higher levels of lactate, alanine, glutamine, and glycine in the irradiated 
MCF-7 cells compared to irradiated MCF-10A cells. The major difference, as observed in the 
metabolic associations (correlation coefficients) summarised in Fig. 4.8, lies in the glutathione 
shifts between the two cell lines. At baseline, MCF-7 cells contained higher amounts of 
glutathione compared to MCF-10A cells however, post IR this was reversed with MCF-10A 
cells containing significantly higher glutathione. In addition, MCF-10A cells had significantly 
lower amounts of phosphocholine pre-IR compared to MCF-7 cells, but this difference was no 
longer significant post IR suggesting a higher phosphocholine utilisation rate by the non-
tumorigenic cell line upon IR exposure.  
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Figure 4.8 Summary of the significant metabolic alterations identified from the OPLS-DA 
models comparing metabolic profiles of MCF-7 and MCF-10A cells with (+IR) and without (-IR) 
radiation exposure (n = 5-6). Colours indicate the correlation coefficient (r) extracted from the 
OPLS-DA model. Red indicates metabolites that are present in higher amounts in MCF-10A 
cells and blue indicates metabolites that are present in lower amounts in MCF-10A cells 




4.3.6 Metabolic perturbations induced by IR combined with PEITC or watercress 
extract pre-treatment 
Valid OPLS-DA models with good predictive ability (Q2Ŷ) were returned for all the pair-wise 
comparisons between irradiated MCF-7 and MCF-10A cells pre-treated with the different 
PEITC and watercress extract concentrations (Table 4.1). The metabolic associations between 
cell type and treatment and how these associations change after exposure to IR are presented 
in Fig. 4.9. 
 
Table 4.1 Summary of the OPLS-DA models returned for the comparisons between irradiated 
control cells against cells treated with the watercress extract (12.5 or 50 μl/ml) and PEITC (10 
or 20 μΜ) for 24 hours from both MCF-7 and MCF-10A cells. 
Treatment R2Ŷ Q2Ŷ P-value 
MCF-7 
Control + IR vs WX 12.5 μl/ml 0.9650 0.6166 0.001 
Control + IR vs WX 50 μl/ml 0.9749 0.6806 0.001 
Control + IR vs PEITC 10μΜ 0.9614 0.8218 0.001 
Control + IR vs PEITC 20μΜ 0.9410 0.6577 0.001 
MCF-10A 
Control + IR vs WX 12.5 μl/ml 0.9589 0.6869 0.003 
Control + IR vs WX 50 μl/ml 0.9949 0.6136 0.001 
Control + IR vs PEITC 10μΜ 0.9259 0.7119 0.001 
Control + IR vs PEITC 20μΜ 0.9735 0.9497 0.001 
 
 
The most striking observation of the impact of the pre-treatment with PEITC or the watercress 
extract followed by IR, was the shift in glutathione levels in both cell lines.  
We previously observed a biphasic response of MCF-7 to PEITC doses with regards to 
glutathione. Low PEITC exposure (10 μM) increased the glutathione content of these cells but 
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was depleted by the high PEITC dose (20 μΜ). This effect of PEITC in MCF-7 cells was the same 
after exposure to IR. Interestingly, in MCF-10A cells, PEITC increased glutathione at both low 
and high doses, but glutathione was significantly decreased after exposure of the PEITC pre-
treated cells to IR.  
Crude watercress extract treament alone, caused an increase in glutathione in MCF-7 
cells and this effect persisted following IR. In contrast, a reduction in GSH was seen in MCF-
10A cells following watercress treatment but was elevated when the watercress treatment 
was followed by IR.  
A great range of metabolic associations established during the pre-treatment of both 
cell lines with watercress extract and PEITC remained largely unchanged following exposure 
of the cells to IR including shifts in lactate, choline, taurine, glycine, UDP-conjugates as well as 
changes in cellular amino acid pools (Fig. 4.10). It should also be noted, that the metabolic 
signature of the MCF-10A cells pre-treated with the high PEITC dose (20 μM) combined with 
IR, is suggestive of a metabolic shut-down in these cells, with the majority of the metabolites 





Figure 4.9 Summary of the metabolites associated with the OPLS-DA models given by the 
correlation coefficient (r) with the response variable, in this case PEITC or watercress (WX) 
treatment and IR (n = 5-6) in comparison to non-irradiated control or irradiated control cells. 
The red colour indicates metabolites that are positively correlated with the respective 
treatment (PEITC or WX) and blue colour indicates a negative correlation between 




Radiotherapy is an important treatment modality in breast cancer. Cancer cells posses several 
aberrant signalling pathways that can result in drug resistance or failure of therapeutic 
outcomes. Current research suggests that combination therapy can kill cancer cells more 
efficiently via diverse mechanisms simultaneously [191]. Isothiocyanates such as PEITC have a 
range of cellular targets for cancer-related outcomes [191]. This property makes PEITC and its 
dietary source watercress, highly desirable for combinatorial therapeutic methods, assuming 
it does not decrease the effectiveness of radiotherapy or enhance its negative effects on local 
healthy tissue.  
The aim of this study was to examine the impact of PEITC and of crude watercress 
extract combined with IR on cancerous and non-cancerous cells. To our knowledge this is the 
first study examining this concept. Our observations suggest that PEITC can sensitise MCF-7 
cells towards IR induced damage but can also harm MCF-10A cells to a lesser extent. The 
watercress extract appears to be protective in MCF-10A rescuing them from IR oxidative 
damage. The potential mechanism of action explaining our observations involves the ability 
of watercress and PEITC to interact with glutathione, modifying the anti-oxidant potential of 
the cell lines. 
 In the cancerous MCF-7 cells IR caused G2 cell cycle arrest as a result of increases in 
DNA damage levels but no significant impact of IR on cell survival was observed, suggesting a 
potential resistance of these cells to IR killing. Our results are consistent with those of Jänicke 
et al. [192] who observed the same cell cycle arrest and failure of IR to activate the 
mitochondrial intrinsic apoptosis pathway. Pre-treatment with PEITC results in significant G1 
arrest parallel to increased DNA damage and significant compromise of cell viability. These 
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observed effects are likely to be mediated by the ability of PEITC to further induce p53 activity 
in MCF-7 cells [193] which is a potent regulator of G1 cell cycle arrest. PEITC can also induce 
apoptosis from the mitochondria in breast cancer cells by caspase activation as well as 
changes in the Bac/Bcl-2 ratio following the release of cytochrome c, all significant elements 
of the intrinsic apoptotic pathway [119]. 
At the biochemical level, different responses were observed in glutathione abundance 
following IR exposure in MCF-7 versus MCF-10A cells. Treatment of MCF-7 cells with IR 
resulted in intracellular glutathione depletion in agreement with other studies where 
important decreases in glutathione were observed in cancer cells exposed to IR [63, 194, 195]. 
In contrast, MCF-10A cells responded to IR induced stress by increasing their glutathione 
content. IR generates reactive oxygen species (ROS), which are quenched in part through the 
glutathione response reducing the potential of ROS to exert oxidative DNA damage. 
Elevations in intracellular glutathione in MCF-10A cells can be considered part of a protective 
response by up-regulating the metabolic anti-oxidant capacity of these cells. This may explain 
their ability to better recover from IR induced damage compared to MCF-7 cells, and which 
may explain the lower levels of DNA damage observed in the healthy cells in this study.  
MCF-10A cells respond to low dose PEITC treatment (10 μM) by elevating their 
glutathione content. When these cells are exposed to IR and PEITC (10 μM), glutathione is 
depleted contrary to the cancer cells. Depleted glutathione pools suggest increased 
utilisation of glutathione for IR-derived ROS scavenging purposes, explaining the decreased 
DNA damage levels in these cells.  
 Pre-treatment of MCF-10A cells with the watercress extract also appeared to be 
protective when the cells were exposed to IR, evidenced by the reduced levels of DNA 
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damage. Watercress extract has been shown to possess anti-genotoxic properties in several in 
vitro models where cells have been challenged with known genotoxic agents [53, 122]. The 
combined treatment of MCF-10A cells with the watercress extract and IR appears to increase 
the glutathione content of these cells, suggestive of enhanced anti-oxidant activity and 
hence a protective effect. It can be argued that other anti-oxidant compounds present in 
watercress spare some of the glutathione in these cells.  
The protective effect of watercress in healthy cells observed here is unlikely to be a 
result of PEITC or any other ITC since they are not present in the extract, as a result of the high 
volatility of these compounds as well as the snap freezing of the plant material, which 
inactivates the myrosinase enzyme. PEITC alone was found to be genotoxic at high 
concentrations in the healthy cells therefore, the anti-genotoxic effect of the watercress 
extract can be attributed to the great range of other phytochemical present such as phenolics 
and carotenoids (phytochemical profiling of watercress described in Chapter 5).  
 The metabolic signatures of MCF-7 cells indicate that glutathione depletion is a major 
target for PEITC, which can lead to the build up of intracellular ROS resulting in cell damage. 
Elevated ROS is a characteristic outcome of IR exposure and combined with the glutathione 
depleting property of PEITC can be exploited for cancer cell killing. Indeed, our results 
suggest that PEITC treatment can sensitise cells to IR induced damage as observed from G1 
cell cycle arrest, elevated DNA damage levels and reduced cell viability. Combined treatment 
of MCF-7 cells with the high PEITC dose (20 μΜ) and IR is also characterised by sparing of 
glucose and reduced lactate abundance, suggesting that the rates of glycolysis are 
diminished. Glycolysis is the main source of energy and of biosynthetic molecules in cancer 
cells. Attenuated activity of this pathway further adds to the cancer killing process.  
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 Cellular membranes are a primary target of IR due to the impact ROS can have on lipid 
bilayers of which phosphocholine is a main constituent. Scavenging of ROS by the higher 
levels of glutathione observed in MCF-10A cells can explain the apparent increase in their 
phosphocholine levels following IR. This may reflect the efforts to maintain cell membrane 
integrity, which can be violated by ROS produced as a result of IR exposure. Conversely, the 
MCF-7 response to IR is characterised by lower levels of phosphocholine. Phosphocholine can 
potentially serve as a breast cancer biomarker since higher levels of this molecule have been 
reported in the clinical setting in breast cancer lesions compared to benign breast cancer 
lesions [196-198] as well as in vitro in comparisons of cancerous cell with normal mammary 
epithelial cells [199]. Decreases in phosphocholine have been observed in tissues after 
chemotherapy and radiation treatment and have been correlated with positive therapy 
outcomes [194, 200-202].  
 PEITC treatment reduces phosphocholine abundance suggesting an impact on cell 
membrane integrity that may contribute to radiation induced cancer cell killing. However, 
this effect is not limited to the tumorigenic landscape. High dose of PEITC combined with IR is 
genotoxic to healthy cells, characterised by DNA and apparent reduced metabolic activity, 
providing further evidence to the hormetic behaviour of dietary isothiocyanates [203]. 
4.5  Conclusions 
These results suggest a potential synergistic effect of PEITC and IR towards MCF-7 cell killing 
and radiosensitisation and that watercress extract, free of PEITC, can rescue healthy cells from 
collateral damage. It is postulated that glutathione has a principal role in the response of cells 
to IR challenge and that the inclusion of dietary watercress during RT may enhance the 
 152 
outcome. Our study examined the acute effects of IR therefore future work could be 
performed to examine the repair mechanisms of both cell lines subjected to the treatments 
over time. In addition, better insight into the apoptotic pathways induced by IR combined 





6 Effects of domestic processing methods on the phytochemical content 
of watercress (Nasturtium officinale) 
 
Hypothesis 
It is hypothesised that common cooking methods will significantly impact the nutrient 
content of watercress and that the phytochemical profiles obtained will differ according to 
the cooking method employed. 
 
Aims & Objectives 
• The effect of boiling, microwaving, steaming, chopping and blending into smoothie 
will be examined on the major phytochemical compounds in watercress. 
• Flavonols, glucosinolates and carotenoids will be quantified using liquid 
chromatography and mass spectrometry. 
• Total antioxidant activity of watercress following the different processing methods will 




Watercress (Nasturtium officinale) belongs to the family of Brassicaceae together with broccoli, 
cabbage, mustard and Brussels sprouts. Epidemiological studies associate a higher intake of 
Brassica vegetables, such as watercress, with a reduced risk of various types of cancers [160]. 
Watercress is an exceptional source of natural, bioactive compounds for which research has 
highlighted a favourable role in anti-genotoxic and anti-cancer processes both in vivo and in 
vitro [53, 57, 58]. The health benefits of watercress have been attributed to phytochemicals 
including glucosinolates, carotenoids and flavonoid compounds. 
 Watercress, and essentially all members of the Brassicaceae family, has been identified 
as a rich source of glucosinolates [63]. Glucosinolates are hydrolysed to isothiocyanates by the 
action of the enzyme myrosinase (β-thiglucoside glucohydrolase; EC 3.2.3.1), upon cell tissue 
damage such as mastication, chopping or cooking. This group of plant bioactive compounds 
is responsible for the characteristic pungent taste that Brassica vegetables possess. 
Gluconasturtiin (2-phelylethyl glucosinolate) is the most prominent glucosinolate in 
watercress [53, 57] with a range of aliphatic and indole glucosinolates adding to its 
glucosinolate profile.  
High concentrations of carotenoids and flavonol compounds are also contained in 
watercress. Carotenoids with well established health benefits such as β-carotene, lutein and 
zeaxanthin are abundant in watercress [76]. Flavonols like quercetin, kaempferol and 
isorhamnetin, make up the polyphenolic core of watercress [204]. Polyphenols have attracted 
great importance due to their many health benefits related to cardiovascular function, 
antioxidant and anticancer activity (Morel, Lescoat, Cillard, & Cillard, 1994 Doostdar, Burke, & 
Mayer, 2000; Galati, Teng, Moridani, Chan, & O'Brien, 2000).  
 155 
While watercress is widely consumed raw in salads, it is becoming increasingly popular 
in cooked foods such as soups, smoothies and also wilted in pasta and meat dishes. Annual 
retail sales of watercress in the United Kingdom amounted to 40 million pounds in 2015. Sales 
of food products with cooked or processed watercress as the main ingredient have taken off 
the last few years, representing approximately 50% of total watercress sales (S. Rothwell, 
Vitacress salads LTD, personal communication, March 10, 2016). Culinary processing is the 
source of several complex biochemical and physical alterations, modifying the phytochemical 
constituents of vegetables, ultimately resulting in nutritional changes [205].  
To our knowledge, phytochemical characterisation of watercress subjected to different 
culinary treatments has not been explored to date. The present research was undertaken to 
elucidate the effects of five common cooking methods on the phytochemical profile of 
watercress and formulate suggestions for the most appropriate method for consuming 
watercress for maximum nutrient ingestion. (The work for this chapter has been published in 
the Journal of Food Chemistry) 
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6.2 Materials and methods 
6.2.1 Plant Material 
Fresh watercress samples were provided from VITACRESS LTD (Andover, Hampshire, UK), 
transferred to the laboratory and stored at 4 °C for up to 24 hours until all watercress 
processing analyses were performed. Only samples free from mechanical damage were used 
in the experiments. All analyses were performed in triplicate using the same batch of plant 
material to minimise variation in our results.  
6.2.2 Reagents & Chemicals 
All chemicals were obtained from Sigma Aldrich (Poole, UK), unless otherwise stated.  
6.2.3 Domestic Processing 
The effect of domestic processing on the phytochemical content and antioxidant activity of 
watercress was examined by cooking of the plant material by boiling, microwaving, steaming, 
chopping and blending with water to make a watercress smoothie. Processing treatments 
and cooking times used were decided upon general consumer preferences and after online 
search of watercress recipes as well as using past research papers looking at the effects of 
domestic processing on other types of Brassica vegetables. 100 g portions of watercress were 
used for each replicate (n=3). Temperature data for boiling and steaming treatments were 
recorded throughout cooking, using a temperature logger (Squirrel OQ610-S, Grant 
instruments, UK) and a type T thermocouple.  
Boiling (n=3): 500 ml of tap water was brought to boil (90 °C) in a stainless steel pot and 
watercress was boiled for 2, 5 and 10 min. Watercress was removed from the boiling water 
and was kept at -20 °C for analysis.  
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Microwaving (n=3): Fresh watercress was placed in plastic trays, then transferred to a 
domestic microwave oven (Panasonic, UK) and cooked at full power (1400 W) for 1, 2 and 3 
min.  
Steaming (n=3): A domestic steamer (Russel Hobbs, UK) was pre-heated at 100 °C with 500 ml 
water at its base. Watercress was placed in the steamer and cooked for 5, 10 and 15 min.    
Chopping (n=3): 100 g of watercress was transferred to a food processor (Waring Commercial, 
New York, USA) and chopped for 30 secs at full speed. To study the effect of storage time on 
the phytochemical content, the chopped watercress was left on the bench at room 
temperature (21 °C) for 0, 10, 30, 60 and 120 min to replicate how watercress can be treated at 
home when chopped in salads or other dishes and not consumed immediately after 
preparation.  
Watercress smoothie (n=3): 100 g of the plant material was transferred to a juice maker 
(Vitamix, Total Nutrition Centre, UK), 200 ml of water was added and the watercress was 
blended for 30 secs at full power. The effect of storage time was also examined by leaving the 
smoothie on the bench at room temperature (21 °C) for 0, 10, 30, 60 and 120 min. 
After processing, all samples were immediately frozen in liquid nitrogen then freeze-dried 
(Christ A 2-4 LD, Christ, Germany); ground to fine powder using a coffee bean grinder 
(De’Longhi, Italy), vacuum packed and stored at -20 °C.  
6.2.4  Preparation of watercress extracts 
Crude methanol (MeOH) extracts: The method used for the preparation of the extracts was 
adapted from Bell et al. [206] Briefly, 40 mg of ground watercress powder was heated in a dry-
block at 75 °C for 2 min to inactivate myrosinase enzyme. Preheated (70 °C) 70% (v/v) MeOH 
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(1 ml) was then added to each sample and placed in a water bath for 20 min at 70 °C. Samples 
were then centrifuged for 5 min at 6,000 rpm and the supernatant was transferred to fresh 
tubes. The final volume was adjusted to 1 ml with 70% (v/v) MeOH and stored at -20 °C until 
the day of analysis. MeOH extracts were used for the FRAP assay, total phenols as well as 
flavonols and glucosinolates identification and quantification. 
Acetone extracts: Total and specific carotenoids were determined in acetone watercress 
extracts. Watercress powder (25 mg) was weighed out in Falcon tubes (12 ml) previously 
wrapped in aluminium foil to minimise the degradation of carotenoids by ultra-violet light. 
Acetone (4 ml) was added to the powder and the samples were shaken for 15 min at 8000 
rpm. Following centrifugation at 4000 rpm for 5 min, the supernatant was transferred to a 
clean tube and the process was repeated (4 ml acetone for the second time and 2 ml the third 
time) until a colourless supernatant was obtained. The combined supernatants were 
transferred in fresh tubes and the final volume was adjusted to 10 ml with 100% acetone.  
6.2.5 Determination of total phenolics  
Total phenols were measured using the method developed by Singleton and Rossi [207] with 
slight modifications. Briefly, 0.2 ml of the MeOH watercress extract (Section 2.4) or blank was 
added to 6.0 ml of distilled water in volumetric flasks and mixed with 0.5 ml of Folin - 
Ciocalteu reagent. A sodium carbonate solution 20% (v/v) (1.5 ml) was added to the mixture 
and the volume was adjusted to 10 ml.  Absorbance was read after incubation of the samples 
for two hours at room temperature, at 760 nm using a UV-Vis Spectrophotometer (UV-VIS, 
Perkin Elmers, UK). A standard curve was made using gallic acid in the following 
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concentrations: 0, 50, 100, 150, 250, 500, 750 &1000 mg/L and total phenols were measured as 
gallic acid equivalents (R2 > 0.99).  
6.2.6  Ferric Reducing Antioxidant Power (FRAP) assay 
Antioxidant activity of the samples was determined using the FRAP assay based on an 
adapted version of the method developed by Benzie and Strain [208].  The FRAP reagent was 
made by mixing 25 ml of 300 mM acetate buffer (pH 3.6), 2.5 ml 10 mM 2,4,6-tripyridyl-s-
triazine solution (TPTZ) and 2.5 ml of freshly prepared ferric chloride hexahydrate 
(FeCl3·6H2O).  A standard curve was made using L-Ascorbic acid in the following 
concentrations: 0, 10, 50, 100, 250, 500, 750, 1000 μmol/L (R2 > 0.99). Each sample (MeOH 
extracts from Section 2.4) or standard (10 μl) was combined with 300 μl of the FRAP reagent 
and 100 μl of the mixture was transferred in duplicate in a 96-well plate. Absorbance was 
measured immediately using a plate reader (Tecan GENios, Geneva, Switzerland) at 595 nm.  
6.2.7 Total carotenoids 
An aliquot of the acetone extracts prepared as previously described (Section 2.4) was used to 
quantify the total carotenoid content of the samples spectrophotometrically. Absorbance was 
measured at 470, 645 and 662 nm in a spectrophotometer (UV-VIS, Perkin Elmers, UK). The 
total amount of carotenoids was calculated according to the following equations by 
Lichtenthaler [209].   𝐶! = 11.24 𝐴!!" − 2.04 𝐴!"# 𝐶! = 20.13 𝐴!"# − 4.19 𝐴!!" 𝐶!!! = 7.05 𝐴!!" + 18.09 𝐴!"# 𝐶!!! =  1000 𝐴!"# − 190 𝐶! − 63.14 𝐶!214  
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*Chlorophyll a (𝐶!), Chlorophyll b (𝐶!), Total Chlorophylls (𝐶!!! ), Total Carotenoids (𝐶!!!). Equations are based 
on specific absorption coefficients for 100% acetone. The pigment concentrations obtained by inserting the 
measures absorbance values are μg/ml plant extract solution.   
6.2.8 Quantification of carotenoids via HPLC 
To determine the amount of lutein, zeaxanthin and β-carotene present, the acetone extracts 
were used (Section 2.4). Carotenoids were quantified using the method developed by 
Guiffrida et al. [210] with modifications.10 ml of the extract was mixed with 10 ml of diethyl 
ether, 10 ml of water and 5ml of 10% (v/v) NaCl. Two layers were formed and the lower - 
acetone phase was discarded. The upper layer containing the ether was collected in a glass 
vial and anhydrous Na2SO4 was added to it to remove any moisture from the solution.   The 
ether phase was transferred to a clean glass vial, the volume was adjusted to 10ml with 
diethyl ether and the solution was condensed under nitrogen gas. The dry residue was then 
reconstituted in 1 ml of methyl tert- butyl ether (MTBE):MeOH (1:1, v/v), filtered using 0.22 μm 
syringe driven filter unit and analysed by HPLC.  The analyses were performed using an 
YMC30 column (5 µm 250 x 4.6 mm) on a HP Agilent 1050 series HPLC system. The mobile 
phases used were as follows: Eluent A, consisting of MeOH:MTBE:H2O (82:16:2 v/v/v) and 
Eluent B, consisting of MeOH:MTBE:H2O (23:75:2 v/v/v). The analyses followed a gradient 
program for the mobile phases, 0 min 0% B, 20 min 0% B, 80 min 70% B, 90 min 70% B. The 
protocol used a 1 mL/min flow rate and a 100 µL injection volume. UV-vis spectra were 
gathered in the range of 190-600 nm and the chromatograms were analysed at 450 nm. 
Identification was based on retention times by comparison with HPLC grade standards of 
lutein, zeaxanthin and β-carotene (Extrasynthese, France).  
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6.2.9 Identification and quantification of glucosinolates and flavonols via LC-MS/MS 
Methanol extracts, prepared as described above, were used for the quantification of 
glucosinolates and flavonols in the samples (Section 2.4.1). Each extract (1 ml) was filtered 
using a 0.22 μm syringe driven filter unit (Millex; EMD Millipore, Billerica, MA, USA) and then 
diluted using 9ml LC-MS grade water. For the quantification of glucosinolates and flavonols, 
external calibration curves of 12 mM sinigrin hydrate and isorhamnetin standards were 
prepared using the following concentrations (56 ng.μl-1, 42 ng.μl-1, 28 ng.μl-1, 14 ng.μl-1, 5.6 
ng.μl-1, R2 > 0.99). Glucosinolates and flavonols were analysed by LC-MS/MS using an Agilent 
1200 LC system coupled to an Agilent 1100 series LC/MS mass trap spectrometer. Separation 
conditions of samples and MS analysis settings used are identical to those described by Bell, 
Oruna-Concha [206] . Glucosinolates were quantified at 229 nm and flavonols at 330 nm. The 
identification was performed using the compounds nominal mass and the analysis of their 
fragmentation patterns, and also by the comparison with previously published data. All data 
were analysed using Agilent ChemStation.  
6.2.10  Statistical Analysis 
The results are presented as the mean of three biological replicates (n = 3) for each sample. 
One-way ANOVA and Dunnett’s multiple comparisons test were used for comparison of all 
treatments related to the raw watercress. These analyses were carried out using GraphPad 
Prism version 5.0a for Mac OS X,GraphPad software (Version 5.0a La Jolla, California, USA). 
Principal component analysis (PCA) and correlation analysis were performed using XL Stat 
(Version 2016 Addinsoft, New York City, New York, USA).   
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6.3 Results and Discussion  
6.3.1 Total phenols content  
Fresh watercress had the highest amount of total phenols (14.86 ± 2.02 mg GAE g-1 DW) 
compared to the processed samples (Fig. 5.1A). Our results are in agreement with that of 
Aires, Carvalho [211] who found the phenolic content of watercress to be 14.00 ± 0.03 mg 
GAE g-1 DW. In comparison to other vegetables in the Brassica family, watercress is a rich 
source of phenolic compounds. It has a similar amount to kale (16.67 ± 0.67 mg GAE g-1 DW) 
[212] and it is much higher than broccoli and cabbage which have a lower phenolic content 
that being 8.86 mg and 5.6 mg GAE g-1 DW respectively [213, 214].  
Boiling of watercress resulted in a significant decrease (P<0.05) in the total phenolic 
content in comparison with the fresh samples. Total phenolic losses ranged from 49% to 71% 
in the samples boiled for 2 and 10 minutes respectively. Microwaving and steaming for up to 
5 minutes did not significantly affect the phenolic content of watercress (P>0.05). Likewise, 
blending with water to make a watercress smoothie and chopping did not have a significant 
effect on the total phenolic content in the watercress. However, storage of the smoothies and 
the chopped watercress samples for 120 minutes at room temperature resulted in a 
significant reduction of the phenolics from 13.65 ± 1.56 to 10.76 ± 1.15 mg GAE g-1 DW and 
from 10.55 ± 1.48 to 8.65 ± 2.29 mg GAE g-1 DW respectively (Figure 1A).  
Our results are corroborated by previous studies showing that boiling of Brassica 
vegetables can lead to significant time dependant losses of phenolics whereas microwaving 
and steaming led to only minor decreases in the phenolic content of broccoli [215, 216], red 
cabbage [217] and cauliflower [218]. During the process of cooking, phenolic compounds 
 163 
appear to be highly reactive undergoing several changes including their release from bound 
forms, oxidation, degradation and polymerisation [213].  
The losses during boiling can be attributed to water-soluble compounds leaching into 
the water used for boiling or due to breakdown of these compounds during thermal 
processing. Indeed, analysis of the water used in the boiling experiments (9.35 ± 0.12 mg GAE 
g-1 DW) for total phenolics revealed that phenols had leached into the boiling water. The total 
amount of phenols in the water used in boiling and the remaining phenol content of 
watercress was no different from the total phenols in raw watercress. The minimal effect of 
microwaving and steaming on the phenolic compounds is potentially a result of limited or no 
contact of the samples with water and also the inactivation of oxidative enzymes preventing 

























Figure 6.1 (A) Total phenols content in raw and processed samples expressed as gallic acid 
equivalents (GAE) in mg g-1of dry weight (DW). (B) FRAP-assay results for the measurement of 
the antioxidant activity in raw and cooked watercress samples. Results are presented as 
ascorbic acid equivalents (AAE) in mg g-1 of DW. Data is mean of three biological replicates + 
SD. Significance: *, P < 0.05; **, P < 0.01; *** P < 0.001 as compared to raw watercress.  (BD: 





































































































































































































































6.3.2 Flavonols identification and quantification 
Flavonol profiling of watercress revealed three main derivatives namely kaempferol, 
quercetin and isorhamnetin as well as feruloyl, ceffeoyl, p-coumaroyl and sinapoyl glucosides 
attached to kaempferol and quercetin. Kampferol-3-diglucoside-7-glucoside was the most 
abundant flavonol detected (3.76 ± 0.09 mg g-1 DW). The flavonols identified in the fresh 
watercress leaves are similar to those defined by Martinez-Sanchez, Gil-Izquierdo [204].  
Domestic processing of watercress resulted in a significant decrease in the levels of all 
quantified flavonols (Table 5.1). The only exception was Q 3,4'diGlc-3'-(p.coum-Glc) + K 3,4'-
diGlc which appeared to be the most stable of all flavonols and were only significantly 
affected by boiling (P<0.05). Total flavonol losses suggest that these compounds are 
particularly sensitive to all cooking regimes used. Boiling for 10 minutes nearly depleted all 
watercress samples of flavonols in a time dependent manner. The unstable nature of 
flavonols was also apparent in chopped watercress and watercress smoothie with the levels 
going down to 3.42 ± 0.32 and 4.11 ± 0.36 mg g-1 DW respectively as compared to the total 
amount of flavonols in the fresh samples (10.70 ± 1.07mg g-1 DW, P<0.001). Similarly to total 
phenols, the highest retention of flavonols was observed in the microwaved watercress 
followed by steamed.  
  
Table 5.1 Concentration of individual and average total flavonols in raw and processed watercress samples. Data are presented in 
mg g-1 of DW (mean ± SD). Experiment was performed with three biological replicates per group. Significance: *, P < 0.05; **, P < 
0.01; *** P < 0.001 as compared to flavonoid content of raw watercress. Abbreviations: K, kaempferol; I, isorhamnetin; Q, quercetin; 
Glc; glucoside, fer, feroloyl; sinp, sinapoyl; p.cisoum, p-coumaroyl; caf, caffeoy
 
 K 3-diGlc- 

















 mg g-1 DW 
Raw 3.76±0.09 1.18±0.03 1.73±0.06 0.52±0.01 0.35±0.02 1.35±0.26 0.76±0.02 0.68±0.14 0.36±0.05 10.70±1.07 
           
Boiled 2m 1.09±0.16*** 0.46±0.04*** 0.62±0.08*** 0.28±0.01*** 0.21±0.04 0.29±0.09*** 0.36±0.08*** 0.20±0.02*** 0.15±0.05*** 3.66±0.30*** 
Boiled 5M 0.55±0.04*** 0.26±0.02*** 0.34±0.03*** 0.17±0.02*** 0.08±0.01*** 0.18±0.09*** 0.19±0.05*** 0.11±0.06*** 0.13±0.06*** 2.01±0.15*** 
Boiled 10m 0.58±0.16*** 0.26±0.06*** 0.35±0.08*** 0.16±0.03*** 0.06±0.03*** 0.12±0.07*** 0.13±0.02*** 0.13±0.15*** 0.08±0.02*** 1.86±0.17*** 
           
MW 1m 2.25±0.33** 0.76±0.06*** 0.99±0.20*** 0.36±0.09* 0.37±0.09 0.63±0.42*** 0.61±0.08* 0.36±0.05*** 0.20±0.04*** 6.53±0.62** 
MW 2m 1.57±0.43*** 0.54±0.16*** 0.74±0.21*** 0.25±0.08** 0.23±0.17 0.47±0.19*** 0.38±0.23* 0.24±0.10*** 0.15±0.04*** 4.57±0.44*** 
MW 3m 1.31±0.22*** 0.44±0.09*** 0.57±0.10*** 0.20±0.04*** 0.25±0.04 0.29±0.01*** 0.44±0.01* 0.23±0.01*** 0.14±0.01*** 3.87±0.36** 
           
Steamed 5m 1.50±0.28* 0.53±0.11*** 0.68±0.13*** 0.27±0.10*** 0.28±0.10 0.40±0.08*** 0.44±0.16* 0.23±0.05*** 0.16±0.03*** 4.47±0.41** 
Steamed 10m 1.41±0.29*** 0.49±0.11*** 0.64±0.11*** 0.22±0.06*** 0.24±0.11 0.36±0.04*** 0.41±0.16** 0.21±0.01*** 0.15±0.06*** 4.12±0.39** 
Steamed 15m 1.25±0.19*** 0.45±0.06*** 0.59±0.11*** 0.22±0.07*** 0.19±0.06 0.32±0.10*** 0.36±0.08*** 0.16±0.03*** 0.15±0.02*** 3.70±0.35*** 
           
Smoothie 0m 1.31±0.01*** 0.47±0.02*** 0.66±0.01*** 0.26±0.02*** 0.27±0.07 0.44±0.26*** 0.37±0.06*** 0.21±0.05*** 0.11±0.04*** 4.11±0.36*** 
Smoothie 30m 0.92±0.10*** 0.35±0.03*** 0.49±0.05*** 0.14±0.03*** 0.18±0.02 0.25±0.14*** 0.24±0.04*** 0.10±0.02*** 0.07±0.01*** 2.73±0.27*** 
Smoothie 60m 1.11±0.16*** 0.44±0.09*** 0.64±0.11*** 0.19±0.03*** 0.28±0.04 0.30±0.08*** 0.28±0.09*** 0.10±0.02*** 0.06±0.01*** 3.39±0.33*** 
Smoothie 120m 1.13±0.20*** 0.42±0.06*** 0.64±0.12*** 0.23±0.07*** 0.19±0.02 0.26±0.11*** 0.29±0.10*** 0.11±0.06*** 0.06±0.03*** 3.34±0.33*** 
           
Chopped 0m 1.12±0.17*** 0.42±0.07*** 0.58±0.09*** 0.15±0.04*** 0.17±0.10* 0.41±0.14*** 0.30±0.11*** 0.16±0.03*** 0.11±0.01*** 3.42±0.32*** 
Chopped 30m 0.96±0.13*** 0.44±0.07*** 0.53±0.07*** 0.13±0.02*** 0.24±0.04 0.24±0.03*** 0.40±0.04** 0.16±0.01*** 0.10±0.01*** 3.21±0.27*** 
Chopped 60m 0.78±0.07*** 0.41±0.04*** 0.49±0.06*** 0.10±0.01*** 0.20±0.02 0.19±0.02*** 0.42±0.10** 0.13±0.02*** 0.09±0.01*** 2.80±0.23** 
Chopped 120m 0.72±0.14*** 0.38±0.11*** 0.49±0.14*** 0.06±0.03*** 0.11±0.08** 0.34±0.17*** 0.26±0.09*** 0.11±0.02*** 0.08±0.03*** 2.56±0.22*** 
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Carotenoid content 
In contrast to the previous assays, boiling of watercress resulted in an increased 
concentration of total measurable carotenoids, from 2.35 ± 0.22 mg g-1 DW in the fresh 
samples to 3.13 ± 0.20 mg g-1 DW after 2 minutes of cooking and up to 3.28 ± 0.30 mg g-1 
DW after 5 minutes of boiling (Table 5.2). Microwaving and steaming did not have a 
significant impact on the level of total carotenoids (P>0.05). On the other hand, the 
watercress smoothie had significantly lower total carotenoid content, with the levels 
decreasing from 1.54 ± 0.21 to 1.11± 0.08 mg g-1 DW after 60 minutes of storage at 
ambient temperature. A similar decreasing trend was observed in the chopped watercress 
samples. 
The individual carotenoids identified and quantified in our watercress samples 
were β-carotene, lutein and zeaxanthin and they all resulted in distinct responses upon 
domestic processing.  β-carotene was the most abundant of the three quantified 
carotenoids (0.95 ± 0.08 mg g-1 DW) and its levels significantly increased after thermal 
treatment of the watercress samples. Boiling for 5 minutes resulted in β-carotene being 
significantly increased up to 1.75 ± 0.09 mg g-1 DW as compared to the raw samples 
(P<0.001). In the microwaved watercress samples β-carotene was increased up to 1.48 ± 
0.26 mg g-1 DW (P<0.01) and in the samples steamed for 15 minutes levels went up to 1.54 
± 0.07 mg g-1 DW (P<0.001). β-carotene was decreased in the watercress smoothie only 
after storage for 30 and 60 and 120 minutes (P<0.01) therefore, immediate consumption 
of a watercress smoothie ensures sufficient intake of β-carotene. No significant differences 
were found in the chopped samples.  
Lutein content of fresh watercress samples was 0.24 ± 0.02 mg g-1 DW and it 
exhibited the highest degree of stability after watercress processing. It was significantly 
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increased only after 5 minutes of boiling going up to 0.36 ± 0.02 mg g-1 DW  (P<0.05). 
Significant decreases in lutein were only observed in the smoothie after 120 minutes of 
storage (P<0.05). Zeaxanthin concentration in fresh watercress was notably lower than β-
carotene and lutein (0.02 ± 0.00 mg g-1 DW). It was dramatically affected by boiling with 
increases higher than 6 and 3 times, as compared to fresh watercress, after boiling for 5 
minutes and steaming for 10 minutes respectively.   
Increases in the carotenoid contents of other Brassica vegetables such as broccoli, 
Brussels sprouts, cabbage and cauliflower upon boiling and steaming have been reported 
by a number of research groups [76, 213, 220]. Elevations in the measurable carotenoid 
concentrations after thermal treatments can be explained by changes in the plant cell wall 
due to the breakdown of cellulose as well as improved extractability of carotenoids from 
the plant as a result of the denaturation of carotenoid-protein complexes due to thermal 
processing [221].  
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Table 6.2 Quantification of total and specific carotenoids, in raw and processed watercress 
samples. Data is presented as absolute carotenoid concentration in mg g-1 of DW (mean ± 
SD). Experiment was performed with three biological replicates per group. Significance:  *, 
P < 0.05; **, P < 0.01; ***P < 0.001 as compared to carotenoid content of raw watercress. a 
Total amount of carotenoids measured spectrophotometrically. 
 
β-carotene Lutein Zeaxanthin Total a 
 mg g-1 DW 
Raw 0.95±0.08 0.24±0.02 0.02±0.00 2.35±0.22 
     Boiled 2m 1.42±0.27** 0.30±0.06 0.09±0.03*** 3.13±0.20** 
Boiled 5M 1.75±0.09*** 0.36±0.02* 0.13±0.01*** 3.28±0.30*** 
Boiled 10m 1.29±0.20 0.24±0.05 0.10±0.03*** 3.00±0.17* 
     MW 1m 1.47±0.26** 0.32±0.04 0.04±0.01 2.53±0.15 
MW 2m 1.19±0.09 0.28±0.04 0.04±0.01 2.57±0.13 
MW 3m 1.48±0.26** 0.26±0.06 0.05±0.00 2.65±0.33 
     Steamed 5m 1.34±0.10* 0.26±0.02 0.05±0.01 2.33±0.23 
Steamed 10m 1.45±0.10** 0.18±0.03 0.06±0.01* 2.27±0.12 
Steamed 15m 1.54±0.07*** 0.17±0.10 0.05±0.01 2.31±0.47 
     Smoothie 0m 0.61±0.15 0.24±0.02 0.02±0.01 1.54±0.21** 
Smoothie 30m 0.39±0.01** 0.18±0.05 0.03±0.01 1.14±0.17*** 
Smoothie 60m 0.36±0.14*** 0.16±0.05 0.02±0.00 1.11±0.08*** 
Smoothie 120m 0.31±0.28*** 0.11±0.09* 0.01±0.01 1.57±0.36** 
     Chopped 0m 0.81±0.05 0.23±0.04 0.02±0.02 1.94±0.23 
Chopped 30m 0.62±0.23 0.17±0.08 0.02±0.01 1.65±0.15* 
Chopped 60m 0.71±0.11 0.22±0.01 0.03±0.01 1.57±0.25** 
Chopped 120m 0.67±0.10 0.18±0.02 0.02±0.01 1.79±0.17 
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6.3.3 Glucosinolate identification and quantification 
Gluconasturtiin was the most abundant glucosinolate in fresh and cooked watercress 
samples followed by the indole glucosinolates: glucobrassicin, 4-methoxyglucobrassicin, 
4-hydroxyglucobrassicin and the aliphatic glucosinolate glucoibarin (Table 5.3). The profile 
characterised here is similar to that previously defined by Boyd, McCann [53], Gill, Haldar 
[57]. 
Glucosinolate quantification revealed a major impact of cooking on the levels of 
these phytochemicals. Boiling reduced the levels of total glucosinolates by up to 63% and 
led to significant loses of all the individual glucosinolates identified in this study (P<0.001).  
Considerable glucosinolate losses after boiling of Brassica vegetables like broccoli, 
cauliflower and Brussels sprouts, have also been observed in other studies performed by a 
number of research groups [222, 223]. Heat application combined with cooking in water 
can result in depletion of glucosinolates in Brassica as a result of enzyme activity 
modification and thermally induced breakdown processes [205, 224]. Boiling of watercress 
in water caused significant loss of glucosinolates that most likely have leached into the 
cooking water. Similar conclusions were drawn by Song and Thornalley [222] who showed 
that boiling of Brassica vegetables leads to significant leaching of glucosinolates in the 
boiling water. Jones [224] have shown that the glucosinolate losses in Brassica vegetables 
are positively correlated with the cooking time.  
Microwaving and steaming had a subtle effect on glucosinolate concentrations 
with minor losses at the longest cooking duration, as compared to the other treatments. 
Microwaving and steaming for 2 or 5 minutes did not result in major losses of total 
glucosinolates suggesting that these cooking methods will ensure a higher retention rate 
of these phytochemicals. Our results are in agreement with that of Song and Thornalley 
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[222] who examined the impact of different cooking methods on broccoli, brussels 
sprouts, cauliflower and green cabbage. This observation is likely due to denaturation and 
subsequent deactivation of the myrosinase enzyme, which depletes glucosinolates in 
favour of their hydrolysis to isothiocyanates, after application of high temperatures during 
cooking [225].  We found that cooking by steaming resulted in a slight increase in 
gluconasturtiin concentrations from 1.76 to 2.04 mg g-1 DW (P<0.05) and it can therefore 
be considered as the preferred method of watercress consumption to maximise 
gluconasturtiin levels. Elevated gluconasturtiin concentrations upon steaming are also 
reported by Gliszczynska-Swiglo, Ciska [213] in broccoli. Increases in other glucosinolates 
in Brassica vegetables subjected to steaming have been also been noted in a number of 
studies [223, 226]. The inactivation of myrosinase at the high temperatures such as the 
ones reached during steaming, can temporarily cease the conversion of glucosinolates to 
isothiocyanates [223] a process which can be undertaken post ingestion, in vivo,  by the 
action of the endogenous bacterial myrosinase in the gut [227].  Furthermore, heat 
application leads to plant cell structure disintegration allowing glucosinolates to be 
released from their bound forms on the plant cell wall making these compounds more 
recoverable during extraction [213]. Steaming is performed without direct contact of the 
plant material and water, preventing the leaching of glucosinolates into it.  
Homogenisation by blending watercress with water to create a smoothie resulted 
in dramatic reductions in glucosinolates stemming mainly from the complete loss of 
gluconasturtiin (P<0.001). Upon chopping losses ranged from 35% to 46% after 120 
minutes of storage at room temperature. Chopping of vegetables before consumption is a 
regular practise and this can lead to decreased glucosinolate content since they are 
exposed to myrosinase for conversion to isothiocyanates. This was reflected in our results 
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and those of others [222, 228], and it was particularly apparent in the gluconasturtiin 
quantification. When watercress was homogenised to create a smoothie, gluconasturtiin 
was completely lost and the levels of other glucosinolates were significantly diminished.  
Our results are comparable with results from a study performed by Smith, Mithen [228] 
where homogenisation for juice extraction from Brussels sprouts led to loss of 
glucosinolates which were converted to isothiocyanates and other breakdown products 
due to the exposure of glucosinolates to myrosinase enzyme. Song and Thornalley [222] 
observed that shredding of Brassica vegetables and subsequent storage at ambient 
temperature results in major losses of glucosinolates with concurrent formation of 
isothiocyanates. Isothiocyanates such as PEITC are highly volatile compounds therefore 
they are prone to evaporation as observed by Rose, Faulkner [58] who did not detect 
PEITC in watercress aqueous extracts. However, Ji, Kuo [229] noted that PEITC remains 
stable in aqueous buffers with a half-life of 56 h at ambient temperature. This suggests 
that smoothies or juices made from watercress, which is rich in PEITC, should be freshly 
consumed after preparation to ensure adequate ingestion.   
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Table 6.3 Concentration of individual and average total glucosinolates in raw and 
processed watercress samples. Data is presented in mg g-1 of DW (mean ± SD). Experiment 
was performed with three biological replicates per group. Significance: *, P < 0.05; **, P < 














 mg g-1 DW 
Raw 1.76±0.07 0.47±0.04 0.22±0.01 0.26±0.01 0.08±0.00 2.79±0.09 
 
      
Boiled 2m 1.02±0.05*** 0.18±0.02*** 0.08±0.01*** 0.09±0.01*** 0.06±0.00 1.44±0.06*** 
Boiled 5M 0.81±0.09*** 0.13±0.02*** 0.07±0.01*** 0.08±0.01*** 0.06±0.00 1.16±0.11*** 
Boiled 10m 0.71±0.06*** 0.10±0.00*** 0.08±0.01*** 0.08±0.00*** 0.06±0.00 1.03±0.07*** 
  
      
MW 1m 1.97±0.22 0.41±0.06 0.18±0.04 0.18±0.06** 0.05±0.04 2.78±0.40 
MW 2m 1.59±0.19 0.32±0.07 0.17±0.00 0.16±0.01** 0.06±0.00 2.30±0.22** 
MW 3m 1.57±0.09 0.38±0.04 0.12±0.03** 0.15±0.02** ND 2.22±0.17** 
  
      
Steamed 5m 2.04±0.09* 0.35±0.01** 0.18±0.04 0.14±0.03** 0.06±0.00 2.77±0.06 
Steamed 10m 1.98±0.06 0.35±0.02** 0.19±0.01 0.17±0.01** ND 2.69±0.08 
Steamed 15m 1.61±0.31  0.30±0.05*** 0.10±0.03*** 0.12±0.02*** ND 2.13±0.34* 
  
      
Smoothie 0m ND 0.27±0.05*** 0.03±0.05*** 0.04±0.05*** ND 0.34±0.11*** 
Smoothie 30m ND 0.30±0.01*** ND ND ND 0.30±0.01*** 
Smoothie 60m ND 0.28±0.04*** ND ND ND 0.28±0.04*** 
Smoothie 120m ND 0.29±0.01*** ND ND 0.02±0.04* 0.31±0.01*** 
  
      
Chopped 0m 1.06±0.09** 0.52±0.05 0.11±0.03** 0.11±0.01*** ND 1.80±0.06** 
Chopped 30m 1.16±0.05** 0.39±0.04 0.10±0.02* 0.10±0.00*** ND 1.75±0.02*** 
Chopped 60m 1.03±0.06** 0.39±0.05 0.10±0.02* 0.10±0.00*** ND 1.62±0.11*** 
Chopped 120m 1.01±0.06** 0.34±0.06** 0.08±0.01*** 0.08±0.01*** 0.01±0.02* 1.52±0.14** 
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6.3.4 Antioxidant activity 
The antioxidant activity of all watercress samples was determined using the FRAP assay 
(Figure 1B). Fresh watercress had an antioxidant activity of 74.54 ± 10.81 μmol AAE g-1 DW. 
Watercress was found to have the highest antioxidant activity when compared to spinach, 
rocket and mizuna [204, 230].  
Boiling dramatically decreased the antioxidant capacity of watercress over time as 
compared to raw watercress, with losses reaching 67% of total antioxidant activity for 
samples cooked for 10 minutes (Fig. 5.1B). Antioxidant activity analysis of the cooking 
water showed that the losses observed during boiling are due to leaching of antioxidant 
compounds in the water (46,03 ± 9.42 μmol AAE g-1 DW). In contrast, microwaving and 
steaming of watercress did not result in any significant losses. Chopping and blending to 
smoothie had no significant impact on the antioxidant activity of the samples, however 
storage of these samples at room temperature for 30 or 120 minutes resulted in a 
significant decrease in antioxidant activity. Chopping and blending to smoothie reduced 
the antioxidant activity to 42.84 ± 8.00 and 48.47 ± 9.63 μmol AAE g-1 DW at 120 minutes 
of storage respectively. The antioxidant activity of raw and cooked samples followed a 
similar trend to that found for total phenols with a significant correlation between these 
measures (R2 = 0.759, P<0.05). 
In a study carried out by Ismail, Marjan [231] it was found that boiling for 1 minute 
significantly decreased the antioxidant activity of kale, but not that of cabbage. Zhang and 
Hamauzu Zhang and Hamauzu [215] showed that after boiling and microwaving, broccoli 
lost 65% and 65.3% of its total antioxidant activity respectively.  
Since the antioxidant activity of plants may be defined by the concentration of phenols 
and ascorbic acid in combination with other phytochemicals, leaching of these 
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compounds into the boiling water, or oxidation and degradation of them during cooking, 
can lead to lower antioxidant activity of watercress [213, 219].  
6.3.5 Watercress phytochemical profile modifications upon cooking 
PCA revealed distinct phytochemical profiles for watercress cooked using different 
regimes (Fig. 5.2). The profiles obtained from microwaved and steamed watercress closely 
resembled that of fresh watercress with these cooking methodologies positively 
correlating with the phenolics, carotenoids and glucosinolate concentrations. In stark 
contrast, boiled watercress has a phytochemical profile very different from that of fresh 
watercress characterised by elevated carotenoid amounts (R2= 0.668) and significant 
losses in glucosinolates and flavonols, which essentially result in compromised antioxidant 
activity (R2= -0.596).  Chopped watercress and watercress smoothie samples have similar 
phytochemical profiles and separate from the fresh samples on the first principal 
component characterised by losses of all the phytochemicals quantified in our study. 
Cooking time appears to be negatively correlated with microwaving, boiling and steaming 
but exposure of chopped samples and watercress smoothie to ambient temperature for 
extended time periods does not appear to have a particular impact on the measureable 
phytochemicals in these samples, expect in the total phenolic content of stored chopped 
watercress. Antioxidant activity as measured by the FRAP assay, exhibits a significant 
positive correlation with microwaving (R2= 0.452) driven by higher concentrations of 
glucosinolates and flavonols suggesting that it should be the preferred method of 
watercress preparation when it is not consumed raw. 
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Figure 6.2 PCA scores of all cooked samples (☐) and loadings plot for all quantified 
phytochemicals (O). Abbreviations: 4-MGB, 4-methoxyglucobrassicin; 4-HGB, 4-
hydroxyglucobrassicin; KSG, K 3-(sinp-Glc)-4’Glc; KSTG, K 3-(sinp-triGlc)-7-Glc; QDGCG, 
QCSG, Q 3-(caf-Glc)-3'-(sinp-Glc)-4'-Glc; KDG, K 3-diGlc-7-Glc; IG, I 3-Glc; KFTG, K 3-(fer-














































This study clearly demonstrates that health-promoting compounds in watercress are 
significantly influenced by domestic processing methods. Cooking by microwaving and 
steaming preserves the levels of most phytochemicals in watercress. Domestic processing 
can have a detrimental effect on the bioactives, which may be responsible for the health 
promoting properties of watercress. Satisfactory retention of beneficial phytochemicals in 
watercress may be achieved by avoiding boiling which results in a compromised 




6 Plasma and urinary metabonomic responses to watercress 
intervention in breast cancer - A pilot study 
 
Hypothesis 
It is hypothesised that watercress consumption during radiotherapy treatment can help in 
limit radiation induced damage in healthy cells, whilst potentially enhancing the response 
of breast cancer patients to the treatment 
 
Aim  
• To explore the ability of watercress intake to modulate the metabolism of breast 
cancer patients undergoing radiotherapy 
Objectives 
• 1H NMR metabonomic profiling of plasma and urine samples will be used to 
identify biochemical differences between breast cancer patients consuming 
watercress throughout the duration of radiotherapy and breast cancer patients 




RT works by significantly increasing ROS formation, damaging the DNA of the 
targeted cancer tissue. It aims in the cease of cancer cell proliferation and ultimately 
cancer cell death. Non-cancerous cells, including blood cells, are unavoidably affected in 
the course of radiotherapy treatment. Side effects include skin reactions, nausea, anorexia 
and generalised pain are extremely common among patients receiving radiotherapy [14]. 
More severe side effects include hyperpigmentation, skin fibrosis and potential influence 
on lung and heart tissues. [15, 21]. The need for radio-protective agents is of paramount 
importance for oncologists especially in cases of radio-resistant tumours where higher 
doses of radiation have to be administered to the patient.  
Of note, the role of nutrition intervention in medium and long-term outcomes in 
cancer has been demonstrated. It is today acknowledged as grade A evidence that 
individualised nutritional counselling and education plays a central role in improving 
long-term outcomes in cancer, by prolonging survival, reducing late radiotherapy toxicity 
and improving quality of life [232, 233]. The present pilot clinical trial of nutritional 
supplementation in cancer, intends to further explore the effects of therapeutic diets 
supplemented with phytonutrients via watercress that may prove useful in global disease 
prognosis.  
Building upon the in vitro data (previously described in Chapter 3 and 4) 
supporting a role of watercress and its components -particularly PEITC- against various 
steps in carcinogenesis, a human intervention study was conducted to explore the 
potential of watercress to reduce DNA damage levels. A randomised crossover study was 
carried out by Gill et al. in 60 healthy volunteers that were instructed to consume one pack 
(85g) of raw watercress daily for 8 weeks [57]. Compared to the control phase, watercress 
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supplementation increased lymphocyte DNA resistance to free radicals, thus reducing 
DNA damage. The hypothesis set out was that watercress might reduce cancer risk via 
decreased damage to DNA and possible effects on antioxidant status by increasing levels 
of plasma carotenoids. Additional evidence was obtained from a study performed by 
Fogarty et al. where acute and chronic watercress attenuated DNA damage and lipid 
peroxidation and decreased H2O2 accumulation following exhaustive exercise [52].  
Watercress is the richest dietary source of PEITC, to which a number of anti-cancer 
properties are attributed. A recognised mechanism by which PEITC inhibits the growth 
and survival of established cancer cells is through the inhibition of angiogenesis [61]. Alwi 
et al. performed a study in twelve healthy women who had previously been treated for 
breast cancer, where dietary intake of 80 g watercress significantly reduced hypoxia-
inducible factor (HIF) signalling activity in peripheral blood cells. HIF is a major positive 
regulator of angiogenesis and its inhibition by watercress consumption suggests that diet-
derived PEITC may be sufficient to modulate angiogenesis [107]. These findings are 
justifiably interesting for potential cancer prevention by watercress.  
Metabolic profiling of bio-fluids obtained from cancer patients undergoing RT can 
provide important information on treatment efficacy and disease prognosis. However, RT-
specific metabolic biomarkers can be difficult to obtain since they are naturally 
confounded by cancer-specific biomarkers. Limited data from human studies are available 
regarding prognostic and predictive metabolic biomarkers in RT. In a recent study, 
metabolomic profiling of urine samples obtained from cancer patients undergoing whole-
body RT before receiving hematopoietic stem-cell transplantation, revealed seven 
metabolic markers differing between pre and post radiation (octanoylcarnitine, 
hypoxanthine, xanthine, trimethyl-lysine, acetyl-carnitine, decanoylcarnitine and uric 
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acid). The metabolites identified were directly related to RT targets such as mitochondria-
related lipid damage and β-oxidation perturbations (carnitines and trimethyllysine), 
oxidative stress and radiation-induced DNA damage (purine catabolism: xanthine, 
hypoxanthine and uric acid) [234].  
In this thesis, Chapter 3 has provided in vitro data on the potential of watercress 
extract and PEITC to interact with the metabolome of breast cancer and healthy cells, 
influencing phospholipid metabolism as well as modulating the antioxidant status of 
these cells. These observations were accompanied by mitochondrial damage, cell cycle 
arrest and DNA damage. Subsequently, in Chapter 4 it was shown that through its ability 
to deplete glutathione, PEITC sensitises breast cancer cells to radiation induced damage 
whereas the watercress extract appeared protect healthy cells from IR toxicity by 
influencing intracellular levels of glutathione. To validate these observations in vivo, the 
present study seeks to investigate and analyse the ability of watercress to act as a 
nutritional adjuvant intervention during radiotherapy treatment, in that it can potentially 
alleviate radiotherapy derived systemic side effects and improve the treatment outcomes 




6.2 Materials and Methods  
6.4.1 Subjects 
The study was conducted in 47 female volunteers aged between 40-71 years old. All 
subjects were early-stage breast cancer patients referred for radiotherapy with curative 
intent at the University Hospital of Santa Maria (Lisbon, Portugal). Exclusion criteria were 
pregnancy, cognitive impairment, and patients carrying implantable electronic devices 
(e.g. pacemaker). Information regarding family history of was collected from all 
participants in the study. Ethical review and approval was provided by the ethics 
committee of both the Lisbon University Hospital and the Faculty of Medicine of the 
University of Lisbon. The clinical trial was registered at http://clinicaltrials.gov 
(NCT02468882).  
6.4.2 Study design 
The study was designed as a non-blinded, prospective randomised controlled trial. The 
volunteers were assigned to either the control or the intervention group. The control 
group received standard care, maintaining their ad libitum diet. The intervention group 
was asked to consume 100 g of watercress per day alongside their habitual diet from the 
onset and for the total duration of the radiotherapy treatment. Breast cancer patients 
participating in the study were prescribed 60-70 Gy of radiotherapy treatment with 
fractionated delivery over a 6-7 week period.  
 Patients received detailed recommendations on how to consume watercress with 
suggestions for preparation including watercress eaten fresh as a salad, or gently cooked 
by steaming or microwaving or stirred into hot food before serving. These suggestions 
were given to the volunteers on the basis of the results obtained in Chapter 5. 
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 Spot urine and blood samples were obtained at baseline and at the end of the RT 
treatment. Blood samples were collected in heparin containing tubes and centrifuged at 
12,000 g for 10 min. Plasma aliquots and urine samples were stored at -80 °C until 
analysed.  
6.4.3 Statistical analysis 
Statistical analysis of clinical characteristics was carried out using GraphPad Prism version 
5.0a for Mac OS X,GraphPad software (Version 5.0a La Jolla, California, USA). P-values were 
calculated by unpaired t-test with Welch’s correction for continues variables and by chi-
squared test for categorical variables. 
6.4.4 1H NMR spectroscopy and data processing 
Metabonomic profiling was performed on all urine samples. A 400 μl aliquot was added to 
200 μl of phosphate buffer (pH 7.4, 100% D2O, 0.2M Na2HPO4/NaH2PO4) containing 1mM of 
the internal standard, 3-(trimethylsilyl)-[2,2,3,3,-2H4]-propionic acid (TSP) and 2mM sodium 
azide (NaN3) as a bacteriocide. Samples were vortexed and spun at 13,000 g for 10 min and 
550μl of the supernatant were transferred into 5mm NMR tubes. Spectroscopic analysis 
was performed on a 600 MHz Bruker AvanceTM NMR spectrometer at 300K using a Bruker 
TXI probe (Bruker Biospin, Rheinstetten, Germany). 1H NMR spectra of the urine samples 
were acquired using a standard one-dimensional pulse sequence [recycle delay (RD) -90°-
t1–90°-tm-90°-acquire free induction decay (FID)]. The water signal was suppressed during 
the RD of 4 s with a mixing time of (tm) 100 ms, t1 was 11.25 μs. For each spectrum, 32 scans 
were obtained into 64K data points using a spectral width of 12.001 ppm. 
Aliquots of 200 μl plasma were combined with 400 μl of saline buffer (100% D2O, 
0.9% NaCl). The samples were mixed by vortexing and were then centrifuged at 13,000 g 
for 10 min and 550 μl of the resulting supernatant were transferred to 5 mm NMR tubes. 1H 
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NMR spectra were acquired on a 600 MHz Bruker AvanceTM NMR spectrometer at 300K 
using a Bruker TXI probe (Bruker Biospin, Rheinstetten, Germany) in a random order. 
Spectra were acquired using a one-dimensional technique using a standard pulse 
sequence with water pre-saturation and Carr-Purcell-Meiboom-Gill (CPMG) spin echo 
sequences to minimise the broader peaks occurring from lipids and proteins 
The acquired NMR spectra were manually phased, corrected for baseline distortions 
and referenced to TSP for urine samples or glucose resonance (α anomeric proton) (δ 5.23) 
for plasma samples (TopSpin 3.0, Bruker, Rheinstetten, Germany) and then imported into 
MatLab (version R2012a, The Mathworks, Inc.; Natwick, MA). The region containing the 
water peak was removed as well as the TSP peak region. The urea resonance region was 
also removed from the urinary spectra. 1H NMR spectra were then aligned manually using 
a recursive segment-wise peak method (RSPA) algorithm to minimise chemical shift 
variation due to residual pH differences within samples. Urine spectra were then 
normalised to unit area to account for inter-sample concentration variation.  
MatLab was used for multivariate modelling. Analysis included principal component 
analysis (PCA) using pareto scaled data to observe clustering in the datasets and identify 
outliers. Orthogonal projection to latent structures (OPLS) models were constructed using 
unit variance scaling to maximise any differences between the groups and to identify 
metabolites driving any potential differences between them. Metabolites were identified 





Clinical information was obtained from the participants in each group. Statistical analysis 
for the comparison of the clinical characteristics between the control and intervention 
group are presented in Table 1. Significant differences with age, BMI and blood pressure 
were observed between the two groups at baseline.  
Table 6.1 Baseline clinical characteristics (mean ± SD) 
 Control (n=25) Watercress (n=22) P value 
Age (y) 58 ± 9 54 ± 8 0.047 
BMI (kg/m2) 30.78 ± 6.96 27.27 ± 4.57 0.044 
High blood pressure* 15 4 0.003 
Smoker 1 4 0.178 
Diabetes Mellitus 2 1 1.000 
Oestrogen receptor (-) 3 1 0.612 
Progesterone receptor (-) 4 0 0.112 
Family History –Breast cancer 6 6 1.000 
Family History – Other cancers 13 16 0.223 
*Numerical data not available for blood pressure. Data was collected in a binomial form 
 
6.4.5 Plasma metabonomic profiling 
Metabolic profiles were measured from the plasma and urine samples of participants in 
the control and watercress intervention groups. Principal component analysis (PCA) was 
applied to these profiles to reveal sources of variation within the metabolic data.  
The PCA scores plot obtained from the model built on all the baseline plasma profiles 
revealed separation in the first principal component by treatment group (control or 
watercress-treatment; PC1 R2 = 44%; Fig. 6.1A). This indicates that before watercress 
consumption occurred the participants in this group were metabolically different from 
those in the control group. The loadings plot for PC1 from this model (Fig. 6.1B) shows 
that increased levels of VLDL in the control group and higher glycerol content in the 
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watercress intervention group explained the variation. The PCA model built on the plasma 
profiles at the end of RT returned similar results (Fig. 6.2). Inclusion of all four experimental 
groups in one PCA model (control baseline and end of RT, watercress baseline and end of 
RT) showed that plasma metabolic profiles differed between the two treatment groups 
along PC1 but there was not observable clustering by RT (baseline vs. RT) (Fig. 6.3) These 
results suggest that the differences between the two groups are most likely to arise from 
the differences in their baseline clinical characteristics.  
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Figure 6.1 (A) PCA scores plot obtained from the plasma metabolic profiles of control and 
watercress consuming patients at baseline (B) PCA loadings plot for PC1. 
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Figure 6.2 (A) PCA scores plot obtained from the plasma metabolic profiles of control and 






Figure 6.3 PCA scores plot comparing the plasma metabolic profiles of patients in the 
control group and those whose diet was supplemented with watercress (WX) at baseline 
and at the end of the radiotherapy treatment (RT). Profiles observed to cluster by 
treatment group.  
Pairwise comparisons were performed between the treatment groups (control 
versus watercress) before and after RT using OPLS-DA models (Fig. 6.4). OPLS-DA models 
with good predictive ability were obtained comparing the two groups at baseline (Q2Ŷ = 
0.18; p = 0.0110) and at the end of RT (Q2Ŷ = 0.26; p=0.0002). The metabolic variation 
between the control and watercress treated patients was found to be greater high-density 
lipoproteins (HDL) in the plasma from watercress treated-patients and higher VLDL in the 
control patients. These differences were present both at baseline (before watercress 
consumption) and after radiotherapy indicating that watercress intake was not driving 
these differences.  
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Figure 6.4 OPLS-DA models comparing the plasma metabolic profiles of control and 
watercress intervention groups at baseline (Q2Ŷ = 0.18; p = 0.0110) (A) and at the end of RT 
(Q2Ŷ = 0.26; p=0.0002). (B).  
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6.4.6 Urinary metabolic profiles 
The PCA scores plot comparing all the urinary metabolic phenotypes from the study did 
not reveal any clustering in the dataset (Fig. 6.5A). The variance in the first component of 
this model was dominated by creatinine and hippurate (Fig. 6.5B) and trimethylamine-N-
oxide exerted the greatest influence on the second principal component (Fig. 6.5C). The 
OPLS-DA model constructed to compare the the two groups at baseline was not valid (Q2Ŷ 
= -0.29, p = 0.89). 
PCA analysis of the urinary metabolic profiles at the end of RT revealed clustering along 
the second principal component by treatment group (Fig. 6.6A). This component 
explained 12 % of the metabolic variation within the dataset. The biochemical signature of 
watercress consumption is characterised by higher excretion of hippurate (Fig. 6.6C). An 
OPLS-DA model was constructed to compare the urinary profiles of control volunteers and 
those consuming watercress post IR. This model identified significant metabolic variation 
between the two groups (Q2Ŷ = 0.2010, p = 0.01). Watercress consumption during RT 




Figure 6.5 (A) PCA scores plot obtained from the urine metabolic profiles of control and 
watercress consuming patients at baseline. PCA loadings plot for PC1 (B) and PC2 (C). 
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Figure 6.6 (A) PCA scores plot obtained from the urine metabolic profiles of control and 




Figure 6.7 OPLS-DA model comparing the urine metabolic profiles of control and 
watercress intervention groups at the end of RT.  
 
Table 6.2 Summary of the OPLS-DA models returned for the comparisons between the 
two treatment groups at baseline and at the end of RT.  
Group Comparison 
Plasma Urine 
Q2Y P value Q2Y P value 
Control Baseline vs WX Baseline 0.18 0.01 -0.29 0.89 
Control End RT vs WX End RT 0.26 0.0002 0.20 0.01 
Control Baseline vs Control End RT -0.17 0.53 -0.20 0.59 




This prospective pilot clinical trial investigated the impact of watercress consumption on 
the response of early stage breast cancer patients to RT. 1H NMR spectroscopy was 
employed to characterise the urinary and plasma metabolic profiles of breast cancer 
patients consuming 100 g/day of watercress (watercress group) and those with no 
watercress consumption (control group) before and after RT. Multivariate data analysis 
identified baseline metabolic variation between the participants assigned to the two 
treatment groups. Those in the control group had higher amounts of circulating VLDL 
whilst those in the watercress group had higher amounts of HDL cholesterol. These 
differences remained after watercress consumption and RT. VLDL carries fat from the liver 
to other parts of the body via the blood and is raised with a high-fat diet. In contrast, HDL 
collects excess cholesterol in the blood and returns it to the liver where it is broken down 
and removed. Hence, these lipoproteins can be associated with dietary intake and 
metabolic health. A significant difference in the BMI values of the two treatment groups 
was found with the control group having an average BMI of 30.78 kg/m2 at baseline 
classifying them as ‘moderately obese’. The watercress intervention group had a BMI of 
27.27 kg/m2, classified as overweight. BMI values remained significantly different at the 
end of the radiotherapy treatment. As a result of this major confounding factor 
comparisons between the two groups must be treated with considerable caution. These 
features also suggest that the watercress intervention group was likely already conscious 
about a healthy lifestyle of which a diet rich in fruits and vegetables is an essential 
element. Following breast cancer diagnosis, these women might have modified their usual 
habits towards a healthier well-being. As a result, any observations made here cannot 
necessarily be attributed to watercress. 
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Hippurate was found in higher concentrations in the urine of the watercress-
consuming group at the end of RT. This is a gut microbial-mammalian co-metabolite and it 
is formed in the liver from the conjugation of dietary or microbially derived benzoic acid 
with glycine [235]. Watercress is a rich dietary source of phytochemicals including 
polyphenolic compounds. Metabolism of phenolic compounds such as chlorogenic acid, 
quinic acid and cinnamic acid results in a range of aromatic compounds like 
phenylpropionate, which can be further metabolised to benzoic acid and essentially, 
increase the amount of urinary hippurate [236]. In studies examining the metabolism and 
absorption of such polyphenols, hippurate was identified as the predominant urinary 
metabolite [237-240]. Further to this, a study comparing the urinary profiles from 
participants consuming either a low phytochemical diet without fruits and vegetables or a 
standard phytochemical diet, showed that the standard phytochemical diet was 
associated with increased hippurate excretion further substantiating the link between 
phytochemicals and hippurate [241].  
Hippurate perturbations might also be attributed to potential modulation of the 
gut microbiota by watercress. Germ free animals do not excrete hippurate demonstrating 
the importance of the gut microbial activity in the production of hippurate [242, 243]. 
Cruciferous vegetables have the potential to modify the gut bacterial composition [244] 
and since certain bacterial species have been linked to specific reactions during the 
metabolism of particular phytochemicals [245] this can result in changes in the microbially 
derived urinary metabolites like hippurate.  
It should be noted that hippurate can be considered as a potential biomarker of 
‘health’ and conditions like high blood pressure and obesity have been correlated with the 
lower excretion of hippurate [246-249]. It is certainly of great interest observing increased 
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hippurate upon watercress consumption, but this result has to be treated with caution 
considering the differences in the clinical characteristics of the two groups at baseline. 
Hippurate is known to be inversely related to BMI and blood pressure Further to this, no 
significant shifts in hippurate concentrations were observed when comparing pre and 
post radiotherapy urine samples therefore no link between this metabolite and radiation 
induced damage can be established. 
Urinary profiles of the cancer patients consuming watercress during their 
radiotherapy treatment exhibited an elevation in the excretion of NMNA (trigonelline). 
NMNA is a product of niacin metabolism and watercress is a good source if niacin and 
other vitamins of the B-complex. Other dietary sources of trigonelline are coffee as well as 
plants like fenugreek and garden peas. Trigonelline has been found to have anti-invasive 
activity against cancer cells in vitro and has also been shown to have beneficial anti-
diabetic actions. 
Several limitations in the study should be discussed. The small number of subjects 
in each group is likely to under-power the study, particular in a metabolic profiling study 
where the high number of variables increases the amount of inter-individual variability 
across the study. Also the sample size was too small for subgroup analyses and most 
importantly affected the randomisation efficacy for allocation of the volunteers in the 
treatment groups. Flawed randomisation resulted in significantly different baseline 
characteristics between the two groups, as discussed above, preventing us from drawing 
unbiased and meaningful conclusions from the analyses. Additionally, no direct 
therapeutic outcomes were recorded such as tumour size or patient survival that could be 
used as a measure of treatment and/or watercress efficacy.  
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In summary, this study provides some initial [236]indications that watercress could 
potentially induce metabolic perturbations in biomarkers of health in breast cancer 
patients possibly aiding in the management of RT induced DNA damage and subsequent 
side effects. Undoubtedly, further studies with larger intervention groups and better 
randomisation strategies are required to verify our observations and explore the possible 
mechanism for watercress’ anti-cancer effect.  
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7 Final discussion 
The framework for this thesis was developed from the work of Boyd et al. [53] that 
provided initial data on the direct anti-cancer effects of watercress in vitro as well as from 
two human trials [57] [52] that demonstrated the potential of watercress consumption to 
reduce DNA damage and increase antioxidant status in adults. As discussed in Chapter 1 
watercress and Brassica vegetables in general, have received great attention for their anti-
cancer properties. Most of the health properties attributed to Brassica are due to their high 
content of glucosinolate-derived bioactives ITCs, and more specifically, in the case of 
watercress, gluconasturtiin-derived PEITC. PEITC has been extensively shown to inhibit 
established hallmarks of cancer, supported by a great number of published in vitro and 
animal studies. The effects of watercress and PEITC on cellular energetics and metabolism, 
which represent essential processes in cancer progression, are largely unexplored. As 
such, the main aim of this thesis was to investigate the impact of watercress on breast 
cancer development as well as to examine how watercress interacts with cancer and 
radiotherapy and understand the different outcomes and biochemical mechanisms 
underlying this interaction. To address the knowledge gap regarding the lack of metabolic 
data, a substantial part of this thesis is dedicated to profiling the biochemical effects that 
watercress and PEITC can have in cancer, using 1H NMR metabonomics. 
In Chapter 3 the metabolic signature of breast cancer in vitro was defined by 
comparing the metabolic phenotypes of breast cancer and healthy cell lines. The profile 
obtained for the breast cancer cells was consistent with that of rapidly proliferating cells as 
indicated by the high amount of phosphocholine and glycolytic characteristics. The 
distinct metabolic perturbations induced by increasing doses of a watercress extract and 
PEITC were then examined and compared between the two cell lines. Untargeted 
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metabolic profiling enabled a vast range of metabolites to be screened allowing a broad 
overview of the metabolic state to be captured. Through this approach, watercress and 
PEITC were found to perturb a range of pathways and processes, such as oxidative 
phosphorylation, glycolysis, and one-carbon metabolism. This also provided further 
evidence supporting the major role of PEITC in the inhibition of mRNA translation in 
cancer models contributing to its chemopreventive and anti-cancer effects [250]. 
The results obtained from Chapter 3 confirmed PEITC as a GSH depleting agent. 
Interestingly, this effect was specific to the breast cancer cell line. Glutathione depletion 
by PEITC is the main mechanism through which excessive ROS are formed intracellularly 
leading to substantial DNA damage and eventually leading to cell death. On the basis of 
these results oxidative stress and the pro-oxidant phenotype induced by PEITC is 
hypothesised to increase the sensitivity of the cancer cells to radiation induced damage, 
which is ROS mediated. Indeed, this is supported by results in Chapter 4 where a 
concomitant increase in DNA damage and GSH depletion was observed in the cancer cell 
model treated with IR and PEITC. This highlights the radiosensitising potential of this 
compound.  
Watercress pre-treatment protected the healthy breast cells from radiation-
induced damage as observed by lower levels of DNA damage. This observation was 
parallel to an increased glutathione content in these cells. Higher abundance of GSH 
antioxidant is likely to rescue the cells from ROS-induced damage. Findings from human 
intervention studies with watercress have provided considerable evidence for a 
prophylactic effect of watercress under pro-oxidant conditions similar to radiotherapy, 
such as smoking [57] and exhaustive exercise [52]. These effects were explained by shifts 
in lipophilic compounds like carotenoids, of which watercress is a very rich source, and by 
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reducing the amount of DNA damage in lymphocytes. It should be noted though, that 
ITCs bioavailability or excretion was not measured in these studies, therefore it is unknown 
if any of the protective effects observed were mediated by these compounds. Further to 
this, the interaction between watercress and the glutathione related detoxification 
enzymes (GPX, GST) is inconclusive and depends highly on the individual’s genotype. The 
rescuing effect of watercress in the healthy breast cell observed here is unlikely to be a 
result of PEITC, since the watercress extract used is devoid of this compound. ITCs are 
highly volatile compounds and do not survive the extraction process. Therefore, we can 
speculate that the prophylactic effect of watercress in vitro is a result of other 
phytochemicals like carotenoids and polyphenols. Extensive phytochemical profiling of 
watercress performed in Chapter 5 further supported this observation.  
 While watercress did not appear to induce any genotoxicity (Chapter 3) in either of 
the two cell lines under study, PEITC at high doses caused significant DNA damage in both 
breast cancer and healthy cells. This observation generates further evidence for the 
hormetic properties of phytochemicals that is, being beneficial at low doses but leading to 
toxicity when ingested at high doses. It is unlikely though that these toxic exposures will 
be reached through the human diet. 
 Findings from Chapter 5 were used to formulate suggestions for participants in 
the human trial reported in Chapter 6 regarding the preferable ways of cooking 
watercress before consumption to preserve phytochemical density. Cooking of Brassica is 
known to inactivate the myrosinase enzyme, which is responsible for the conversion of 
glucosinolates to bioactive ITCs. However, bacteria in the gut possess myrosinase activity 
and present a potential means through which ITCs can arise in circulation and possibly 
mediate the health benefits of glucosinolates to the host. The degree to which this is 
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occurring is unclear and merits further investigation [251]. The significant role of the gut 
microbiome was also apparent from the increased urinary excretion of the hippurate, a 
gut-derived metabolite associated with the consumption of polyphenols and a general 
biomarker of health, in the group of volunteers consuming watercress. These observations 
highlight the importance of incorporating metagenomic and metabonomic data in the 
interpretation of clinical trials and epidemiological studies examining the anti-cancer 
potential of Brassica vegetables.  
 Results from in vitro (and animal) studies examining the impact of whole plant 
extracts or specific phytochemicals on health and disease can be highly informative. 
However, caution should be taken when interpreting these observations and drawing 
conclusions about the potential benefits they can confer to humans. Evidence derived 
from such studies regarding the mechanisms of action of phytochemicals in Brassica 
vegetables might not translate to the human. These studies ignore the role of the food 
matrix in the observed effects since they only use whole juice extracts from the plant 
under study. More work focusing on the processes of absorption, metabolism, and 
excretion upon watercress ingestion, has to be undertaken. Phytochemicals contained in 
watercress like glucosinolates and their hydrolysis products as well as flavonols, undergo 
complex modifications and conjugations when in the system. The form and quantity at 
which they reach the target site are poorly understood and they are affected by multi-
organ interactions, the gut microbiome and variations in individual’s genotype. Chapter 5 
has also highlighted the importance of preparation and cooking methods on the quality 




Study limitations and future perspectives 
The work described in this thesis, has addressed a number of research questions, while 
highlighting some opportunities for future research. Further work would advance our 
understanding regarding the molecular mechanisms of action of watercress and PEITC in 
cancer and provide further data on the relevance of watercress consumption during 
breast cancer therapy in vivo.  
 Breast cancer is a highly heterogeneous disease, with distinct molecular subtypes 
leading to differential responses to target therapies. The experiments in this thesis were 
carried out using MCF-7 breast cancer cells and MCF-10A healthy cells. MCF-10A cells are 
the most commonly used healthy breast cells and represent the best model for the study 
of normal human mammary epithelial function available to date. On the other hand, MCF-
7 cells represent only one molecular subtype of breast cancer. Consequently, further work 
should be carried out to examine whether the findings from the experiments carried out 
in this thesis are consistent with other in vitro models of breast cancer, which represent 
different degrees of sensitivity, endocrine responsiveness, metastatic potential and 
immunoprofile.  
 In Chapter 3 significant shifts in the levels of lactate were observed upon 
treatment with watercress and PEITC in both cells lines suggestive of disruptions in 
oxidative and glycolytic metabolism. Increased lactate is postulated to arise from a 
compromised ability for oxidative phosphorylation due to mitochondrial membrane 
damage and a switching of cells to glycolysis as a last resort for energy acquisition. As 
discussed previously glycolysis is a key pathway in cancer cell metabolism, therefore 
further work is recommended to elucidate the mechanism behind our observation. Real-
time rates of oxidative phosphorylation and glycolysis can be studied using Seahorse Cell 
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AnalysisTM, which provides functional cellular metabolic data. Furthermore, experiments 
using radiolabeled glucose isotopes to study glucose uptake and metabolism combined 
with glucose and lactate transporters expression data could provide a more mechanistic 
overview on the impact of watercress and PEITC on glucose cellular energetics.  
 In Chapter 4 a protective effect of watercress against radiation induced damage in 
healthy breast cells was observed parallel to a radiosensitising impact of PEITC in breast 
cancer cells. Cell cycle and Comet assay data supported these observations, however 
additional experiments are required to further explore these effects. Transcriptomics for 
the interrogation of DNA damage, apoptosis, as well as repair pathways would further our 
understanding of the chemoprotective effect of watercress and the genotoxic effect of 
PEITC. Information obtained from such an exploratory approach could be integrated with 
metabonomic data and provide a better picture of the interactions between genetic, 
metabolic and physiological shifts in an irradiation-perturbed system. 
 Despite obtaining encouraging results from the in vitro work performed; the results 
could not be validated in vivo (Chapter 6) therefore the relevance of our observations 
remains to be examined. This was a consequence of a flawed study design, characterised 
by low participant numbers, as well as an incorrect randomisation strategy and no record 
of treatment endpoints from the patients enrolled in the trial. A revised clinical trial 
investigating the impact of watercress consumption during radiotherapy should be 
performed.  It is recommended that the new study should be performed at a hospital with 
a high intake of breast cancer patients to allow for the recruitment of enough volunteers 
to adequately power the study. The study design should consist of four treatment groups: 
a) healthy individuals on their habitual diet, b) healthy individuals consuming watercress, 
c) breast cancer patients undergoing radiotherapy without consuming watercress and d) 
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breast cancer patients consuming watercress throughout their radiotherapy treatment. 
Collection of plasma and urine samples from volunteers in these groups would help draw 
meaningful conclusions on the metabolic fingerprint of breast cancer, radiotherapy and a 
nutritional intervention through watercress ingestion. Pre-screening of the participants 
prior to their participation in the clinical trial is of paramount importance to avoid the 
introduction of bias from differences in anthropometric and physiological factors. In 
addition, a proper randomisation method should be employed to ensure the acquisition 
of valid and interpretable results. Additionally, treatment endpoints such as radiotherapy 
efficacy as described by tumour size and histopathological measures, as well as cancer 
recurrence, should be recorder for all participants in the trial. This will allow for the 
correlation of metabonomic measures with cancer treatment outcomes and the 
generation of meaningful results.  
Concluding remark 
This thesis has provided evidence for the potential of watercress and PEITC to induce 
significant metabolic perturbations in breast cancer, a previously unexplored area. Novel 
preliminary evidence have been obtained, for the potential prophylactic impact of 
watercress during radiotherapy, through protecting healthy tissue from damage as well as 
enhancing the therapeutic outcomes of the treatment. The systemic impact of watercress 
against breast cancer should be further explored, for the generation of robust evidence in 
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Figure S1 OPLS-DA model comparing the metabolic response of MCF-7 and MCF-10A 
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